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Summary 
Nearly 7 million children die each year before the age of 5 despite the availability of effective 
low-cost interventions. Integrated Management of Childhood Illness (IMCI) guidelines have 
proven, when used correctly, to improve quality of care and reduce under-5 mortality. However, 
the actual impact of IMCI worldwide has been less than anticipated due to limited uptake of the 
intervention, and poor compliance to algorithms by clinicians. A recent study in Tanzania 
showed poor compliance to the IMCI protocols, resulting to low quality of care. Indeed 78% of 
the patients attending outpatient clinics with fever who tested negative for malaria were 
prescribed antibiotics although this was appropriate in less than 20% of the case. Such 
procedures lead to poor health outcomes, huge wastage of medicines and rapid spread of 
bacterial resistance. The rapidly changing patterns of disease, the rapid spread of resistance to 
antimicrobial drugs, the poor compliance to clinical guidelines using paper-based algorithms, 
and the increasing availability of new technologies that can improve both diagnoses accuracy 
and compliance to evidence-based clinical algorithms were the basis of this PhD thesis.  
The objectives of the thesis were:  
 To develop a new algorithm on paper and on electronic support for the management of 
childhood illness (based on a literature review, results of a fever study conducted in 
Tanzania and discussions with IMCI experts and which aims to improve clinical outcome 
and rational use of antimalarial and antibiotics. 
 To assess whether the new ALgorithm for MANAgement of CHildhood illness 
(ALMANACH), which was derived from IMCI and based on the new evidence about 
disease patterns and drug resistance algorithms, is as safe as routine practice (IMCI) 
and lead to a more appropriate use of antibiotics 
 To describe the distribution of acutely ill children in the various pathways of the new 
algorithm for the management of childhood illness in order to find out potential branches 
(symptoms and signs) that could be modified or dropped to facilitate its use, and hence 
uptake, but keeping it suitable to the epidemiology and burden of paediatric illnesses in 
outpatients departments of primary health care settings. 
 To assess potential barriers and facilitators for the uptake of the new algorithm on 
electronic support in pragmatic conditions in order to recommend ways for its 
sustainable use and optimal compliance by clinicians in primary health care settings.  
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Methods 
These four objectives were addressed in three different studies with the following designs and 
methodologies: 
(i) A structured literature review in Medline, Embase and the Cochrane Database for Systematic 
Reviews (CDSR) searching for available evidence on (a) disease prevalence in paediatric 
outpatients, (b) accuracy of clinical predictors and (c) performance of point of care tests on 
targeted diseases (Clotilde Rambaud-Althaus et al, submitted).   
(ii) A controlled non-inferiority trial to compare the clinical outcome and antibiotic prescriptions of 
children managed according to ALMANACH or to standard practice (IMCI). Consecutive 
children aged 2-59 months with acute illness were managed using ALMANACH (2 intervention 
facilities), or standard practice (2 control facilities) in Dar es Salaam and Morogoro in Tanzania 
(urban and rural settings). Children enrolled in the intervention arm were managed by two study 
clinicians (one for each setting) who were trained to strictly comply with the ALMANACH 
algorithm. Primary outcomes were proportion of children cured at day 7 and who received 
antibiotics on day 0.  
(iii) A descriptive analysis of the data collected in the intervention arm of the study described 
under ii). Outcomes were i) proportions of children presenting with danger signs, with main 
symptoms and signs, ii) proportions of children who were prescribed antimicrobials and iii)  
clinical outcomes.  
(iv) A qualitative study using in-depth interviews and focus group discussions among 40 primary 
health care workers from 6 public primary health facilities in the three municipalities of Dar es 
Salaam, Tanzania where the electronic clinical algorithm ALMANACH was used. Health 
workers’ perceptions related to factors facilitating or constraining the uptake of the electronic 
device were identified.  
 
Results 
i) Development of new algorithm for the Integrated Management of Childhood Illness to 
improve rational use of antimicrobials (ALMANACH) while maintaining health outcome 
(Clotilde Rambaud-Althaus et al, submitted). 
The new algorithm (ALMANACH) differs from IMCI 2008 version in the following aspects: 
(a) 10 general danger signs are assessed; (b) the non-severe children are classified in to febrile 
and non-febrile patients, the latter not being recommended to receive antibiotics; (c) pneumonia 
is based on a respiratory rate threshold of ≥ 50 breaths per minute that is assessed twice for 
children aged 12-59 months; (d) all febrile patients are tested with malaria rapid diagnostic test; 
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when no identified source of fever at the end of assessment, then (e) urine dipstick is performed 
in febrile children <2 years to identify urinary tract infection (UTI), f) abdominal tenderness is 
performed in febrile children >2 years to ‘classify possible typhoid’; (g) classification of likely 
viral infection is made in cases where nothing specific is found. 
 
ii) Clinical outcome and antibiotic prescriptions using ALMANACH 
130/842 (15·4%) in ALMANACH and 241/623 (38·7%) in control arm were diagnosed with an 
infection in need for antibiotics, while 3·8% and 9·6% had malaria. 815/838 (97·3%;96·1-98.4%) 
were cured at day 7 using ALMANACH versus 573/623 (92·0%;89·8-94·1%) using standard 
practice (p<0·001). Of 23 children not cured at day 7 using ALMANACH, 44% had skin 
problems, 30% pneumonia, 26% upper respiratory infection and 13% likely viral infection at day 
0. At day 0, antibiotics were prescribed to 15·4% (12·9-17·9%) using ALMANACH versus 84·3% 
(81·4-87·1%) using standard practice (p<0·001) corresponding to a reduction of 82%. 2·3% (1·3-
3.3%) and 3·2% (1·8-4·6%) respectively received an antibiotic secondarily. Secondary 
hospitalization occurred for one child using ALMANACH; one child died at day 4 in the standard 
practice arm.  
 
iii) Description of the distribution of acutely ill children in the various branches of the new 
algorithm for the management of childhood illness (ALMANACH) 
842 consecutive patients were assessed. 0.1% (1/842) of children had general danger signs. 
67.8% (571/842) entered the fever, 59.1% the cough, 21.9% the diarrhoea and 14.5% the skin 
problems branches. 0.3% (1/351) of patients with fever and cough had lower chest indrawing. 
71.5 % (251/351) of them had a final classification of upper respiratory tract infection and 28.5% 
(100/351) of pneumonia. 5.6% (32/570) patients, for whom a malaria rapid diagnostic test was 
performed, had malaria. 7.1% (6/85) patients for whom a urine dipstick was performed had a 
positive result. None of the 39 patients, in whom abdominal tenderness (considered as 
predictive for typhoid fever) was searched for, presented this sign. On day 0, 1.9% (5/271) of 
non-febrile patients received antibiotics compared to 21.9% (125/571) of febrile patients.  Day 7 
cure rate in febrile and non-febrile patients was 97.2% and 97.4% respectively.  
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iv) Potential barriers and facilitators for the uptake of the new algorithm on electronic 
support (mobile devices) in pragmatic conditions 
In general, the ALMANACH was assessed positively. The majority of the respondents felt 
comfortable to use the devices during consultations and stated that patient’s trust was not 
affected. Most health workers said that the ALMANACH simplified their work, reduced antibiotic 
prescription and gave correct classification and treatment for common causes of childhood 
illnesses.  
Few reported technical challenges using the mobile devices and complained about having had 
difficulties typing. Majority of the respondents stated that the devices increased the consultation 
duration compared to routine practice. In addition, health system barriers such as lack of staff, 
lack of medicine and lack of financial motivation were identified as key reasons for the low 
uptake of the devices.   
Conclusion 
The new algorithm has the potential to improve clinical outcome of pediatric patients presenting 
at primary care facilities and drastically reduce antibiotic prescription. This was achieved 
through more accurate diagnoses and hence better identification of children in need of antibiotic 
treatment or not. A detailed count of patients with defined symptoms, signs, laboratory test 
results, and clinical outcome when managed by ALMANACH allowed to precisely assessing the 
value of each of the proposed branches of the algorithm in a primary care setting. This helped to 
decide on the relevance of keeping, modifying or dropping each of the algorithm components. A 
vast majority of children had mild illnesses and most of them did not require antibiotics to be 
cured. ALMANACH building on mobile technology allowed easy access, rapid update of the 
decision chart and has a potential to improve quality and timely use of clinical data collected at 
the point of care for planning at all levels of health care. Further studies are recommended to 
assess feasibility of phased scale up of an improved ALMANACH on mobile devices in order to 
improve rational use of antimicrobials and the quality of health care for children in developing 
countries.  
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Zusammenfassung 
Fast 7 Millionen Kinder sterben jährlich vor dem fünften Lebensjahr trotz der Verfügbarkeit von 
wirksamen und kostengünstigen Interventionen. Richtlinien zu Integriertem Management von 
Kinderkrankheiten (IMCI) haben gezeigt, dass wenn richtig angewendet, diese zu einer 
Verbesserung der Qualität der Gesundheitsversorgung und einer Reduktion der Sterblichkeit 
von Kindern unter fünf Jahren führen können. Die tatsächliche Wirkung von IMCI weltweit ist 
jedoch aufgrund beschränkter Umsetzung der Interventionen und mangelnder Einhaltung von 
Algorithmen durch Ärzte geringer als erwünscht. Eine neulich publizierte Studie aus Tansania 
zeigte, dass mangelnde Einhaltung des IMCI Protokolls zu geringer Qualität der 
Gesundheitsversorgung führt. Tatsächlich wurden 78% der Patienten mit Fieber, die zur 
ambulanten Behandlung eine Klinik aufsuchten und die negativ auf Malaria getestet wurden, ein 
Antibiotikum verschrieben, obwohl dies nur in 20% der Fälle nötig war. Solche 
Vorgehensweisen führen zu schlechten Gesundheitsergebnissen, einer enormen 
Verschwendung von Medikamenten und schneller Verbreitung von bakteriellen Resistenzen. 
Die sich ständig verändernden Krankheitsmuster, die schnelle Verbreitung von Resistenzen 
gegenüber antimikrobiellen Arzneimitteln und die unzureichende Einhaltung von klinischen 
Richtlinien sowie die zunehmende Verfügbarkeit von neuen Technologien, welche die 
Diagnosegenauigkeit und die Einhaltung von auf evidenzbasierenden Verfahren verbessern 
können, waren Grundlage dieser Dissertation. 
 
Die Ziele dieser Dissertation waren folgende: 
- Entwicklung eines neuen Algorithmus‘ zum Management von Kinderkrankheiten in 
Papierformat mit entsprechender elektronischer Unterstützung basierend auf einer 
Literaturrecherche, den Resultaten einer in Tansania durchgeführten Fieberstudie und 
Diskussionen mit IMCI Experten. Der neue Algorithmus hatte zum Ziel klinische 
Ergebnisse zu verbessern und den sinnvollen Gebrauch von Antimalariamedikamenten 
und Antibiotika zu fördern. 
- Beurteilung des neuen Algorithmus‘ zum Management von Kinderkrankheiten 
(ALMANACH) hinsichtlich seiner Sicherheit im Vergleich zum Standardverfahren (IMCI) 
und der angemessenen Verschreibung von Antibiotika. ALMANACH basiert auf den 
IMCI Richtlinien und auf den neuen wissenschaftlichen Nachweisen bezüglich 
Krankheitsbildern und Medikamentenresistenzalgorithmen. 
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- Beschreibung der Aufteilung von akut kranken Kindern in die verschiedenen Zweige des 
neuen Algorithmus‘ zum Management von Kinderkrankheiten zur Identifizierung von 
Verzweigungen (Symptome und Anzeichen), die möglicherweise verändert oder 
wegelassen werden könnten. Dies mit dem Ziel den Gebrauch des Algorithmus‘ und 
damit dessen Umsetzung zu fördern, aber trotzdem die Angemessenheit des 
Algorithmus’ bezüglich den epidemiologischen Gegebenheiten und pädiatrischen 
Krankheiten in Ambulatorien von Primärversorgungseinrichtungen sicher zu stellen. 
- Beurteilung von möglichen hemmenden und unterstützenden Faktoren bezüglich der 
Umsetzung des neuen Algorithmus‘ in elektronischer Form unter Realbedingungen um 
damit Wege für dessen nachhaltigen Nutzen und optimaler Umsetzung durch die Ärzte 
in Primärversorgungseinrichtungen aufzuzeigen. 
Methoden: 
Die zuvor genannten vier Ziele wurden im Rahmen von drei verschiedenen Studien mit 
folgendem Design und Methodologie verfolgt: 
(i) Eine strukturierte wissenschaftliche Literaturrecherche in Medline, Embase und der 
Cochrane Datenbank für systematische Übersichten (CDSR) zur Suche von 
vorhandenen Nachweisen bezüglich a) Krankheitsprävalenz von ambulanten 
pädiatrischen Patienten, b) Genauigkeit der klinischen Indikatoren und c) 
Ergebnissen von vor Ort zu verwendenden Tests (Point-of-care-Tests) bei 
ausgewählten Krankheiten (Clotilde Rambaud-Althaus et al, Publikation eingereicht).  
(ii) Eine kontrollierte Nicht-Unterlegenheitsstudie um klinische Ergebnisse und 
Verschreibung von Antibiotika bei Kindern basierend auf ALMANACH oder dem 
Standardverfahren (IMCI) zu vergleichen. Kinder im Alter von 2-59 Monaten mit 
akuten Krankheitsbildern wurden gemäss ALMANACH oder dem Standardverfahren 
in Dar es Salaam und Morogoro in Tansania behandelt (2 Interventions- und 2 
Kontrollstandorte, je einer in ländlicher und urbaner Region). Zwei Ärzte (einer für 
jede Region), die ausgebildet wurden den ALMANACH Algorithmus strikt 
anzuwenden, behandelten alle Kinder im Interventionszweig. Das Hauptergebnis war 
der Anteil der Kinder, die seit dem Tag 0 Antibiotika verschrieben bekamen und am 
Tag 7 geheilt waren 
(iii) Eine beschreibende Analyse der Daten, die im Interventionszweig der unter ii) 
beschriebenen Studie gesammelt wurden. Ergebnisse waren folgende: i) Anteil der 
xvi 
 
Kindern mit Warnzeichen, mit Hauptsymptomen und Anzeichen, ii) Anteil der Kinder, 
denen Antibiotika verschrieben wurde und iii) klinische Ergebnisse. 
(iv) Eine qualitative Studie basierend auf ausführlichen Interviews und Fokusgruppen-
Diskussionen mit 40 Personen angestellt in 6 Primärversorgungseinrichtungen in 
den drei Stadtbezirken in Dar es Salaam, Tansania, wo der elektronische, klinische 
Algorithmus ALMANACH benutzt wurde. Es wurden hemmende und unterstützende 
Faktoren identifiziert, die die Akzeptanz des elektronischen Gerätes der im 
Gesundheitswesen tätigen Personen beeinflussten.  
 
Resultate 
 
i) Entwicklung eines neuen Algorithmus zum Integriertem Management von 
Kinderkrankheiten (Integrated Management of Childhood Illnes, ALMANACH) um den 
Gebrauch von antimikrobiellen Arzneimitteln zu verbessern und gleichzeitig das 
Gesundheitsergebnis beizubehalten (Clotilde Rambaud-Althaus et al, Publikation 
eingereicht). 
Der neue Algorithmus (ALMANACH) unterscheidet sich von der IMCI 2008 Version in den 
folgenden Aspekten: 
 
a) Es werden 10 allgemeine Warnzeichen bewertet 
b) Die minderschwer kranken Kinder werden in Patienten mit und ohne Fieber eingeteilt, 
wobei für letztere keine Antibiotika-Behandlung empfohlen wird 
c) Lungenentzündung für Kinder zwischen 12-59 Monaten wird diagnostiziert basierend auf 
einer Atmungsfrequenz von >= 50 Atemzügen pro Minute, die zweimal gemessen wird 
d) Falls während der Untersuchung kein anderer Grund des Fiebers identifiziert wurde, 
dann wurden ein Malariaschnelltest durchgeführt 
e) Danach wird in Kindern unter 2 Jahren mit Fieber eine Harnuntersuchung gemacht um 
eine Harnwegsinfektion (UTI) zu diagnostizieren 
f) Kinder über 2 Jahre mit Fieber werden auf eine schmerzhafte Bauchdeckenspannung 
untersucht, um sie auf eine mögliche Typhuserkrankung zu testen 
g) Wenn nichts Spezifisches gefunden wird, werden sie der Gruppe der viralen Infektionen 
zugeteilt 
 
ii) Klinische Ergebnisse und Verschreibung von Antibiotika nach ALMANACH 
 
130 von 842 Kinder (15·4%) in der ALMANACH Gruppe und 241 von 623 Kinder 
(38·7%) in der Kontrollgruppe wurden mit einer Infektion diagnostiziert, die eine 
Antibiotikabehandlung benötigte, während 3·8% und 9·6% Malaria hatten. Gegenüber 
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dem Standardverfahren, bei dem 573 von 623 Kindern (92·0%; 89·8-94·1%) nach 7 
Tagen geheilt waren (p<0·001), war dies bei der Anwendung von ALMANACH bei 815 
von 838 Kinder (97·3%; 96·1-98.4%) der Fall. Von 23 Kindern, die nicht nach 7 Tagen 
geheilten waren und bei denen ALMANACH angewendet wurde, hatten am Tag 0 44% 
Hautprobleme, 30% Lungenentzündung, 26% eine Infektion der oberen Atemwege und 
13% eine virale Infektion. Wenn ALMANACH angewendet wurde, bekamen am Tag 0 
15·4% (12·9-17·9%) der Kinder Antibiotika verschrieben und 84·3% (81·4-87·1%) wenn 
das Standardverfahren angewendet wurde (p<0·001). Dies entsprach einer Abnahme 
der Antibiotikaverschreibung von 82%. 2·3% (1·3-3.3%) und 3·2% (1·8-4·6%) bekamen 
sekundär ein Antibiotikum verschrieben. Spätere Aufnahme ins Krankenhaus erfolgte 
bei einem Kind im ALMANACH-Zweig, beim Standardverfahren verstarb  ein Kind am 
Tag 4. 
 
iii) Beschreibung der Aufteilung von akut kranken Kindern in die verschiedenen Zweige des 
neuen Algorithmus‘ zum Management von Kinderkrankheiten 
 
Es wurden 842 Patienten untersucht. 0.1% (1/842) der Kinder hatten allgemeine 
Warnzeichen. 67.8% (571/842) wurden der Fieber-, 59.1% der Husten-, 21.9% der 
Durchfall- und 14.5% der Hautproblem-Gruppe zugeteilt. 0.3% (1/351) der Patienten mit 
Fieber und Husten hatten eine Brustwandeinziehung. Bei 71.5% (251/351) dieser 
Patienten wurde eine Infektion der oberen Atemweg diagnostiziert und bei 28.5% 
(100/351) eine Lungenentzündung. 5.6% (32/570) der Patienten, bei denen ein Malaria 
Schnelltest gemacht wurde, hatten Malaria. Bei 7.1% (6/85) der Patienten zeigte der 
Urintest ein positives Resultat. Keiner der Patienten, der auf eine schmerzhafte 
Bauchdeckenspannung (dies wurde als Symptom für Typhusfieber angesehen) 
untersucht wurde, wies dieses Anzeichen auf. Am Tag 0 erhielten 1.9% (5/271) der 
Patienten ohne Fieber Antibiotika, während für 21.9% (125/571) der Patienten mit Fieber 
eine Antibiotikabehandlung verschrieben wurde. Die Heilungsrate am Tag 7 in Patienten 
mit und ohne Fieber war 97.2% respektive 97.4%. 
 
iv) Mögliche hemmende und unterstützende Faktoren bezüglich der Umsetzung des neuen 
Algorithmus‘ mit elektronischer Unterstützung (Mobilgeräte) unter Realbedingungen 
 
ALMANACH wurde im Allgemeinen gut aufgenommen. Die Mehrheit der Befragten 
fühlte sich beim Benutzen von ALMANACH während den Konsultationen wohl und 
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gaben an, dass das Vertrauen der Patienten dadurch nicht beeinträchtigt sei. Die 
Mehrheit des Gesundheitspersonals gab an, dass ALMANACH deren Arbeit erleichterte, 
die Antibiotikaverschreibungen reduzierte und zu korrekten Klassifizierungen und 
Behandlungen für gängige Ursachen von Kinderkrankheiten führte. 
Nur wenige der Befragten gaben technische Schwierigkeiten bei der Benutzung der 
mobilen Geräte und Probleme beim Tippen an. Eine Mehrheit der Benutzer stellte fest, 
dass die Geräte verglichen zum Standardverfahren die Konsultationszeit verlängerten. 
Zusätzliche wurden Systemprobleme, wie das Fehlen von Personal, Medikamenten und 
finanziellen Anreizen, als Hauptgründe für das nicht Benützen der  Mobilgerät 
identifiziert. 
Schlussfolgerung 
Der neue Algorithmus hat das Potential klinische Ergebnisse bei Kindern in 
Primärversorgungseinrichtungen zu verbessern und die Verschreibung von Antibiotika drastisch 
zu reduzieren. Dies wurde durch genauere Diagnosen und eine bessere Identifizierung von 
Kindern, die Antibiotikum benötigen, erreicht. Eine detaillierte Zählung von Patienten mit 
definierten Symptomen, Anzeichen, Labortestresultaten und klinischen Ergebnissen, die mit 
ALMANCH untersucht wurden, erlaubte es den Nutzen der einzelnen Zweige des Algorithmus 
in Primärversorgungseinrichtungen detailliert zu untersuchen. Dies half zu entscheiden, ob ein 
bestimmter Zweig des Algorithmus behalten, geändert oder weggelassen werden sollte. Ein 
Grossteil der Kinder hatte milde Erkrankungen und die meisten von ihnen brauchten keine 
Antibiotikabehandlung für deren Heilung. Die elektronische Version von ALMANACH erlaubte 
einen einfachen Zugang zu und eine schnelle Aktualisierung des Entscheidungsschemas und 
hat das Potential, die Qualität und den zeitgemässen Gebrauch von klinischen Daten zu 
verbessern, die während der Behandlung gesammelt und zu Planungszwecken auf allen Stufen 
des Gesundheitssystems verwendet werden. Es werden weitere Studien empfohlen, um die 
Machbarkeit einer schrittweisen Ausbreitung eines verbesserten ALMANACH auf mobilen 
Geräten zu untersuchen, umso den sinnvollen Gebrauch von antimikrobiellen Arzneimitteln zu 
fördern und die Qualität der medizinischen Versorgung von Kindern in Entwicklungsländern zu 
verbessern. 
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Muhstasari 
Karibu watoto milioni saba hufa kila mwaka kabla ya kufikisha umri wa miaka mitano pamoja na 
kuwepo kwa mipango ya huduma za kiafya za gharama nafuu. Mwongozo wa matibabu ya 
magonjwa ya watoto (IMCI) umethibisiha kwamba  ukitumiwa kwa usahihi unaongeza ubora wa 
huduma na unapunguza vifo vya watoto walio chini ya umri wa miaka mitano.  Hata hivyo 
matokeo halisi ya IMCI duniani kote yamekuwa chini ya matarajio kwa sababu ya utumiaji 
mdogo na ufuatiliaji hafifu wa watumishi wa afya.  Utafiti uliofanyika Tanzania hivi karibuni 
umeonyesha kuwa ufuatiliaji hafifu wa mwongozo wa IMCI hupelekea huduma hafifu za afya. 
Hakika asilimia 78% ya wagonjwa wa nje wanaohudhuria kliniki wakiwa na homa 
wanaopatikana na kipimo hasi cha malaria, walipewa dawa za vimelea vya bacteria, ingawa 
waliostahili kwa usahihi ni chini ya 20% ya wagonjwa hao. Taratibu kama hizo hupelekea 
matokeo dhaifu ya kiafya, upotevu mkubwa wa dawa na usaambaaji wa kasi wa usugu wa 
vimelea vya bakteria dhidi ya dawa. Mabadiliko ya kasi ya mwelekeo wa magonjwa, usaambaaji 
wa kasi wa usugu wa vimelea vya bakteria dhidi ya dawa, ufuatiliaji hafifu wa miongozo ya 
matibabu iliyochapishwa kwenye vijitabu na kuongezeka kwa upatikanani wa teknolojia mpya 
ambazo zinaweza kuboresha utambuzi sahihi wa magonjwa na ufuatiliaji wa mwongozo wa tiba 
uliodhibitishwa  ndio msingi wa tasnifu hii ya digrii ya udaktari wa falsafa . Malengo ya tasnifu 
yalikuwa:  
• Kuandaa mwongozo uliochapishwa na wa kielektroniki kwa ajili ya matibabu ya 
magonjwa ya watoto ( kulingana na mapitio ya fasihi, matokeo ya utafiti wa homa 
ulifanyika Tanzania na majadiliano na wataalam wa IMCI ambayo yalilenga kuboresha 
matokeo ya matibabu na matumizi sahihi ya dawa dhidi ya vimelea vya malaria na 
baktreria. 
• Kutathmini iwapo mfumo mpya wa  matibabu ya magonjwa ya watoto (ALMANACH) 
ambao umekokotolewa kutokana na IMCI na kulingana na uthibitisho mpya wa 
muelekeo wa magonjwa na usugu dhidi ya dawa, ni salama kama mfumo uliopo wa 
IMCI na unapelekea matumizi sahihi ya dawa za vimelea vya bakteria.  
• Kuelezea mgawanyiko wa watoto wanaoumwa katika matawi tofauti ya mwongozo mpya 
wa matibabu ya watoto ili kubaini matawi yanayofaa (dalili na alama) ambayo zingefaa 
kuboreshwa au kuachwa ili kurahisisha matumizi yake, na hivyo matumizi yake, huku 
ikiwekwa sawa kiepidemiolojia na ukubwa wa magonjwa ya watoto kwenye idara ya 
magonjwa ya nje kwenye vituo vya awali vya afya. 
• Kutathmini vikwazo na vitu vinavyosaidia utumikaji wa mwongozo mpya wa kielectronic 
katika mazingira halisi ili kutoa mapendekezo yatakayowezesha matumizi endelevu na 
ufuatiliaji wa hali ya juu na wahudumu wa afya katika vituo vya awali vya afya. 
 
Njia:  
Malengo manne ya utafiti huu yalielezewa kwenye tafiti tatu zilizokuwa na muundo na 
taratibu zifuatazo 
i. Upitiaji wa fasihi uliopangiliwa kwenye vyanzo vya Medline Embase na The 
Cochrane Database for Systmatic Reviews (CDSR) uliokuwa unatafuta uwepo 
wa ushahidi wa (a)Wingi wa magonjwa kwa  watoto wanaotibiwa bila kulazwa (b) 
usahihi wa ubashiri wa kikliniki wa ugonjwa na (c)utendaji na vipimo vya 
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ugunduzi vya papo hapo  vya magonjwa yaliyodhaniwa. (Clotilde Rambaud-
Althaus t al). 
ii. Majaribio yalifanyika kulinganisha matokeo ya kiafya na madawa waliyopewa 
watoto kwa kutumia mwongozo wa ALMANACH au kwa kutumia utendaji uliopo 
wa IMCI.  Watoto wenye umri kati ya miezi 2 hadi 59 wenye magonjwa ya muda 
mfupi walihusishwa kwa kutumia ALMANACH (utafiti kwenye vituo viwili), au 
utendaji wa kawaida (vituo viwili kwa uangalizi) Dar es Salaam, na Morogoro 
nchini Tanzania (mazingira ya mjini na kijijini).  Watoto walioandikishwa kwenye 
vituo vya utafiti waliohudumiwa na watumishi wa afya waliofundishwa kufuatilia 
kwa karibu mwongozo wa  ALMANACH. Matokeo ya msingi yalikuwa ni uwiano 
wa watoto walioponywa siku ya saba na waliopewa dawa dhidi ya vimelea vya 
bakteria siku ya mwanzo (0) 
iii. Uchambuzi wa maelezo ya taarifa zilizokusanywa katika vituo vya utafiti kama 
ilivyoelezwa (ii) hapo juu, matokeo yalikuwa i) Uwiano wa watoto wenye alama 
hatarishi wenye dalili na alama kuu, ii) uwiano wa watoto waliopewa dawa dhidi 
ya vimelea vya vijidudu iii) matokeo ya kitabibu 
iv. Pia utafiti wa mahojiano ya kina na majadiliano katika makundi yalishirikisha 
wafanyakazi 40 kutoka vituo 6 vya awali vya afya vya umma katika manispaa 
tatu za mkoa wa Dar es Salaam, Tanzania ambapo mfumo wa kielektroniki wa 
matibabu (ALMANACH) ulitumika. Mtazamo wa wahudumu wa afya kusiana na 
vitu vinavyorahisisha au kukwaza utumiaji wa mfumo wa kielektroniki wa 
ALMANACH vilibainishwa. 
Matokeo 
Uandaajii wa mfumo mpya wa matibabu ya watoto ili kuboresha matumizi sahihi ya dawa dhidi 
ya vimelea vya vijidudu (ALMANACH) bila kuathiri matokeo ya kiafya (Clotilde Rambaud-
Althaus et al) 
Mwongozo mpya (ALMANACH) unatofautiana na ule wa IMCI toleo la 2008 katika nyanja 
zifuatazo: 
a) Dalili 10 hatarishi zinatathminiwa (b) watoto wasiokuwa na dalili hatarishi wanawekwa 
katika kundi la wenye homa  au wasio na homa. Kundi la pili linashauriwa kutopewa 
dawa dhidi ya vimelea vya bakteria. (c)Homa ya mapafu inafikiwa iwapo kiwango cha 
upumuaji ni pumzi 50 au zaidi kwa dakika na, kiwango hicho kinatathminiwa mara mbili 
kwa watoto wenye umri wa miezi 12 hadi 59 (d) Kila mwenye homa  anapimwa kwa 
kipimo cha haraka cha malaria. Iwapo hamna chanzo cha homa mwishoni mwa tathmini 
hiyo, (e) kipimo cha haraka cha mkojo kinafanyika kwa wenye homa walio chini ya 
miaka 2 ili kuona kama wana maambukizi kwenye njia ya mkojo (UTI), (f) tumbo 
linapapaswa kutambua maumivu kwa watoto wenye miaka miwili au ili zaidi kuweza 
kutambua homa ya matumbo na g) Ainisho la uwezekano wa maambukizi ya virusi 
linafikiwa endapo hakuna kitu mahususi kilichogundulika.  
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ii) Matokeo ya kitabibu na matumizi ya dawa dhidi ya vimelea vya bakteria kwa kutumia  
ALMANACH 
 
130/842 (15.4%) kwa ALMANACH na 241/623 (38.7%) kwenye uangalizi waligundulika 
kuwa na maambukizi na wakahitaji dawa dhidi ya vimelea vya bakteria, wakati 3.8% na 
9.6% walikuwa na malaria. 815/838 (97.3%; 96.1-98.4%) walikuwa wamepona siku ya 7 
kwa kutumia ALMANACH dhidi ya 573/623 (92.0%; 89.8-94.1%) kwa kutumia 
mwongozo wa kawaida (p<0.001). Miongoni mwa watoto 23 ambao hawakupona siku ya 
saba kwa kutumia ALMANACH, 44% walikuwa na matatizo ya ngozi, 30% homa ya 
mapafu, 26% maambukizo ya njia ya juu ya hewa na 13% wanahisiwa kuwa na 
maambukizi ya virusi siku ya mwanzo. Katika siku ya mwanzo,  dawa dhidi ya vimelea 
vya bakteria zilitolewa kwa 15.4% (12.9-17.9%) kwa kutumia ALMANACH dhidi ya 
84.3% (81.4-87.1%) kwa kutumia mfumo wa kawaida (p<0.001) ikishabihiana na 
punguzo la asilimia 82%. 2.3% (1.3-3.3%) and 3.2% (1.8-4.6%) walipewa dawa dhidi ya 
vimelea vya bakteria baada ya kuonwa tena. Mtoto mmoja alilazwa kwa mfumo wa 
ALMANACH na mmoja alifariki siku ya nne kwenye mfumo wa kawaida. 
 
iii) Maelezo ya mgawanyiko wa watoto waliokuwa wanaumwa katika matawi mbali mbali 
ya mfumo mwa matibabu ya magonjwa ya watoto (ALMANACH) 
 
Wagonjwa 842 walitathminiwa, 0.1% (1/842) ya watoto walikuwa na alama hatarishi. 
67% (571/842) walikuwa na homa, 59.1% kikohozi, 21.9% kuhara na 14.5% matatizo ya 
ngozi. 0.3% ((1/351) ya wagonjwa wenye homa na kikohozi walikuwa na tatito la kuingia 
ndani kwa sehemu ya chini ya kifua. 71.5% (251/351) miongoni mwao walidhibitishwa 
kuwa na maambukizo ya njia ya juu ya hewa na 28.5% (100/351) homa ya mapafu. 
5.6% (32/570) ya wagonjwa ambao kipimo cha haraka cha malaria kilifanywa walikuwa 
na malaria. 7.1% (6/85) ambao kipimo cha haraka cha mkojo kilifanywa walikuwa na 
kipimo chanya. Hakuna hata mmoja miongoni mwa wagonjwa 39 ambao maumivu ya 
tumbo yalitathminiwa (ilichukuliwa kama ishara ya homa ya matumbo) alikuwa na dalili 
hiyo. Katika siku ya mwanzo, 1.9% (5/271) ya wagonjwa wasio na homa walipatiwa 
dawa dhidi ya vimelea vya bakteria ikilinganishwa na 21.9% (125/571) ya wenye homa. 
Kwenye siku ya 7, kiwango cha uponaji kwa wagonjwa wenye homa na wasio na homa 
kilikuwa 97.2% na 97.4% kwa mfuatano huo. 
 
iv) Vikwazo na viwezeshaji kwa ajili ya matumizi ya muongozo mpya wa Kieletroniki 
kwenye kazi za utabibu 
Kwa ujumla, ALMANACH ilipata tathmini chanya. Wengi wa wahudumu waliojibu 
walijisikia vizuri kutumia vifaa hivyo wakati wa kuhudumia wagonjwa, walisema imani ya 
wagonjwa haikuathiriwa.  Wafanyakazi wengi wa afya walisema kuwa ALMANACH 
ilirahisha kazi yao, ilipunguza matumizi ya dawa dhidi ya vimelea vya bakteria na iliwapa 
majibu na matibabu sahihi kwa visababishi vya kawaida vya magonjwa ya watoto.  
 
Wachache walieleza matatizo ya kiufundi wakati wa kutumia vifaa hivyo na kulalamikia 
shida ya kuandika kwenye vifaa hivyo. Wengi wa waliojibu walieleza kuwa vifaa hivyo 
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vinahitaji muda mwingi kumuona mgonjwa ikilinganishwa na utaratibu wa kawaida. Zaidi, 
vizuizi vya mfumo wa huduma ya afya kama upungufu wa  wahudumu, kukosekana kwa 
madawa na kukosa uhamasisho wa kifedha vilibainishwa kama sababu za msingi kwa  
matumizi madogo ya hizi simu/vifaa. 
 
Hitimisho: 
Mfumo huu mpya una nafasi kubwa ya kuboresha matokeao ya kikliniki ya watoto wagonjwa 
wanaohudhuria vituo vya awali vya afya na kupunguza kwa kasi utoaji wa dawa dhidi ya 
vimelea vya bakteria. Hii ilifikiwa kutokana na ugunduaji sahihi na hivyo utambuaji bora wa 
watoto wanaohitaji au wasiohitaji dawa dhidi ya vimelea vya bakteria. Tathmini ya kina ya 
wagonjwa wenye dalili zilizomahsusi, alama, na majibu ya vipimo vya maabara na matokeo ya 
kikliniki anapotibiwa na muongozo wa ALMANCH uliruhusu kutathmini thamani ya kila tawi 
linalopendekezwa la muongozo kwenye vituo vya afya vya awali.  Hii ilisaidia kuamua umuhimu 
wa kubakiza, kubadili au kupunguza kila sehemu ya muongozo. Watoto wengi walikuwa na 
magonjwa yasio makali na wengi wao hawakuhitaji dawa dhidi ya vimelea vya bakteria ili 
kupona. ALMANACH imetengenzwa kwenye misingi ya kiteknolojia inayoruhusu upatikanaji 
rahisi, utumiaji wa haraka wa chati ya maamuzi na ina uwezoya kuboresha ubora na utumiaji 
wa wakati wa taarifa ya za kikliniki zinazikusanywa wakati wa kutoa huduma katika ngazi zote 
za huduma za afya. Tafiti zaidi zinashauriwa kutathmini upembuzi wa kupanua matumizi kwa 
awamu ya ALMANACH iliyoboreshwa kwenye vifaa vya kielectroniki ili kuboresha matumizi 
sahihi ya dawa dhidi ya vimelea vya vya vijidudu na ubora wa huduma za afya kwa watoto 
kwenye nchi zinazoendelea.  
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PART 1: BACKGROUND 
Chapter 1: Introduction 
1.0 Low compliance of clinicians to evidence-based recommendations for the 
management of childhood illness 
About 7 million children under 5 years of age die each year despite the availability of effective 
low-cost interventions (Chopra et al., 2013). One reason for the continuing high rates of death in 
children below five 5 years of age is the poor quality of medical care that many children receive 
due to shortage of health personnel and the limited training that is often available in child health. 
In response to this toll, the World Health Organization (WHO) has developed the Integrated 
Management of Childhood Illness (IMCI) treatment algorithms which consist of an evidence 
based approach to the assessment, classification and treatment of the most common causes of 
childhood mortality. The impact of the effective use of IMCI has been documented in a series of 
multi-country evaluations done by the WHO (Bryce et al., 2004, Bryce et al., 2005) that 
conclude that IMCI has the potential to improve quality of care, reduce the cost of treatment, 
and reduce under-5 mortality when used correctly. This impact has also been shown in 
Tanzania (Armstrong Schellenberg et al., 2004a, Bryce et al., 2005). 
However, there is a growing body of evidence that the actual impact of IMCI worldwide has 
been less than anticipated due to limited uptake of the intervention, especially among the 
world’s most poor (Victora et al., 2006). There are several reasons for this including the 
following: 
 The cost and time for IMCI training (11-16 days of initial training is required) has limited 
their uptake worldwide. Further, the revision of algorithms as disease patterns and drug 
resistance change is limited since retraining and reprinting of all materials is required, 
which is expensive and difficult to organize. This means that outdated algorithms are often 
used well beyond the need for change; this is particularly detrimental when there are new 
evidence available requiring a change in one or more recommendations. 
 The current practice of IMCI algorithms requires health workers to follow flow diagrams, 
understand and use accessory information on each page, and accurately flip through up 
to 8-10 pages of the chart booklet in front of the patient. In actual practice, most health 
workers decide not to use the chart booklets because it takes time and due to the 
embarrassment of using a chart booklet in front of patients. 
As a result, in Tanzania and elsewhere health worker’s compliance to IMCI algorithms is 
uneven and often quite low, both in rural and urban setting (Walter et al., 2009, Horwood et al., 
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2009, Armstrong Schellenberg et al., 2004a). A study in Papua New Guinea, where some of 
the earliest algorithms were developed, found that despite a correct diagnosis of malaria, and 
the existence of paper-based algorithms, only 11% of community health workers used the 
correct treatment (Beracochea et al., 1995). In Tanzania, health workers’ compliance to IMCI 
was found to be poor in terms of consultation time, use of job aids, space use and adherence 
to referral (Prosper et al., 2009) 
1.1 Changes in disease patterns and drug resistance 
During the past 20 years since the first IMCI protocols were developed, patterns of disease and 
drug resistance has changed dramatically but the IMCI protocols have not kept pace with these 
changes.  
As an example, malaria among febrile children in Dar es Salaam has gone down dramatically 
since the 90’s due to improvements in sanitation and housing and the wider use of insecticide 
treated bed nets. This fall of malaria transmission has been observed in many countries in 
Africa (D'Acremont et al., 2010a, Ceesay et al., 2010, O'Meara et al., 2008). Further, the 
medicine of choice for treatment has gone from chloroquine and quinine which were 
inexpensive and relatively safe to artemether/lumefantrine (ALU) and artesunate which are 
more expensive. Despite the evidence that only 10% of children with fever in Dar es Salaam 
have malaria, all these children are still often treated for malaria at great expense and with the 
risk of not being treated for other potentially fatal diseases (Kahama-Maro et al., 2011). Moving 
from presumptive to confirmed malaria diagnosis in order to improve the rational use of 
medicines and slow down the emergence of antimalarial resistance, is highly needed and called 
for revision of IMCI (D'Acremont et al., 2009). Since 2010, WHO recommends, a parasitological 
diagnosis to all patients with malaria suspicion before treatment is started, including children 
below 5 years of age (WHO, 2010a) .  
For bacterial infections, there are similar changes. The global problem of antibiotic resistance is 
particularly pressing in developing countries, where the infectious disease burden is high and 
cost constraints prevent the widespread application of newer, more expensive agents (Okeke et 
al., 2005b). In Tanzania, recent evidences show that common microorganisms are multi-
resistant to drugs recommended as first line treatment. For example, in 2007, all Shigella strains 
isolated from diarrhoea patients showed high level of resistance to ampicillin, tetracycline, co-
trimoxazole and chloramphenicol; moreover, 5% and 2% were also resistant to amoxycilline-
clavulanate and azithromycin respectively (Temu et al., 2007). Resistance of bacteria causing 
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acute respiratory infections (ARI) has not been extensively studied. In a carriage study 
published in 2003, S. pneumoniae showed a level of resistance to co-trimoxazole of 47% and to 
penicillin of 21% (Batt et al., 2003). One half of community-acquired Salmonellae were resistant 
to ampicillin and co-trimoxazole, the currently prescribed treatment in Tanzania. 90.6% of 
Diarrhoeagenic Escherichia coli (DEC) and 93.3% of Shigella are resistant to Cotrimoxazole 
(Moyo et al., 2011). Although the correlation between reduced antibiotic susceptibility in vitro 
and clinical response is not always straightforward, recent data from Tanzania show that 
bacterial resistance has indeed clinical implications since children infected with resistant 
microorganisms were more likely to die (Blomberg et al., 2007). 
One reason for this increase in antibiotic resistance is the wide inappropriate use of antibiotics 
in clinical practice (Hart and Kariuki, 1998). Surveys on antibiotic use in developing countries 
show antibiotics are prescribed in 35 to 60% of clinical encounters although appropriate in less 
than 20% (Trostle, 1996). In Tanzania a recent study recorded that 78% of patients with fever 
attending the outpatient clinic and testing negative for malaria were given antibiotics, and this 
mainly in relation to ARI (D'Acremont et al., 2011). Although we know that the inappropriate use 
of antibiotics by health workers has led to dangerous widespread of drug resistance, the 
different approaches used to reverse this trend have been largely ineffective. In a systematic 
review of the effectiveness of all possible intervention to promote rational use of antibiotics 
(WHO and DMP., 2001), educational/training interventions successfully improved targeted 
antibiotic prescribing outcomes by only 20% and even these changes were not necessarily 
sustainable over time. A holistic strategy is needed to contain antibiotic resistance, and 
improvement of clinician compliance to evidence-based guidelines is one proposed component 
(Okeke et al., 2005a). 
1.2 Availability of new technologies for accurate diagnosis and treatment 
Two recent technologies have shown significant promise in improving both diagnosis and 
treatment for children with fever. One of the technologies is the introduction of Rapid Diagnostic 
Tests for Malaria (mRDTs) which demonstrate the ability to accurate diagnose malaria, both non 
immune (Marx et al., 2005) and semi-immune populations (Ochola et al., 2006), as well as in 
urban and rural Tanzania (Kahama-Maro et al., 2011). In two systematic reviews mRDTs 
performed as well (Marx et al., 2005), or even better than microscopy (Ochola et al., 2006, 
Kahama-Maro et al., 2011) 
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A second technology is the development and use of hand held electronic decision support that 
makes it easier and faster for health workers to accurately follow electronic IMCI (e-IMCI) 
algorithms in a clinical setting (DeRenzi et al., 2008). Guiding health workers step-by-step 
through the assessment, classification (diagnosis) and treatment of sick children in rural clinics 
in Tanzania using mobile device has showed that e-IMCI has the potential to improve 
compliance to procedures, and thus the quality of care (DeRenzi et al., 2008).Training time for 
e-IMCI was 20 minutes, after which clinicians were easily able to follow even complex 
algorithms. The clinicians unanimously preferred e-IMCI to following the paper chart booklet, 
citing it as faster and easier to use. This same technology is being tested for other diagnostic 
areas such as the screening of patients living with HIV/AIDS on treatment with antiretroviral 
therapy for infections or side effects of treatment (Mitchell et al., 2009). 
In addition to these two technologies, other diagnostic tests and decision support algorithms are 
being developed. Rapid diagnostic tests for many causes of both childhood and adult illness 
may be available in a near future (see for example Bill and Melinda Gates Foundation Grand 
Challenges http://www.gcgh.org/Pages/BrowseByTechnology.aspx#Diagnostics). Incorporating 
these new technologies into electronic decision support algorithms will be much easier than into 
paper charts. 
  
5 
 
Chapter 2: Rationale 
Poor compliance to paper-based algorithms by health care workers has led to about 7 million 
children dying before reaching the age of five years because of poor quality of health care (poor 
diagnosis and poor treatment) they receive.  In addition, poor compliance to paper-based 
algorithms has led to huge wastage of medicines (unnecessary costs to caretakers and health 
systems) and rapid spread of resistance of microorganisms to antibiotics and antimalarials.  
High costs due to long duration for training health workers on paper-based IMCI algorithms has 
contributed to poor compliance because health care systems lack enough resources to train 
required number of health care workers. This problem has been reported to affect poor 
countries. Whenever updates on changes in disease patterns and new recommendations on 
treatment are reported, changes in paper-based algorithms such as IMCI need to be updated, 
then printed and training conducted to all health care workers. Due to high costs, this exercise is 
not often done in many countries leading to health care workers using out of date paper-based 
algorithms.  However, the use of electronic devices in pilot studies has shown to improve 
compliance of health care workers for paper-based algorithms. Following such results, different 
questions needed to be responded to before much more wide implementations of clinical 
algorithms using electronic devices for the management of childhood illness in primary health 
care settings. It is the objective of this thesis to provide responses to some of the questions 
raised.  
The first question is more about finding out the best process to intergrate the available evidence 
on child health and use it to design new clinical algorithm on paper and electronic support for 
the management of childhood illness. Such an understanding will provide potential information 
for guiding clinical guideline developers; program designers and policy makers to shift from 
developing paper-based algorithms to electronic decision supports based algorithms. The 
description on how this new tool was developed, its contents and the evidence behind it is 
provided in chapter five.   
The second question is whether the use of new algorithm designed for management of 
childhood illness aged 2 months to 5 years with the objective of improving rational use of 
medicines (antibiotics and antimalarials) will be as safe as what routine practice, i.e. a vast 
proportion of children being treated with antimalarials and/or antibiotics. It was important to 
respond to this question because there is huge wastage of drugs especially antibiotics in 
relation to the decline in malaria. In addition, despite of the use of rapid diagnostic tests for 
malaria, most of febrile children testing negative for malaria were still given antibiotics. The 
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consequences of such practices are poor health outcomes and increase of resistance to 
microorganisms. The safety of the new algorithm is reported in chapter six where the clinical 
outcomes and antibiotics prescriptions of children managed using the new algorithm were 
compared to a similar control population of children managed following the current practice.  
Since ALMANACH was derived from paper-based IMCI algorithms but improved to address 
rational use of medicines based on literature review, results of fever study conducted in 
Tanzania and discussions with IMCI experts, it was important to analyze the distribution of 
acutely ill children to various pathways of the new algorithm in order to determine the clinical 
relevance and usefulness of each recommended branch/pathway of the new algorithm. Such 
findings from data resulting from strict compliance by health care workers can provide useful 
information for recommendations on how to further improve the new algorithm for management 
of childhood illness for sustainable uptake and compliance by health care providers. The 
findings of such analysis are reported in chapter seven following a careful review of safety study 
data.  
The fourth question is whether the new algorithm built on electronic device will be taken up 
smoothly by clinicians or will it face uptake challenges as any other new intervention when 
implemented in real life conditions. The use of electronic devices in pilot studies has shown to 
improve compliance of health care worker for paper-based algorithms (DeRenzi et al., 2008). 
However, it is not known whether the use electronic devices over time and in pragmatic 
conditions in primary health care facilities will improve compliance of health care workers to 
algorithms sustainably. For example, use of these new tools might fail to improve compliance 
and ultimately the quality of health care of children either because the health care workers do 
not like them, or because these algorithms are too complex to follow or too long to follow. The 
responses to such questions can guide health care programme design, guideline developers 
and policy makers to prepare and plan well in advance on how to mitigate potential uptake 
challenges of interventions which have shown success in controlled conditions. The facilitating 
as well as constraining factors for the uptake of the new algorithms for the management of 
childhood illness (ALMANACH) are discussed in chapter eight using a qualitative approach to 
understand the perspectives of primary health care workers when using the new algorithm on 
mobile devices during clinical consultations.  
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PART II: OBJECTIVES AND METHODOLOGY 
Chapter 3: Goals and objectives 
The present PhD thesis is part of the PeDiAtrick project, lead together with Dr Clotilde 
Rambaud-Althaus, Swiss PhD student, and will address some of the project’s specific objectives 
describes below: 
3.0 Goal 
To improve the quality of health care for children in developing countries by making 
standardized diagnostic and treatments easily accessible to providers using electronic decision 
support systems, with a special emphasis on the rational use of antibiotics and antimalarials. 
3.1 Specific objectives 
3.1.1 To develop a new algorithm on paper and electronic support for the management of 
childhood based on literature review, results of fever study conducted in Tanzania and 
discussions with IMCI experts that aims to improve clinical outcome and rational use of 
antimalarial and antibiotics. 
3.1.2 To assess whether the new algorithm for the management of childhood illnesses is 
equivalent in terms of health outcomes (safety) as routine practice and to assess the rate of 
antibiotic and antimalarial prescription. 
3.1.3 To describe the distribution of acute ill children in to various pathways of the new algorithm 
for the management of childhood illness in order to improve in the future the overall algorithm 
relevance. 
3.1.4 To identify potential barriers and facilitators for the uptake of the new algorithm on 
electronic support in programmatic conditions 
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Chapter 4: Methods 
4.1 Study area and setting  
The data used in this thesis were collected within the PeDiAtrick project which aimed at 
improving the quality of healthcare for Tanzanian children by assessing the use of electronic 
decision support to promote evidence-based medicine and rational use of drugs. The project 
was implemented in Dar es Salaam, the largest city in Tanzania, and in a rural area in Morogoro 
region, in south-eastern Tanzania. Detailed description of study area and setting is covered in 
chapter six, seven and eight of the thesis.  
4.2 Thesis structure 
The PeDiAtrick project was conducted sequentially in 3 phases and the structure of this thesis is 
based on those phases as described subsequently. In the first phase, a paper as well as an 
electronic version of a new algorithm for management of childhood illness (ALMANACH) was 
developed. The description on how this new tool was developed, its contents and the evidence 
behind is provided in chapter five. The second phase of the project comprised the safety 
assessment of the ALMANACH, as well as the evaluation of the relevance and usefulness of 
the various pathways (branches of new algorithm) through the analysis of data collected during 
the safety study. The description of safety assessment of the ALMANACH is covered in chapter 
six while the relevance and usefulness of each branch of the new algorithm is covered in 
chapter seven.  
The third phase of the project had two components. The first component assessed the 
compliance of clinicians in routine conditions to the new algorithm for the assessment and 
treatment of children 2 months-5 years of age. This study component was conducted in 
randomly selected health facilities in urban Dar es Salaam and had 3 arms: i) one arm with 
training and use of new decision chart using paper support, ii) one arm with training and use of 
new decision chart using electronic support, iii) one control arm with IMCI or routine practice. 
This compliance component is part of Dr. Clotilde Rambaud-Althaus PhD thesis and will not be 
covered in this thesis. The second component assessed qualitatively the barriers as well as the 
facilitating factors related to the uptake of the electronic decision support with the new algorithm 
among the clinicians working in the intervention health facilities in Dar es Salaam. It is described 
in chapter eight of this thesis. 
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4.3 Study design and population 
4.3.1 Development of ALMANACH, an evidence-based electronic algorithm to manage 
childhood illness 
With an objective to design evidence based new algorithm for the management of childhood 
illness, a structured review of literature in Medline, Embase and Cochrane Database for 
Systematic review was conducted. This review looked for the available evidence on (i) disease 
prevalence in paediatric population, (ii) accuracy of clinical predictors and (iii) performance of 
point of care tests for the targeted diseases. The retrieved evidence was combined with results 
of fever study (aetiology of fever) conducted in Tanzanian children to design the ALMANACH.  
4.3.2 Safety assessment of the new algorithm for management of childhood illness 
(ALMANACH) 
We conducted a controlled non-inferiority trial to compare the clinical outcome of children 
managed according to ALMANACH or to standard practice. Consecutive children aged 2 to 59 
months were included if they fulfilled the inclusion criteria: 1) first consultation for the current 
illness; 2) absence of severe illness requiring immediate life-saving procedures; 3) main 
complaint(s) not related to injury or trauma; 4) living in the catchment area of the HF and; 5) 
written informed consent by the caretaker.The primary outcome measures were: i) proportion of 
children cured at day 7, and ii) proportion of children who received antibiotics on day 0. 
Secondary outcome measures were i) proportion of children admitted secondarily or who died, 
ii) proportion of children who received antibiotics during the whole study period. 
4.3.3 Assessment of the relevance and usefulness of various pathways of the new 
algorithm for the management of childhood illness 
An investigation of the detailed pathway followed by the clinician to assess and manage the 
children included in the intervention arm (ALMANACH algorithm) was performed. An 
assessment of the relevance of each branch was then conducted. Detailed procedures are 
covered in chapter seven of the thesis.  
 
Main outcome measures 
Outcomes were i) proportions of children presenting with danger signs, with main symptoms 
and signs, ii) proportions of children who were prescribed antimicrobials, iii)  clinical outcomes.  
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4.3.4 Assessment of the factors constraining and facilitating the uptake of the new 
algorithm for management of childhood illness (ALMANACH) 
Intervention 
Health workers (HWs) from 6 selected health facilities (HFs) in Dar es Salaam received 
ALMANACH training by the field investigators on the rational use of antibiotics and antimalarials 
using smartphones and tablets, and face-to-face supervision by the field investigators with 
several real patients onsite. In addition, user manuals on how to operate the smartphones and 
tablets were developed and given to each health facility for reference with training and face-to-
face supervision. 
During the use of smartphones and tablets in the field over the course of three months, a 
decrease in the number of cases sent to the server was observed (Figure 11 in chapter eight). 
The qualitative study which was carried out in Dar es Salaam between February and March 
2012 (smartphones) and between September and October 2012 (tablets) was thus designed to 
investigate the determinants of uptake of these electronic devices to support clinical practice. 
Methods of evaluation 
We collected data using in-depth interviews and focus group discussion from clinicians who 
were involved in the project. The in-depth interviews were conducted by the author using a 
semi-structured and pilot tested interview guide in the local language, Kiswahili from 24 HWs 
(12 of the smartphone and 12 of the tablet arm).  
In addition, at least 2 HWs from each of the 6 health facilities, who did not participate in the in-
depth interviews, were invited to participate in focus group discussions.  
Main outcome measures 
Data analysis was based on content analysis (Mayring, 2000). ATLAS.ti version 6.0 software 
was used to code interview transcripts for identification of common themes. Emerging themes 
were debated by a multidisciplinary team involved in the study. Data from both arms 
(smartphones and tablets) were compared to gain insights into similarities as well as differences 
of barriers and facilitating factors related to the uptake of the new algorithm.  
4.4 Ethical consideration 
Written informed consent was obtained from the caretakers of every study participant after the 
caretaker was explained the purpose of the study, the risks and the benefits of the study.  
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For the qualitative assessment, each clinician who participated in the in-depth interview signed 
a written informed consent form after explaining the purpose, the risks and the benefits of the 
study.  
The study was approved by the National Institute for Medical Research (NIMR) Review Board in 
Tanzania (NIMR/HQ/R.8a/Vol.IX/823). Approval was also provided by the institutional review 
boards of the University of Basel (EKBB) and the Ifakara Health Institute (IHI). All study 
participants provided written informed consent.  
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Abstract 
Objective: 
To review the available knowledge on epidemiology and diagnoses of acute infections in 
children aged 2 to 59 months in primary care setting and develop an electronic algorithm for the 
Integrated Management of Childhood Illness to reach optimal clinical outcome and rational use 
of medicines 
 
Methods: 
A structured literature review in Medline, Embase and the Cochrane Database of Systematic 
Review (CDRS) looked for available estimations of diseases prevalence in outpatients aged 2-
59 months,  and for available evidence on  i) accuracy of clinical predictors, and ii) performance 
of point-of-care tests for targeted diseases. A new algorithm for the management of childhood 
illness (ALMANACH) was designed based on evidence retrieved and results of a study on 
etiologies of fever in Tanzanian children outpatients. 
 
Findings: 
The major changes in ALMANACH compared to IMCI (2008 version) are the following: i) 
assessment of 10 danger signs, ii) classification of non-severe children into febrile and non-
febrile illness, the latter receiving no antibiotics, iii) classification of pneumonia based on a 
respiratory rate threshold of 50 assessed twice for febrile children 12-59 months; iv) malaria 
rapid diagnostic test performed for all febrile children. In the absence of identified source of 
fever at the end of the assessment, v) urine dipstick performed for febrile children <2years to 
consider urinary tract infection, vi) classification of ‘possible typhoid’ for febrile children >2 years 
with abdominal tenderness; and lastly vii) classification of ‘likely viral infection’ in case of 
negative results.  
 
Conclusion: 
This smartphone-run algorithm based on new evidence and two point-of-care tests should 
improve the quality of care of <5 year children and lead to more rational use of antimicrobials. 
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Background 
The rapid spread of resistant pathogens worldwide calls for urgent action to improve the rational 
use of antimicrobials. In low and middle income countries, where infectious diseases childhood 
mortality is high (Liu et al., 2012), substandard drugs, auto-medication and health workers 
(HWs)’ over-prescription of antimicrobials are driving the rapid spread of antimicrobial 
resistance (Mayor, 2010, World Health Organization, 2009).Recent experience in malaria case 
management has shown that using appropriate diagnostic tools (malaria rapid diagnostic tests – 
mRDT) has the potential to improve rational use of antimalarial (D'Acremont et al., 2011, 
Msellem et al., 2009, Thiam et al., 2011).without negative impact on health outcome (Baiden et 
al., 2012, d'Acremont et al., 2010b, Msellem et al., 2009, Mtove et al., 2011, Senn et al., 2012). 
Unfortunately it has often been accompanied with an increased antibiotics prescription (Baiden 
et al., 2011b, D'Acremont et al., 2011, Msellem et al., 2009), reflecting the challenge faced by 
HWs in front of a negative malaria test result, where diagnostic tools and skills to rule out 
bacterial diseases are scarce. 
 
To support HWs’ decision making in the management of a sick child in low resource settings, 
WHO and UNICEF have developed the Integrated Management of Childhood Illness (IMCI) 
clinical algorithm in the mid 90’s (Gove, 1997). The IMCI guidelines rely on the classification of 
patients based on clinical signs that can be recognized by trained HWs even if their educational 
background is limited (Gove, 1997); no laboratory test was included in the IMCI version of 2008: 
presumptive malaria treatment was recommended for all febrile children (in high malaria risks 
area). Other causes of fever were not considered (except if the child presented also a complaint 
leading to another branch of the algorithm). With the advent of new evidence on etiologies and 
management of childhood illness and reliable point-of-care tests (POCTs), there is a need to 
rethink the IMCI guidelines and to propose a new algorithm for the management of acute 
medical illness for children aged 2 to 59 months living in low resource settings. This new 
algorithm should integrate reliable POCTs and, when the latter are not available, clinical 
predictors for acute illnesses, so that guidance based on best available evidence is provided to 
clinicians to decide on withholding antimalarials and antibiotics when not beneficial to the child. 
When no tool or strong evidence is available to propose appropriate procedures, expert opinion 
should be sought.  
An algorithm developed for HWs in remote primary health care facilities (PHCF) should rely on 
simple clinical signs and easy-to-perform POCTs. Its structure should remain simple, although 
addressing a larger set of diseases may require a more complex one. The use of hand-held 
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electronic technology to deliver the algorithm may facilitate the use of a complex clinical 
algorithm by HWs of varying backgrounds. Smartphones and tablets have the potential to 
facilitate the scale-up of standard recommendations in low resource settings. 
 
Materials and Methods 
Structured literature reviews 
In order to identify the relevant diseases to be addressed in the algorithm, estimated data on the 
causes of global childhood mortality and morbidity from the Child Health Epidemiology 
Reference Group (CHERG)(CHERG) publications, and from the Global Burden of Disease 
website (IHME, n.d.)  were reviewed to assess the burden of diseases in African children. A 
structured literature review (SLR) was also conducted to understand the clinical presentation 
(accurate clinical predictors) and diseases’ distribution in children under 5 years of age (U5) 
attending PHCFs in developing countries, as well as appropriate POCTs for the diagnosis of the 
targeted diseases.  
Medline (PubMed), Embase (Ovid), and the Cochrane Database of Systematic Reviews 
(CDSR) were explored from inception to December 31st 2010, looking for articles assessing i) 
the prevalence of diseases and clinical features in U5 attending outpatient facilities in 
developing countries, and ii) the accuracy of diagnostic procedures for each of the targeted 
diseases. The detailed search strategy is described in Table 1. 
 
Papers involving U5 managed for acute medical conditions in ambulatory settings were 
selected. Studies involving only infants below 3 months of age or only adults were excluded. For 
prevalence of syndromes and diseases at PHCF, studies describing the clinical presentation 
and/or diagnoses presented by U5 attending outpatients facilities in developing countries were 
selected. For diagnostic procedures of targeted diseases, studies assessing accuracy of either 
clinical predictors or POCT were chosen. Systematic reviews addressing the questions of 
interest were also considered. An additional hand searching of reference lists of selected papers 
completed these searches. In order to better explore the accuracy of the clinical diagnosis for 
pneumonia, a systematic review of the literature and meta-analyses of studies assessing the 
diagnostic accuracy of clinical predictors was conducted, reported elsewhere (Rambaud Althaus 
et al, submitted). 
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Table 1: Structured literature reviews: search strategy 
 Pubmed Embase 
1 "primary health care" OR "outpatients" OR 
"family practice" OR "emergency service" OR 
"ambulatory care" 
  
2 "fever/etiology"[MeSH Terms] OR 
"fever/diagnosis"[MeSH Terms] OR 
"fever/epidemiology"[MeSH Terms] 
  
3 "developing countries"   
4 prevalence OR epidemiology OR incidence   
5 "predictive value of tests"[MeSH Terms] OR 
"sensitivity and specificity"[MeSH Terms] OR 
"reproducibility of results"[MeSH Terms] OR 
diagnostic test OR diagnostic tests OR 
"physical examination"[MeSH Terms] 
OR"medical history taking"[MeSH Terms] 
'diagnostic accuracy'/exp OR 
'predictor variable'/exp  
6 "pneumonia"[MeSH Terms] 'pneumonia'/exp OR 'lower 
respiratory tract infection'/exp 
OR 'respiratory tract 
infection'/exp 
7 “typhoid fever” [MeSH Terms]  'typhoid fever'/exp  
8 “urinary tract infections”[MeSH Terms]  'urinary tract infection'/exp 
9 “otitis media”[MeSH Terms]  'otitis media'/exp 
10 “shigella”[MeSH Terms] OR “dysentery”[MeSH 
Terms] 
'shigellosis'/exp 
11 Filters: Infant: 1-23 months; Preschool Child: 2-
5 years 
'child'/exp 
Prevalence [ 1 AND ( 2 OR [3 AND 4]  ] ) AND 11   
Diagnostics 6 AND 5 AND 11 6 AND 5 AND 11 
 
7 AND 5 AND 11 7 AND 5 AND 11 
 
8 AND 5 AND 11 8 AND 5 AND 11 
 
9 AND 5 AND 11 9 AND 5 AND 11 
  10 AND 5 AND 11 10 AND 5 AND 11 
Findings of the study on causes of fever in outpatient Tanzanian children 
In a recently published study on etiologies of fever conducted in outpatient clinics in Tanzania 
(Tanzanian fever study), clinical assessments and laboratory tests were performed in 1005 
febrile children aged 2 months to 10 years (95% were U5) to establish the most probable 
causes of fever (D'Acremont et al., 2014). The distribution of diagnoses, overall and stratified by 
age, was taken into account to select the targeted disease included in the final algorithm. The 
clinical predictors for the targeted diseases identified in the Tanzanian fever study were also 
used to build the new algorithm (De Santis et al, in preparation). 
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Algorithm construction 
With the IMCI algorithm for children 2-59 months of age as departure point, the evidence 
retrieved from the SLRs and from the Tanzanian fever study was used to propose modifications 
and new recommendations when relevant, and to design a new decision tree. Diseases were 
included in the algorithm if they were treatable, and responsible for i) high child mortality and 
morbidity, ii) high attendance rate at outpatient facilities, and, iii) high antimicrobial prescription 
rate. Clinical features that could easily be assessed by HWs of varying background and POCT 
easy to deploy in low resource ambulatory settings were integrated in the classification 
procedures, when its use improved the classification accuracy. The treatment options proposed 
in ALMANACH were in line with the 2008 WHO IMCI (WHO, 2008)  and the Tanzanian National 
Standard Treatment guidelines (Ministry of Health and Social Welfare, 2007) since the algorithm 
was intended to be used in Tanzania and had to comply with local policies. Once the new 
algorithm was finalized, both a paper booklet and an electronic software running on android 
smartphones and tablets were developed. For the paper booklet, the IMCI structure in 3 steps 
was kept - “Assess, Classify, and Treat” - , as well as the color-coded triage system: red for 
conditions that require urgent referral, orange for conditions requiring specific treatment, and 
green for condition needing simple counseling and symptomatic home management (Gove, 
1997). 
 
Results  
Flow diagrams of studies selection for the SLRs are available in Figure 1. 
All modifications made to the IMCI content based on new findings are presented in Table 2. 
The major changes concerned: malaria and pneumonia diagnosis; otitis media treatment; the 
addition of urinary tract infection (UTI) and possible typhoid fever; and a new classification 
entitled “likely viral infection”. The most important modifications are discussed below. 
Selection of syndromes or diseases to be addressed by the algorithm 
Estimations of burden of diseases by CHERG (Liu et al., 2012)  and IHME (IHME, n.d., Lozano 
et al., 2012) reported that low respiratory tract infections/pneumonia, malaria, and diarrhea were 
the leading causes of child mortality in 2010, globally and in Sub Saharan Africa (SSA). These 3 
infectious diseases were estimated to be responsible for more than 40% of U5 deaths in SSA. 
They were also the leading causes of morbidity, responsible for 41% of the total 2010 DALYs in 
SSA (IHME, n.d.) Other frequent causes of child mortality were HIV/AIDS (3.5 to 4% of U5 
deaths in SSA (IHME, n.d., Liu et al., 2012), meningitis (3 to  
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Figure 1. Flow diagram of study selection process in the structured literature reviews 
4% (IHME, n.d., Liu et al., 2012), measles (1%) (IHME, n.d., Liu et al., 2012), and tuberculosis 
(0.8%). In infants aged 1 to 11 months, pertussis (2.8% of deaths in 1-11 months infant in SSA) 
and syphilis (2.3%) were also frequent causes of death (IHME, n.d.). In children aged 1 to 4 
years, typhoid fever was estimated to be responsible for 0.6% of both DALYs and deaths, and 
bacterial skin diseases for 0.7% of  DALYs, and 0.2% of deaths (IHME, n.d.).  
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 Table 2:  Major changes in ALMANACH as compared to IMCI algorithm based on evidence and experts’ opinion 
Location Topic IMCI ALMANACH Rationale 
Management 
of very 
severe 
diseases 
section 
Very 
severe 
diseases 
“A child with any general 
danger signs needs 
URGENT attention; 
complete the assessment 
and pre-referral treatment 
immediately so that referral 
is not delayed” 
If the child has any general 
danger sign, HWs are not 
asked to complete the 
assessment of all symptoms, 
but rather to “Give pre-
referral treatment and 
REFER URGENTLY”  
To complete the assessment would delay pre-
referral treatment, and impair prognosis. In 
presence of general danger sign, the priority is 
to give rapidly presumptive AB/AM treatment 
(Dellinger et al., 2008, Gaieski et al., 2010) and 
to refer to hospital, where further etiological 
investigations will allow adapting the treatment. 
List of 
general 
danger 
signs 
“Lethargic; Convulsing; 
Unable to drink/breastfeed; 
Vomits everything; History of 
convulsion” 
 
“Convulsing; Lethargic; 
Unable to drink/breastfeed; 
Vomits everything; History of 
convulsion; Jaundice; 
Cyanosis; Stiff neck; Severe 
pallor; Severe wasting” 
Stiff neck, severe pallor, and severe wasting 
(assessed later on in IMCI) are part of the 
ALMANACH initial assessment, in order to 
facilitate and fasten the detection and 
management of very severe diseases. 
Jaundice and cyanosis that are strong 
predictors for serious bacterial diseases and 
severe respiratory conditions (D'Acremont et 
al., 2014), have been added to the general 
danger signs. 
Pre-
referral 
treatment 
Available in the “TREAT 
THE CHILD” section in the 
middle of the booklet 
Available in the “Management 
of very severe diseases” 
section in the first pages of 
the booklet 
To facilitate and fasten the management of 
severe patients, the first section “Management 
of very severe diseases” has all assessment, 
classification and treatment charts together. 
Management 
of children 
with no 
general 
danger 
signs 
Fever§ Fever§ is one of the 4 “Main 
symptoms”.  
 
Fever is a crossing point in 
ALMANACH: different 
recommendations are made 
for children (non-severe) with 
or without fever§. 
In children having no underlying chronic 
condition, and no danger signs, only few 
bacterial infections should be considered. Apart 
from dysentery and soft tissue infection, 
antibiotics are not recommended in the 
treatment of non-severe non-febrile conditions 
in ALMANACH. 
Fever Classifications considered in 
the Fever chart are: “Very 
severe disease”, “Malaria” 
and “Measles”.  
Additional classification in 
Classifications considered in 
the Fever algorithm: “Malaria”, 
Acute respiratory infections, 
including “Pneumonia”; 
Diarrhea related 
Designing a specific chart for patients with fever 
allows considering more fever related 
classifications than in IMCI, thus to address 
relevant non-malaria fever. This design allow 
also to consider “Likely Viral infections” after 
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low malaria risk contexts: 
“Fever, malaria unlikely” 
classifications; Ear related 
classification; Measles; Skin 
infections; “UTI”, “Typhoid 
fever”, “Likely viral infection” 
having excluded potentially life threatening 
conditions  
Febrile chart Malaria Presumptive diagnosis of 
malaria for all children with 
fever in high malaria risk 
contexts 
Test-based malaria diagnosis 
is recommended, using 
mRDTs in all children with 
fever. Antimalarials only 
recommended in test positive 
patients 
The accuracy, the performance and the safety 
(d'Acremont et al., 2010b) of a diagnostic 
strategy based on mRDTs have been evaluated 
and demonstrated in U5. 
Febrile 
Cough chart 
Pneumonia Pneumonia diagnosis rely 
on increased respiratory rate 
(RR) above age specific 
threshold: 50 breath/min if 
aged 2-11 months; 40/min if 
aged 12-59 months 
Pneumonia is considered in 
children aged 2-59 months, if 
they report the presence of 
fever and have a RR equal to 
or above 50 breaths/min  
The need of antibiotics in children aged 2-59 
months with non-severe pneumonia as defined 
in IMCI is questioned(Hazir et al., 2011). In 
children aged 12-59 months the gain in 
sensitivity doesn’t balance the loss of specificity 
for the diagnosis of pneumonia when using the 
threshold 40 instead of 50 breath/min. (see 
results section) 
Ear problem 
chart 
Acute ear 
infection 
Oral antibiotics are 
recommended for “Acute ear 
infection” defined as either 
“ear pain” or “ear pus/ 
discharge for less than 14 
days” 
Oral antibiotics are only 
recommended for children 
with fever and “ear pus/ 
discharge for less than 14 
days” 
The need for antibiotics for otitis media is 
questioned (Sanders et al., 2010). Ear pain is a 
weak predictor of otitis media (Ingvarsson, 
1982, Niemela et al., 1994, Uhari et al., 1995) 
especially in children below 2 years of age. AB 
are most useful for children with otitis media 
and ear discharge (Sanders et al., 2010).  
Skin 
problem 
chart 
Skin and 
soft tissue 
infections 
Some guidance provided in 
an annex and not integrated 
with the complaints of the 
main algorithm 
Referral to hospital is 
recommended for febrile skin 
lesions with a size >4 cm or 
associated with red streaks or 
tender nodes, and for multiple 
abscesses. 
Local treatment and home 
management is 
recommended for impetigo 
and minor abscesses 
Severe soft tissue infections require in hospital 
treatment and injectable antibiotics. 
Limited skin infections can be safely managed 
by topical treatment. 
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Febrile chart 
for “Fever 
with no 
identified 
cause” after 
symptom 
charts 
assessment 
Urinary 
tract 
infection 
Not considered in IMCI Considered in non-severe 
febrile children, under 2 years 
of age, with no primary focus 
identified; and in children, 
above 2 years of age, with 
dysuria. Urinalysis using a 
dipstick is recommended for 
the diagnostic.  
UTI is most frequent in children under 2 years 
of age. Above 2 years of age, the specificity of 
dysuria symptoms is low.  
The accuracy and performance of dipstick for 
UTI diagnosis have been demonstrated. 
Dipsticks for pregnancy follow-up were already 
broadly available in PHCFs in Tanzania; 
dipsticks for urinalyses were available in Health 
Centers.  
Typhoid 
fever 
Not considered in IMCI In non-severe febrile children 
above 2 years of age, with no 
primary focus identified, 
abdominal palpation is 
recommended. In presence of 
tenderness, a presumptive 
treatment for typhoid fever 
and invasive intestinal 
bacterial infections is 
recommended. 
Typhoid fever and other invasive enteric 
infections are life threatening conditions. In low 
resource care facilities, HWs fear to miss these 
diagnoses and tend to overprescribe antibiotics 
to children with no identified causes of fever. In 
the Tanzanian fever study, abdominal 
tenderness was associated with invasive 
bacterial infections and typhoid (D'Acremont et 
al., 2014), in children above 2 years of age. 
 
AB: antibiotics, AM: antimalarials, HW: health worker, IMCI: Integrated Management of Childhood Illness, PHCF: primary health care 
facility, U5: children under 5 years of age, UTI: urinary tract infection. §Fever is defined by either history of fever or axillary 
temperature above 37.5°C or child feels hot.  
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The SLR identified 22 articles assessing either symptoms or diagnoses distributions, or both, in 
children attending outpatient facilities in developing countries. In all selected papers assessing 
symptoms, fever (by history or measured, hereafter referred as fever), cough and diarrhea were 
the most frequent symptoms reported, respectively by 65 to 93% (Barat et al., 1999, Kolstad et 
al., 1997, Perkins et al., 1997, Rowe et al., 2007, Van Hemelrijck et al., 2009, Weber et al., 
1997), 44 to 82% (Kolstad et al., 1997, Perkins et al., 1997, Rowe et al., 2007, Van Hemelrijck 
et al., 2009, Weber et al., 1997), and 22% to 45% (Kolstad et al., 1997, Perkins et al., 1997, 
Rowe et al., 2007) of children. Diseases of potential bacterial origin reported in the studies 
retrieved by the SLR were: pneumonia (reported in 5 to 30% of children (Animut et al., 2009, 
Chanda et al., 2009, D'Acremont et al., 2014, Factor et al., 2001, Khallaf et al., 1996, Kolstad et 
al., 1997, Njama-Meya et al., 2007, Perkins et al., 1997, Salaria and Singhi, 2003, Simoes et al., 
1997, Van Hemelrijck et al., 2009, Weber et al., 1997),  
typhoid fever (3 to 13% (Animut et al., 2009, D'Acremont et al., 2014, Van Hemelrijck et al., 
2009), dysentery (3 to 12% (Factor et al., 2001, Kolstad et al., 1997, Simoes et al., 1997), otitis 
media (2 to 12% (d'Acremont et al., 2010b, Factor et al., 2001, Khallaf et al., 1996, Kolstad et 
al., 1997, Njama-Meya et al., 2007, Perkins et al., 1997, Simoes et al., 1997, Weber et al., 
1997), UTI (1 to 7% (D'Acremont et al., 2014, Downs, 1999, Factor et al., 2001, Njama-Meya et 
al., 2007, Shaikh et al., 2008, Van Hemelrijck et al., 2009); and meningitis (0 to 3% (Factor et 
al., 2001, Kolstad et al., 1997, Salaria and Singhi, 2003). Tonsillitis was reported in 1% of 1005 
children in the Tanzanian fever study; all had a negative streptococcal diagnostic test 
(D'Acremont et al., 2014).  Another study  reported tonsillitis or pharyngitis in 10% of the 
children, but no streptococcal test was performed (Njama-Meya et al., 2007).  
Among the bacterial infections frequently reported, only typhoid fever, UTI and tonsillitis were 
not yet addressed in IMCI. The fear of these 3 infections is often a reason to prescribe 
antibiotics in low resource setting. With regards to tonsillitis, early recognition and treatment of 
streptococcal tonsillitis is of high importance to prevent rheumatic fever and its complications, 
but prevalence of group A β-hemolytic streptococcus is much lower in U5 than in older 
children(Shaikh et al., 2010), and close to zero in children under 2 years of age (Woods et al., 
1999). Moreover, acute rheumatic fever and rheumatic heart disease are rare in U5 (Carapetis 
et al., 2000, Tibazarwa et al., 2008). Therefore addressing streptococcal tonsillitis in the 
management of U5 was considered not to be necessary. UTI and typhoid fever were thus 
selected to be addressed in the new algorithm, together with the other diseases already 
addressed in IMCI. 
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Identification of severe illnesses  
In the IMCI algorithm, urgent referral to hospital is recommended in the presence of any of 5 
general danger signs (difficulty in drinking, repeated vomiting, had convulsion, lethargy or 
unconsciousness, convulsing) or in presence of any of the 8 symptom-related danger signs 
(danger sign related to fever: stiff neck; related to cough: stridor or chest indrawing; related to 
measles features: clouding of cornea or extensive mouth ulcers; related to malnutrition: severe 
wasting or oedema of both feet; related to pallor: severe palmar pallor). The usefulness of these 
IMCI referral criteria were evaluated in two studies (Paxton et al., 1996, Kalter et al., 1997). 
These studies estimated the accuracy of the presence of any of the danger signs to predict 
hospital referral. Estimates of sensitivity and specificity were  46% and 79% respectively in the 
Kenyan study (Paxton et al., 1996) and 86% and 64% respectively  in the study conducted in  
Bangladesh (Kalter et al., 1997). In the Kenyan study, accuracy of these criteria to predict death 
in admitted U5 patients was also assessed (sensitivity 89%, specificity 44%) (Paxton et al., 
1996). A systematic review for children in developed countries (Van den Bruel et al., 2010) has 
also identified reduced consciousness, convulsions, cyanosis, rapid breathing, and slow 
capillary refill as the strongest predictors of severe illness. Meningeal irritation was also a strong 
predictor of serious bacterial infection in 3 reported studies [likelihood ratio (LR) ranging from 
2.57 to 275] (Van den Bruel et al., 2010). While reviewing the underlying evidence used to build 
the recommendations for referral in IMCI, only very few studies were identified. As for IMCI, one 
of the main aims of the present algorithm is to allow early identification and referral of children 
with severe conditions and serious bacterial infections; therefore, to ensure good sensitivity, all 
the IMCI referral criteria were kept although underlying evidence was scarce , and 2 signs 
predicting serious infections were added to the IMCI general danger signs, i.e. cyanosis that is 
broadly recognized as a sign of severe hypoxemia (Van den Bruel et al., 2010) and jaundice 
that was shown to be predictive of bacterial disease in the Tanzanian fever study (D'Acremont 
et al., 2014) and can also be associated with severe malaria (WHO, 2000). In order to improve 
and fasten the identification of severe patients,  all general danger signs, were grouped together 
with stiff neck, severe wasting, and severe pallor at the beginning of the assessment chart, 
instead of having some of them included in the branches for each syndrome. Danger signs 
related to specific symptoms were kept within the symptoms related charts, such as chest 
indrawing with cough, or tender swelling behind the ear with ear problem. Children with general 
danger signs are classified as having ‘Very severe disease’. These children with general danger 
signs are at risk of severe sepsis. In ALMANACH, acknowledging that early antimicrobials can 
improve the outcome of these children prognosis (Dellinger et al., 2008, Gaieski et al., 2010), 
24 
 
and realizing that the full assessment would not modify this recommendation, a separate 
management chart was developed for patients with danger signs, allowing prompt presumptive 
treatments, and skipping assessment tasks that would only delay the rapid management and 
referral these children require. 
 
Malaria diagnosis 
Decline in the proportion of fevers due to malaria (D'Acremont et al., 2010a) together with the 
availability of easy-to-use, reliable POCTs– i.e. mRDTs – have driven the WHO 
recommendations to shift in 2010 from presumptive to test-based malaria case management 
(WHO, 2010a). The safety of a mRDT-based malaria case management in U5 has been 
demonstrated (d'Acremont et al., 2010b, Baiden et al., 2012, Faucher et al., 2010, Mtove et al., 
2011, Mubi et al., 2011, Senn et al., 2012). Several African countries have now changed their 
malaria diagnosis policy and adopted the use of mRDTs in their national programs.  Following 
the new WHO malaria treatment guidelines, the use of mRDTs was integrated in present 
algorithm. mRDTs were also recently added officially to the WHO/UNICEF generic IMCI 
algorithm (WHO and UNICEF, 2014). 
 
Pneumonia diagnosis 
In a recent meta-analysis of clinical predictors for radiological pneumonia (Rambaud Althaus et 
al, submitted), the clinical features with the higher pooled LR were respiratory rate ≥50 
breaths/min (LR 1.90; 95%CI 1.45-2.48), grunting (1.78; 1.10-2.88), lower chest indrawing 
(1.76; 0.86-3.58), and nasal flaring (1.75; 1.20-2.56). The best features to rule out the diagnosis 
(having the lowest pooled LR) were: no history of fever (0.53; 0.41-0.69), and respiratory rate 
≥40 breaths/min (0.43; 0.23-0.83). Cough had also a low but heterogeneous LR (0.30; 0.09-
0.96). The IMCI criterion for pneumonia classification, i.e. age-related fast breathing (≥50/min 
from 2 to 11 months, and ≥40/min from 12 to 59 months) showed low diagnostic performance in 
the meta-analysis, both to rule in the disease (presence of fast breathing had a pooled LR of 
1.55 (0.44-5.42) and to rule it out (absence of fast breathing had a pooled LR- of 0.63 (0.16-
2.55). In the Tanzanian fever study, the best predictors to rule in radiological pneumonia among 
all febrile children were difficult breathing (LR 7.9, 2.8-22.1), chest indrawing (7.1; 2.9-17.6), 
nasal flaring (7.0; 2.5-19.4), respiratory rate ≥50/min (6.1; 3.5-10.4) and abnormal chest 
auscultation (5.5; 3.7-8.1). No feature was good at ruling out the diagnosis. In the present 
algorithm, in the absence of a reliable point-of-care diagnostic test, we decided to combine the 
best available clinical predictors (history of fever, cough, difficult breathing and fast breathing), 
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except nasal flaring and grunting, and abnormal chest auscultation because most IMCI trained 
clinicians are not familiar with these features. Chest indrawing was kept but to decide on referral 
to hospital rather than to diagnose pneumonia, because of the relatively high proportion of these 
children that harbor hypoxemia (Subhi et al., 2009). Regarding fast breathing, because using an 
age-related threshold did not improve the diagnostic test accuracy in the meta-analysis 
(Rambaud Althaus et al, submitted), a single threshold of ≥50/min for all age groups was 
chosen; 50/min rather than 40/min was chosen to ensure a reasonable specificity, knowing that 
most of pneumonias in young children are due to viruses (Feikin et al., 2013). The 
recommendation in the present algorithm is thus to prescribe antibiotics for pneumonia to 
children with [history of fever or elevated temperature] AND [cough or difficult breathing] AND 
respiratory rate ≥50/min, regardless of the malaria test result. 
 
Otitis Media 
In the SLR 7 articles and a systematic review that addressed the question of the accuracy of 
symptoms and signs for the diagnosis of otitis media were retrieved (Coker et al., 2010). In 
these studies, some otoscopic signs were strongly associated with otitis media diagnosis (Coker 
et al., 2010), but in low resource settings otoscopy is not available in ambulatory care. Other 
symptoms, such as earache, ear rubbing, and fever, although reported as associated with otitis 
media in 4 old studies (LR 3.03 to 7.3 (Heikkinen and Ruuskanen, 1995, Niemela et al., 1994, 
Uhari et al., 1995), were not associated with this diagnosis when reported by parents of children 
aged 6 to 36 months attending primary care offices in a more recent study (Sanders et al., 
2010). Otitis media is often a self-limiting condition in young children. The 2010 Coker (Coker et 
al., 2010) and Sanders’ Cochrane (Sanders et al., 2010) reviews, looking at available evidence 
of the benefit of antibiotic treatment for otitis media, report that there is little benefit (compared 
to placebo) and no evidence that antibiotics reduce complications or recurrence (Coker et al., 
2010, Sanders et al., 2010). An individual patient data meta-analysis from 6 randomised trial 
reported that antibiotics were more beneficial in children aged less than 2 years with bilateral 
otitis media, and in those with both otitis media and otorrhoea. In children with otorrhoea, 60% 
of controls and 25% of those on antibiotics still had pain, fever or both at 3-7 days, with a rate 
difference of -36% (95%CI -53% to -19%) and a number needed to treat of 3, whereas in 
children without otorrhoea the rate difference and NNT were respectively -14% (-23% to -5%) 
and 8 (Rovers et al., 2006). 
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Otitis media being often a self-limiting condition in young children, in the absence of accurate 
non-otoscopic clinical predictors the new algorithm propose to limit antibiotic prescription to 
children presenting with ear discharge.  
 
Urinary tract infection  
Two articles and 12 reviews assessing the accuracy of clinical predictors for the diagnosis of 
UTI in children were retrieved from the SLR. No additional article since the most recent review 
published in 2007 was found (Shaikh et al., 2007). The following predictors were identified: 
temperature >40°C (2 studies, LR 3.3; 1.3-8.3 (Hoberman et al., 1993) and LR 3.2; 0.7-15.6 
(Krober et al., 1985), jaundice (LR 2.1; 0.3-17.4) (Musa-Aisien et al., 2003), and suprapubic 
tenderness (LR 4.4; 1.6-12.4) (Shaw et al., 1998).  The absence of another source of fever on 
examination increased the probability of UTI (3 studies, summary LR 2.8; 1.9-4.3) (Shaikh et al., 
2007). Among children ≥2 years, abdominal pain (LR: 6.3; 2.5-16.0) (Musa-Aisien et al., 2003), 
dysuria (LR 2.4; 1.8-3.1) (Heale, 1973) and new-onset of urinary incontinence (LR 4.6; 2.8-7.6) 
(Heale, 1973) also increased the probability of UTI.  
In the Tanzanian fever study, the following predictors to rule in UTI were found: pollakiuria (LR 
3.5; 1.4-8.8), temperature >40°C (3.1; 1.4-7.1), fever for more than 3 days (2.1; 1.2-3.6) and 
age<2 years (1.4, 1.22-1.57); the best predictors to exclude UTI were: age≥3 years (LR 0.22; 
0.07-0.66), headache (0.27; 0.04-1.89) and diarrhea (0.33; 0.08-1.32) (De Santis et al, in 
preparation). Based on these predictors, several national and international guidelines 
recommend to consider this condition in febrile children below 2 years of age, with no obvious 
cause of fever (Downs, 1999, WHO, 2005b). No symptom or sign, nor combination of them is 
predictive enough in this age group to appropriately identify children with UTI. The gold standard 
(urine culture) is generally not available in low resources ambulatory setting. Urinalysis with 
urine dipsticks detecting leucocyte esterase and nitrite has been evaluated in many settings: 4 
systematic reviews with meta-analyses estimated  sensitivities for leucocyte esterase and/or 
nitrites to be 81% (Whiting et al., 2005), 88% (Gorelick and Shaw, 1999, Williams et al., 2010), 
and 93% (Downs, 1999) and specificities 72% (Downs, 1999), 79% (Williams et al., 2010), 93% 
(Gorelick and Shaw, 1999) and 97% (Whiting et al., 2005). A dipstick urinalysis negative for 
both nitrites and leukocyte esterase had a LR of 0.2 (95% CI, 0.16-0.26) (Shaikh et al., 2007). 
With either leucocyte esterase or nitrite positive the LR was 6.1 (95% CI, 4.3-8.6), increasing to 
28 (95% CI, 17-46) when both leucocyte esterase and nitrite were positive (Whiting et al., 2005). 
In 2005, the WHO department of Child and Adolescent Health and Development recommended 
the use of urinalysis by urine dipstick for the diagnosis of UTI in children wherever dipstick were 
27 
 
feasible (WHO, 2005b). With the implementation of the WHO focused antenatal care guidelines, 
urine dipstick for proteinuria detection have been implemented and are thus available in PHCFs 
in many African countries. Based on the good diagnostic performance of urine dipstick, and it’s 
feasibility in low resource setting, the new algorithm proposes to perform urine dipstick for the 
diagnostic of UTI in the patients at higher risk of UTI, i.e. children below 2 years of age having 
fever with no cause identified during the assessment (but regardless of the malaria test result, 
due to the possibility that the parasites might only correspond to an incidental infection and not 
the actual cause of the acute illness). For children from 2 to 5 years of age, only those 
complaining of dysuria are proposed a dipstick urinalysis. Antibiotic treatment for UTI is 
recommended when either leucocyte esterase or nitrite, or both are positive. 
 
Typhoid fever 
Regarding the diagnosis of enteric fever, 6 articles assessing clinical predictors of enteric fever 
were retrieved (Davis et al., 1999, Hosoglu et al., 2006, Khan et al., 1998, Kuvandik et al., 2009, 
Neopane et al., 2006, Vollaard et al., 2005). Only 2 were conducted in outpatients: one included 
patients above 15 years of age (Hosoglu et al., 2006) and the other patients above 4 years of 
age (Vollaard et al., 2005). None of the studies thus included our target population of U5 
outpatients. In the Tanzanian fever study (D’Acremont et al., 2014), the following predictors to 
rule in typhoid where identified: liver pain (LR 9.8; 2.7-35.5), abdominal tenderness (7.0; 3.3-
15.2), jaundice (6.2; 3.1-12.4) and age >2 years (2.0; 1.6-2.4). To rule out typhoid, only ‘not 
during rainy season’ was predictive (LR 0.50; 0.27-0.92) (De Santis et al, in preparation). 
Jaundice being already included as danger sign and liver pain being difficult to assess in a child, 
the new algorithm recommends looking for abdominal tenderness in children ≥2 years of age 
having fever with no cause identified during the child’s assessment (regardless of the malaria 
test result). When present, antibiotic treatment for typhoid fever is indicated. 
Likely viral infection 
Likely viral infection is a classification proposed in the present algorithm that does not exist in 
IMCI. Unnecessary antibiotics are often prescribed in febrile children by HWs when they do not 
manage to reach a diagnosis after their assessment, because they fear to have potentially 
missed a life-threatening bacterial infection. Because in the present algorithm most of the 
frequent bacterial infections have been assessed for, the probability that the child is still 
suffering from one is low if all findings are negative. Therefore, in the absence of danger signs, 
cough or fast breathing, diarrhea, ear discharge, symptoms of measles, infected skin lesion, 
abdominal tenderness, a positive dipstick urinalysis and a positive malaria RDT, the child is 
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classified as having a “Likely viral infection”. HWs are then proposed to withhold antibiotics and 
antimalarials, prescribe symptomatic treatment for fever if any, and advise the caretaker on 
when to come back if symptoms persist or worsen. 
Design of the algorithm 
Based on the modifications and adjunctions to IMCI that were retained, a new algorithm for the 
management of childhood illnesses (ALMANACH) was designed. Efforts were made to keep the 
ALMANACH structure simple and graphically easy to follow by HWs. Therefore the IMCI 3 steps 
assessment and color codes were kept. However, in order to increase the number of conditions 
addressed, ALMANACH has been divided into 3 charts. The first chart provides 
recommendations for assessment of general danger signs and management of severe patients, 
the second chart provides recommendations for patients with fever, and the last one for patients 
without fever (see Figure 2 for an overview of ALMANACH’s structure).  
 
This 3-charts structure allows i) fastening the assessment and management of severe children, 
for whom all recommendations are available in the very first part of the algorithm and ii) a more 
comprehensive and specific assessment of children, with pneumonia, malaria, UTI and typhoid 
fever being considered only in febrile children. In the IMCI algorithm, fever is one of the main 
symptoms. The IMCI fever box only considers malaria and measles for a child with acute fever 
(≤7 days) without danger signs. Within ALMANACH, the aim was to address non-malaria fever 
causes. Although parts of the algorithms, such as the diarrhea chart, are the same in both the 
‘febrile’ and ‘non-febrile’ algorithms, replacing the fever box by a full algorithm for children with 
fever or history of fever was necessary to propose meaningful considerations of fever causes in 
sequential pathways, allowing considering some conditions in a subset of patients only. In 
addition, this categorization allowed limiting antibiotic treatment in children without fever or 
history of fever.   
 
 
29 
 
 
 
Figure 2. An overview of the ALMANACH's structure 
ALMANACH was first designed as a paper booklet (Figure 3), it was then developed as an 
android application for smartphones, coding the different steps of the algorithm into a Java-
Rosa X form run by OpenDataKit and OpenMRS software (Open Data Kit, n.d., OpenMRS, 
n.d.). The electronic ALMANACH (e-ALMANACH) guides HWs through the child’s assessment 
up to the classification and treatment recommendations (Figure 4).Treatment dosages are 
computed according to the body weight or age when weight is not available. Moreover e-
ALMANACH collects in real time information on child demographic characteristics, disease 
classification and treatment prescribed. This information is stored by the mobile device, can be 
sent to a server and feed health information systems. 
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Discussion 
The aim of ALMANACH is to provide guidance to health workers on antimicrobial prescription, in 
order to treat only children aged 2 to 59 months who will potentially benefit from them. Apart 
from malaria, IMCI was not directly addressing causes of fever, leaving HWs with their fear of 
life-threatening conditions once malaria was ruled out by mRDT. On the other hand, viral 
infections that represent the vast majority of the causes of fever in U5 children (D'Acremont et 
al., 2014) are never explicitly mentioned or proposed as diagnosis in IMCI, giving a wrong 
impression to health workers that bacterial infections are frequent and that children should often 
be prescribed antibiotics. Using the best available and feasible diagnostic procedures for the 
main causes of acute illness in children attending PHCFs, the present new algorithm should 
address most of the concerns of HWs regarding bacterial infections and remind them that 
children often suffer from self-limited viral conditions that do not warrant any specific treatment 
beside antipyretics. By providing tools to rule out malaria, UTI, and typhoid fever and by 
proposing a new ‘Likely viral infection’ classification, the use of ALMANACH has thus the 
potential to improve the health outcome of febrile children and at the same time decrease 
unnecessary antimalarial and antibiotic prescriptions. The content of ALMANACH was based on 
literature reviews and expert opinions. The level of evidence provided by the literature was 
generally low and no formal process was followed to reach a broad expert consensus. Within 
the current project, only the POCTs currently available in low resource settings were 
considered, constraining the new algorithm to rely mostly on the best available simple clinical 
predictors. To further improve the quality of the management of pediatric illnesses and the 
rational use of medicines, accurate and affordable POCTs for bacterial or even viral infections 
are highly needed.  
While broadening the spectrum of diseases to be addressed, the algorithm became more 
complex than IMCI. This might be an issue for the targeted audience, i.e. HWs of different 
background working in low resource ambulatory settings. In order to facilitate understanding and 
usability of the decision chart, the 3 steps IMCI structure (Assess, Classify and Treat) and the 
color coded triage, already known by IMCI trained HWs, were kept. Electronic algorithms, by 
guiding HWs step by step through the algorithm, allow to using a more complex structure with 
lower risk of misuse. The electronic version of ALMANACH running on smartphones and tablets 
was designed to address these needs. 
Although ALMANACH broadened the spectrum of diseases addressed in the algorithm, some 
aspects of childhood illness were left uncovered. Indeed ALMANACH does not provide 
recommendations for the management of chronic or non-infectious conditions.  
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Figure 3. Samples of ALMANACH in the paper booklet form
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    Figure 4. Samples of ALMANACH in the electronic form 
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Within the current project, only identifiable and treatable acute infections were targeted because 
the objective was to improve the use of antimicrobials in order to tackle both the risk of 
resistance development due to their overuse and the high childhood mortality related to 
infectious diseases. 
Because the algorithm was meant for remote PHCF, full algorithms for the management of 
severe conditions, for HIV-infected and/or malnourished children were not developed; only 
recommendations on how to identify children suffering from these conditions and advice to refer 
them to the second level of care were provided. We foresee that developing and integrating 
additional algorithms for the management of these conditions, but also for other patients, either 
at primary or secondary level of health care systems, would allow further improvement of the 
quality of health services, but also better acceptability of the tool by HWs. However this was out 
of the scope of the present project.The paper and electronic ALMANACH have the potential to 
improve the management of the sick child. This has been demonstrated in a recently completed 
feasibility study, which showed the ALMANACH algorithm to improve health outcome of children 
managed with this tool and to drastically reduce antibiotic prescription (Shao et al, companion 
paper submitted). These results were obtained in two settings, urban and rural, albeit with a 
limited number of patients enrolled. They do not represent a definite validation of ALMANACH, 
but show great promise and should invite researchers to further explore the potentials of this 
new approach for a rational management of children aged 2-59 months. Further improvement 
could be brought by integrating other POCT detecting key pathogens once they become 
available, or even better, by integrating host biomarkers able to predict children in need of 
antibiotics or at risk of dying.  
Conclusion 
This smartphone-run algorithm based on new evidence and two point-of-care tests should 
improve the quality of care of <5 year children and lead to more rational use of antimicrobials. 
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Abstract 
Introduction 
The decline of malaria and scale-up of rapid diagnostic tests calls for a revision of IMCI. A new 
algorithm (ALMANACH) running on mobile technology was developed based on the latest 
evidence. The objective was to ensure that ALMANACH was safe, while keeping a low rate of 
antibiotic prescription. 
Methods 
Consecutive children aged 2-59 months with acute illness were managed using ALMANACH (2 
intervention facilities), or standard practice (2 control facilities) in Tanzania. Primary outcomes 
were proportion of children cured at day 7 and who received antibiotics on day 0.  
Results 
130/842 (15·4%) in ALMANACH and 241/623 (38·7%) in control arm were diagnosed with an 
infection in need for antibiotic, while 3·8% and 9·6% had malaria. 815/838 (97·3%;96·1-98.4%) 
were cured at D7 using ALMANACH versus 573/623 (92·0%;89·8-94·1%) using standard 
practice (p<0·001). Of 23 children not cured at D7 using ALMANACH, 44% had skin problems, 
30% pneumonia, 26% upper respiratory infection and 13% likely viral infection at D0. Secondary 
hospitalization occurred for one child using ALMANACH and one who eventually died using 
standard practice. At D0, antibiotics were prescribed to 15·4% (12·9-17·9%) using ALMANACH 
versus 84·3% (81·4-87·1%) using standard practice (p<0·001). 2·3% (1·3-3.3) versus 3·2% (1·8-
4·6%) received an antibiotic secondarily. 
Conclusion 
Management of children using ALMANACH improve clinical outcome and reduce antibiotic 
prescription by 80%. This was achieved through more accurate diagnoses and hence better 
identification of children in need of antibiotic treatment or not. The building on mobile technology 
allows easy access and rapid update of the decision chart. 
  
 
 
 
 
 
 
36 
 
Background 
About 7 million children under 5 years of age die each year despite the availability of  effective 
low-cost interventions (Chopra et al., 2013). The Integrated Management of Childhood Illness 
(IMCI) strategy developed by the World Health Organization (WHO), UNICEF and other 
partners in mid 1990s (Gove, 1997) could potentially prevent two-thirds of these deaths 
(Claeson et al., 2003). To date, IMCI is still a good tool and studies that assessed its impact 
showed borderline reduction of childhood mortality (Armstrong Schellenberg et al., 2004b). 
When health workers were trained to use IMCI, their performance in case management 
improved (Gouws et al., 2004, Nguyen et al., 2013), although cautious interpretation is needed 
due to heterogeneities in methodologies of assessment (Nguyen et al., 2013). Worldwide, the 
impact of IMCI has been less than expected due to health system challenges, such as shortage 
of health workers (Bryan et al., 2006, Munga and Maestad, 2009, Dominic A and Kurowski C, 
2005),  poor motivation and lack of supervision (Maestad et al., 2010, Huicho et al., 2005). All 
this leads to low compliance to the IMCI guidelines (Kelley et al., 2001, Simoes et al., 1997, 
Camara et al., 2008) and probably poorer health outcomes than it could be.  
 
IMCI is facing additional challenges. First, a precise evaluation of the clinical outcome of 
children when managed with the IMCI algorithm is lacking, which leaves a doubt about its real 
benefit. Some studies evaluated the clinical outcome of children with specific diseases or 
conditions, such as severe pneumonia at peripheral health facilities (Chowdhury et al., 2008, 
Hazir et al., 2008, Soofi et al., 2012) or malaria and pneumonia at community level (Mukanga et 
al., 2012, Hamer et al., 2012). These studies also demonstrated that effectively trained and 
supervised community health workers using malaria rapid diagnostic tests (mRDTs) with 
(Mukanga et al., 2012), or without (Hamer et al., 2012) respiratory rate (RR) timers could 
adequately classify and treat children less than 5 years with malaria and/or pneumonia at 
community level. The overuse of antimalarials was limited, but varying degrees of antibiotics 
over-prescription were observed (Mukanga et al., 2012). Secondly, patterns of disease and drug 
resistance have evolved dramatically in the last 20 years. The prevalence of malaria has 
considerably declined in the last decade across different settings (D'Acremont et al., 2010a). 
While mRDT has just been incorporated in the new IMCI version (MoHSW. et al., 2013), many 
national IMCI guidelines still recommend to treat presumptively all febrile children with 
antimalarials. Third, since the advent of mRDT, the proportion of patients receiving antibiotics 
has increased (D'Acremont et al., 2011, Batwala et al., 2011, Msellem et al., 2009), probably 
because clinicians have not enough guidance on how to proceed when mRDTs results are 
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negative. The new IMCI guidelines do not include precise guidance on typhoid fever, urinary 
tract infections (UTI) or other causes of unspecific fever. Even if these conditions might have 
limited impact on mortality, they are feared by primary health care clinicians who often prescribe 
antibiotics to prevent potential complications.    
 
Based on the IMCI algorithm, a review of the literature, and the results of an etiology of fever 
study conducted in Tanzania (D'Acremont et al., 2014), a novel ALgorithm for the MANAgement 
of CHildhood illness (ALMANACH) was developed (Rambaud Althaus et al, submitted). This 
algorithm was primarily aimed at decreasing unnecessary prescription of antibiotics in children, 
while ensuring same or even better clinical outcome compared to routine practice (non inferiority 
trial).The objective of the present study was to measure the impact of its use on clinical outcome 
and antibiotic prescription in children attending primary care facilities in rural and urban settings 
of Tanzania.  
Materials and Methods  
Study sites and subjects 
The study was conducted as part of a larger project which aimed at improving the quality of care 
and rational use of medicines for children in Tanzania (PeDiAtrick project, registration number 
PACTR201011000262218 at www.pactr.org). For the present study, two pairs (one from urban 
Dar es Salaam and one from the rural Morogoro region) of two nearby primary care health 
facilities (HF), similar in terms of natural environment, malaria prevalence, socio-economic 
status of the catchment population, and type of services available, were conveniently selected. 
Then, in Dar es Salaam, Ilala municipality (city center), Buguruni was randomly selected as 
intervention and Vingunguti as control HF; in Morogoro region, Kilombero district, Signal was 
selected as intervention and Mangula as control. We chose to conduct the study in different 
health facilities rather than to use a parallel design or recruit consecutively patients in the same 
health facility because the latter increased the risk of including patients with different disease 
frequency between the intervention (ALMANACH) and routine practice arms due to seasonal 
variation. There was also the risk of biased results due to contamination between arms because 
clinicians would have gained a better understanding of disease classification or change their 
behaviour in terms of antimicrobial prescription because of the ALMANACH training and use. 
Consecutive children aged 2 to 59 months were enrolled by trained study nurse if they fulfilled 
the inclusion criteria: 1) first consultation for the current illness; 2) absence of severe illness 
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requiring immediate life-saving procedures; 3) main complaint(s) not related to injury or trauma; 
4) living in the catchment area of the HF and; 5) written informed consent by the caretaker. 
Study design and procedures 
A controlled non-inferiority trial was conducted to compare the clinical outcome of children 
managed according to ALMANACH or to standard practice. Children enrolled in the intervention 
arm were managed by two study clinicians (one for each setting) who were trained to strictly 
comply with the ALMANACH algorithm, which was available on paper at the start of the study 
and used in the first 100 patients, and then built in an electronic support (smartphone running 
Open MRS) and used for the remaining 742 patients. Both versions were identical. In the control 
arm, children were attended by the usual HF clinicians, of which about 80% had been trained for 
IMCI (Adam et al., 2005). In general, this training had taken place several years before, and 
compliance to guidelines was known to be rather poor, with most patients receiving antibiotics, 
especially when tested negative for malaria (D'Acremont et al., 2011). mRDT and commonly 
prescribed medicines were made available throughout the study period in both arms.  
During the one-month pilot phase, study clinicians in the ALMANACH arm received face-to-face 
supervision with several real patients to check their ability to identify all relevant signs, including 
RR measurement. In the control arm, no algorithm, training or supervision was performed. 
Observing study clinician obtained oral consent from the routine clinician and observed the 
consultation to record key information such as symptoms, signs, laboratory investigation(s) 
performed, diagnosis(es), advice to caretakers and treatment(s) prescribed. He was instructed 
not to interfere with the consultation to avoid introducing additional bias to the observer effect.  
Ethics Statement 
All procedures followed the Good Clinical Practice guidelines. The study protocol and related 
documents were approved by Ethikkommission beider Basel in Switzerland, by the Institutional 
Review Board of the Ifakara Health Institute and by the National Institute for Medical Research 
Review Board in Tanzania (NIMR/HQ/R.8a/Vol.IX/823).  
Content of the ALMANACH algorithm  
The development and content of ALMANACH is described in another paper (Rambaud-Althaus 
et al, submitted). In brief, this new algorithm was based on IMCI, but differed on some key 
features presented in Table 3.  
Management of children during spontaneous re-attendance 
In the intervention arm, caretakers were informed to bring the child back to the study HF if 
he/she was not able to drink or breastfeed, became sicker, developed fever, fast or difficult 
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breathing, or blood in stool. During working hours, sick children were reassessed by the study 
clinician, and managed again according to ALMANACH. Out of working hours, children were 
managed by routine clinicians who were asked to record demographic data, laboratory results, 
diagnoses, treatments and need for referral in order to hand them back to the study clinician the 
day after. In the control arm, children were advised on when to come back and managed during 
re-attendance at the discretion of the routine clinician, who were asked to record the same 
information on the re-attendances and to hand them back to the study team. In both arms, 
information regarding visits to other health facilities than the study facilities, and on additional 
treatment received, was recorded during the follow-up visit at day 7.  
Follow-up of children at day 7 and 14 
Caretakers in both arms were asked to bring back their child on day 7 to assess if he/she was 
cured or not. Children were declared cured if the caretaker reported the child to be well. All 
children reported as not cured were attended by the clinician and managed again according to 
ALMANACH in the intervention arm and to usual practice in the control one. When the child had 
not recovered at day 7, caretakers were asked to return on day 14 for a new assessment. 
Caretakers whose children did not turn up at day 7 were reminded by phone about the visit and, 
if not reached, visited at home.  
Data collection, management and analysis 
In the intervention arm, a standardized case report form (CRF) was completed during the paper 
phase of the study. Data collection included demographics, all relevant symptoms and signs, 
laboratory investigation(s), diagnosis(es), advice and treatment(s) received. During the 
electronic phase (smartphone), a shorter version of the CRF was used not to repeat data that 
were automatically sent to the server when running through the decision chart. In the control 
arm, the observing study clinician filled another CRF that included all relevant information 
mentioned above. The CRFs were adapted from the health facility survey checklist 
questionnaire developed by WHO (WHO, 2003).  
Beside data sent directly from the smartphone to the server, all information was double-entered 
in Epi-info software version 3·5·3 (CDC Atlanta, USA). Data management and analysis were 
done using STATA software version 10·1 (College Station, Texas, USA). 
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Table 3: Key differences the IMCI and the new Algorithm for the MANAgement of 
Childhood illness (ALMANACH) (section dedicated to the management of acute 
conditions in children aged 2 months to 5 years 
 
IMCI algorithm New algorithm (ALMANACH)  
Danger 
signs 
5 danger signs managed at the 
start: unable to drink or 
breastfeed; lethargic or 
unconscious; vomits everything; 
convulsing now or has had 
convulsions  
Six additional danger signs 
assessed later: stridor; chest 
indrawing; sunken eyes; skin 
pinch goes back very slowly; 
stiff neck; tender swelling 
behind ear 
10 danger signs managed at the start: 
unable to drink or breastfeed; lethargic 
or unconscious; jaundice; vomits 
everything; convulsing now or has had 
convulsions; cyanosis; severe pallor; stiff 
neck and severe wasting 
Six additional danger signs assessed 
later: stridor; chest indrawing; ; sunken 
eyes; skin pinch goes back very slowly; 
tender swelling behind ear; infected skin 
lesion or lump larger than 4 cm or with 
red streaks or with tender nodes or 
multiple abscesses 
Fever  1 out of 4 Main symptoms  A dividing point between a febrile branch 
and a non- febrile branch 
Pneumonia Cough  
+ fast breathinga  
Fever + cough  
+ very fast breathingb 
Urinary 
Tract 
Infection Not considered  
Febrile child<2 years with no source 
identified at this pointc, and with a 
positive (leucocytes or nitrites) urine 
dipstick. 
Typhoid 
fever Not considered 
Febrile child ≥2 years with no source 
identified at this pointc, and with 
abdominal tenderness 
Likely viral 
infection Not existing 
Febrile child with no classification at the 
end of the algorithm 
Legend: 
a
 50 breaths/min for children aged 2 to 12 months, 40 breaths/min for children aged 12 months 
to 5 years.  
b
 50 breaths/min for all children (aged 2 months to 5 years).  
c
 No cough or difficult breathing, no diarrhea, no ear problem, no measles, no infected skin 
lesion or lump.  
 
The primary outcome measures were: i) proportion of children cured at day 7, and ii) proportion 
of children who received antibiotics on day 0. Secondary outcome measures were i) proportion 
of children admitted secondarily or who died, ii) proportion of children who received antibiotics 
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during the whole study period. The above proportions were compared between the intervention 
and control group using Chi-square test and, when appropriate, Fisher exact test.   
To calculate the sample size, we assumed that 95% of children managed with standard practice 
would be cured on day 7 (d'Acremont et al., 2010b). To show non-inferiority of the intervention 
arm with a 3% margin, 80% power and 0.05 level of significance, and using a ratio of 3:2 in 
order to have more patients in the intervention arm, we calculated that 816 patients in the 
intervention and 544 in the control arm were needed. Taking into account a 3% rate of loss to 
follow-up, the target sample size was thus 840 and 560 patients in the intervention and control 
arms respectively. 
 
Results 
Status at inclusion 
Between December 2010 and June 2011, 1467 children (median age 14 months) were enrolled, 
844 (523 in the urban and 321 in the rural setting) in the ALMANACH and 623 (353 in the urban 
and 270 in the rural setting) in the standard practice arm. Two children were then excluded, one 
because he was not visiting the health facility for the first time for the current problem, and one 
who was <2 months of age. Baseline characteristics of patients included are presented in Table 
4.  
The diagnoses distribution in the ALMANACH and standard practice arms are featured in Figure 
5 respectively. Acute respiratory infections (ARI), either alone or in combination with another 
condition besides malaria, accounted for 57% and 58% of the diagnoses in intervention and 
control arms. However, the classification within respiratory infections was quite different 
between arms: 10·3% (95%CI 8·3-12·4%) were classified as having pneumonia in the 
ALMANACH arm while 18·5% (15·4-21·5%) as having pneumonia and 17·0% (14·1-20·2%) as 
having ARI (a diagnosis given by routine clinicians when they did not classify further the 
respiratory infection but for which they tended to prescribe antibiotics) in the standard practice 
arm. Only 1·0% (0·1-1·2%) in the ALMANACH versus 12·0% (9·3-14·4%) in the standard 
practice arm were classified as having UTI. 3·8% (2·5-5·1%) were diagnosed with malaria alone 
or in combination with another diagnosis in the ALMANACH versus 9·6% (7·3-12·0%) in the 
standard practice arm, despite full availability of mRDT in all HFs. 
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Table 4. Baseline characteristics of the patients in the intervention (ALMANACH) and 
control (standard practice) arms 
 
Characteristic 
    ALMANACH Standard practice 
n/N % n/N % 
Gender  
   
 Females 407/842 48·3 300/623 48·2 
Age (in months)   
   
 2-12 426/842  50·6 241/623 38·7 
 13-24 216/842 25·7 174/623 27·9 
 25-36 106/842  12·6 89/623 14·3 
 37-48 64/842  7·6 81/623 13·0 
 49-59 30/842  3·6 38/623 6·1 
Main symptoms  
   
 Fever 571/842  67·8 511/623 82·0 
 Cough  498/842  59.1 355/623 57·0 
 Diarrhoea 184/842  21·9 76/623 12·2 
 Vomiting 57/842  6·8 78/623 12·5 
 Ear problem 14/842    1·7 13/623 1·5 
Fast breathing  
   
 ≥50 breaths per minute 100/351  28·5 42/310 13·6 
Danger signs 1/842  0·1 5/623 0·8 
 Lethargic 1/842 0·1 0/623 0 
 Vomiting everything 0/842  0 1/623 0·2 
 Unable to drink/breastfeed 0/842  0 2/623 0·3 
 History of convulsion  0/842  0 2/623  0·3 
Hospitalization at inclusion  
   
 Admission on day 0* 3/842  0·4 21/623 3·4 
 
*The control health facility of the rural area (Mang’ula Health Center) had a higher number of 
admissions on day zero because of the possibility to admit patients on site (unlike the 
intervention rural health facility (Signal Dispensary). 
Clinical outcome  
Cure rate at day 7 and 14 
0·5% (4/842) of children in the ALMANACH and 0·2% (1/623) in the standard practice arm were 
lost of follow-up. 97·3% children managed with ALMANACH were cured on day 7 versus 92·0% 
by standard practice (p<0·001) (Table 5). In the ALMANACH arm, of the 23 children not cured 
at day 7, 11 received an antibiotic on day 7; 22 were cured on day 14 and one on day 28 
(Figure 6). 10 of these 23 (44%) children had been diagnosed at inclusion with skin problems, 
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either alone or in combination with another diagnosis, 7 (30%) with pneumonia, 7 (30%) with 
URTI, 3 (13%) with likely viral infection outside URTI, and one patient with acute ear infection 
(Table 6). In the control arm, of the 50 children not cured on day 7, 48 children were cured on 
day 14, one child died and one was lost of follow-up (Figure 6).  
Among diagnoses found in at least 10 children at inclusion, pneumonia (7/101=7·0%), skin 
conditions alone (5/84=6·0%) and multiple conditions not requiring antibiotics (4/81=4·9%) were 
the conditions leading to the highest proportions of clinical failure at day 7 in the ALMANACH 
arm, and ARI (13/119=11·0%), skin conditions (3/28=11·0%) and diarrhea (3/33=9·0%) in the 
standard practice arm. 
A B
 
Figure 5. Distribution of diagnoses at the inclusion in the ALMANACH (A) and the 
standard practice (B) arms.  
*Diagnosis given by clinicians when they do not classify further the respiratory infections 
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Table 5. Clinical outcome and antimicrobials prescribed in children managed by 
ALMANACH and standard practice 
Outcome measure ALMANACH  Standard practice p-value 
  n/N % 95%CI  n/N % 95%CI  
Clinical outcome 
        
 Cured on day 7 815/838 97·3 96·1-98·4  573/623 92·0 89·8-94·1 <0·001 
 Cured on Day 14 837/838  99·9 96·6-
100·1 
 621/622  99·8 99·5-
100·2 
0·8 
Antibiotics prescribed 
        
 On day 0 130/842  15·4 12·9-17·9  525/623  84·3 81·4-87·1 <0·001 
 Between day 0 and 7 19/838 2·3* 1·3-3·3  20/623  3·2 1·8-4·6 0·3 
 On day 7 11/838  1·3 0·7-2·3  0/623 0 0 0·003 
 Total (at any day) 160/838  19·0 16·3-21·6  545/623  87·5 84·9-90·1 <0·001 
Antimalarials 
prescribed 
        
 On day 0 33/842 3·9 2·6-5·2  41/623  6·6 4·6-8·5 0·02 
 Between day 0 and 7 1/838  0·1 -0·1-0·4  7/623  1·1 0·3-2·0 0·01 
 On day 7 0/838  0 0  2/623  0·3 -0·1-0·8 0·2 
 Total (at any day) 34/838  4·1 2·7-5·4  50/623  8·0 5·9-10·2 0·001 
 
* 10 patients received antibiotics from study clinicians during working hours and 9 from routine 
clinicians out of working hours 
 
Complications 
Of the 838 children managed with ALMANACH, one child with likely viral infection on day 0 was 
brought by the caretaker on day 5 to a referral hospital where he was diagnosed with cellulitis. 
He was hospitalized for 10 days, received antibiotics and had recovered when visited on day 28. 
Of the 623 children managed by standard practice, two children were hospitalized secondarily. 
One had diarrhoea on day 0 and received cotrimoxazole, oral rehydration salt and zinc tablets. 
At day 3 he was brought to the same HF and diagnosed with severe dehydration. He was 
admitted for one day, received ringer lactate intravenously and was discharged the next day. At 
day 7 he had recovered. The other child was diagnosed with pneumonia on day 0, received 
benzyl penicillin and amoxicillin, and was sent home.  He was brought 5 days later to another 
HF where he was admitted for the same diagnosis and died 4 days later (see Figure 6). 
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Table 6. Characteristics of the 23 patients who were not cured at day 7 in the 
ALMANACH arm 
URTI=Upper respiratory tract infection, RR=respiratory rate, NA=not available 
 
* This patient is the same as patient n°8 in Table 7. He was secondarily admitted for cellulitis on day 5, 
received antibiotics on admission, was discharged after 10 days and was cured on day 28. 
 
 
 
 
 
N° 
Age 
(month) Diagnosis at day 0 
RR 
at day 
0 
Antibiotic 
prescribed 
on day 0 Diagnosis at day 7 
Antibiotic 
prescribed 
on day 7 
 
 
Hospitalized 
Cured 
at day 
14 
1 2 Severe pneumonia NA Yes Pneumonia Yes No Yes 
2 6 Pneumonia 52 Yes Pneumonia Yes No Yes 
3 6 Pneumonia 55 Yes Pneumonia Yes No Yes 
4 7 Pneumonia NA Yes URTI and dysentery Yes No Yes 
5 12 Pneumonia 53 Yes URTI and diarrhoea No No Yes 
6 13 Pneumonia  66 Yes URTI No No Yes 
7 7 Pneumonia and 
impetigo 
NA Yes Infected heat rashes No No Yes 
8 23 URTI NA No Diarrhoea No No Yes 
9 18 URTI NA No URTI No No Yes 
10 9 URTI NA No Diarrhoea No No Yes 
11 15 URTI and impetigo  32 No URTI and soft tissue 
infection  
Yes No Yes 
12 10 URTI and impetigo 44 No Impetigo No No Yes 
13 7 URTI, diarrhoea and 
impetigo 
36 No Pneumonia and 
diarrhoea 
Yes No Yes 
14 10 URTI and scabies NA No Pneumonia Yes No Yes 
15 12 Impetigo  No Soft tissue infection Yes No Yes 
16 16 Impetigo  No Soft tissue infection  Yes No Yes 
17 10 Infected skin rashes  No Skin abscess Yes No Yes 
18 3 Scabies  No URTI No No Yes 
19 16 Fungal infection   No Fungal infection No No Yes 
20 12 Likely viral infection NA No URTI No No Yes 
21 20 Likely viral infection NA No URTI No No Yes 
22* 11 Likely viral infection NA No Cellulitis Yes Yes No 
23 38 Acute ear infection  No Acute ear discharge Yes No Yes 
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Spontaneous attendance before day 7 
4·2% of children (35/838) in the ALMANACH and 5·1% (32/623) in the standard practice arm re-
attended spontaneously between day 0 and 7 (p=0·4). In the intervention arm, 19 (2·3%) 
patients were secondarily prescribed an antibiotic, 10 because of pneumonia, 5 diarrhea, 2 UTI, 
1 cellulitis and one tonsillitis (Table 7). All were cured at day 7, except the one who was 
hospitalized with cellulitis. Among 8 children who developed pneumonia secondarily, 6 were 
<12 months and had a RR at inclusion between 36 and 48/min, and 2 were ≥12 months and 
one had a RR of 42 (not measured for the other child due to absence of cough). On the other 
hand, 30 children ≥12 months with a RR between 40 and 50/min at inclusion did not develop 
pneumonia, and were cured at D7 without antibiotic. 
 
1467 children 
enrolled
2 children excluded: 
- not the first visit for the present problem (1)
- age <2 months (1)
1465 children 
included
842 managed with 
ALMANACH
623 managed with standard 
practice
4 lost of follow up
815 (97.3%)
cured at day 7
23 (2.7%)
not cured at day 7
50 (8.0%)
not cured at day 7
573 (92.0%)
cured on day 7
1 lost of follow up
1 died at day 9
1 hospitalized at day 5 
2 hospitalized at day 3 and 5 
1 cured on day 28
837 (99.9%) cured at day 14 621 (99.8%) cured on day 14
Day 7
Day 0
Day 1 to 6
Day 14
Day 28
35 (4.2%) re-attendances
32 (5.1%) re-attendances
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Table 7. Characteristics of the 19 patients who received antibiotics during re-attendance 
in the ALMANACH arm 
 
N° 
Age 
(month) Diagnosis at day 0 
Respiratory 
rate 
at day 0 
Antibioti
c 
prescrib
ed on 
day 0 
Clinician 
who 
prescribed 
antibiotics* 
Diagnosis 
at re-
attendance 
visit 
Cured 
at 
day 7 
1 10 Pneumonia 53 Yes Study Pneumonia Yes 
2 8 Pneumonia NA Yes Routine Pneumonia Yes 
3 10 Pneumonia 52 Yes Study UTI Yes 
4 8 
Pneumonia and 
measles 52 Yes Routine Diarrhoea Yes 
5 18 Likely viral infection NA No Study Pneumonia Yes 
6 21 Likely viral infection NA No Study Tonsillitis Yes 
7 56 Likely viral infection NA No Study UTI Yes 
8& 11 Likely viral infection NA No Study Cellulitis No 
9 10 Likely viral infection NA No Routine Diarrhoea Yes 
10 37 Likely viral infection NA No Routine Diarrhoea Yes 
11 6 URTI 46 No Study Pneumonia Yes 
12 4 URTI NA No Study Pneumonia Yes 
13 5 URTI NA No Routine Pneumonia Yes 
14 11 URTI 40 No Routine Pneumonia Yes 
15 13 URTI 42 No Routine Pneumonia Yes 
16 8 URTI and diarrhoea 48 No Study Pneumonia Yes 
17 5 UTI  Yes Study Pneumonia Yes 
18 9 Diarrhoea  No Routine Diarrhoea Yes 
19 36 Impetigo  No Routine Diarrhoea Yes 
 
*Out of working hours, the patient was evaluated and managed by a routine clinician of the HF 
rather than the study clinician. &This patient is the same as patient n°22 in Table 6 
 
Treatment prescribed 
15·4% (130/842) of children managed with ALMANACH received antibiotics on day 0 compared 
to 84·3% (525/623) by standard practice (p<0·001). In the ALMANACH arm, only 19 (2·3%) 
and11 (1·3%) children out of 842 received antibiotics secondarily, during spontaneous 
attendance and visit at day 7 respectively. The cumulative proportion of children prescribed 
antibiotics over the whole follow-up period (on day 0, between day 0 and day 7 and on day 7) 
was 19·0% in the intervention versus 87·5% in the control arm (p<0·001) (Table 5). In the 
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ALMANACH arm, the diagnoses at inclusion present in at least 10 patients for which antibiotics 
were most frequently prescribed secondarily were pneumonia (8/101=7·9%), likely viral infection 
(6/96=6·3%) and skin problem (4/84=4·8%).  
Discussion  
When strictly applied, the new ALMANACH algorithm resulted in better clinical outcome than 
standard practice, and in 80% reduction of antibiotics prescribed to children with acute illness. 
These improvements are probably due to a better identification of children with likely viral 
infection, and hence not needing antibiotics, while still identifying those with bacterial infections, 
or at least those who were likely to benefit from antibiotics.   
 
The rate of clinical failure with ALMANACH was expected to be equivalent to that of the control 
arm, because the standard practice in Tanzania is to prescribe antibiotics to most of the febrile 
patients, especially when mRDT are available (D'Acremont et al., 2011). One could have even 
expected more failures with ALMANACH since the algorithm withholds antibiotics (compared to 
IMCI) in frequent clinical situations such as cough and RR between 40 and 50/min in children 
≥12 months, or for children without a classification at the end of the algorithm (likely viral 
infection). On the contrary, we observed a better cure rate with ALMANACH, probably because 
clinicians were able to better identify and treat children with possible bacterial infection. 
Moreover, the better outcome at day 7 was neither at the price of a higher rate of spontaneous 
re-attendance, nor of secondary prescription of antibiotics. These rates were indeed almost 
identical in both arms. These findings suggest that significant bacterial infections were not 
missed when using ALMANACH, which is the big fear of clinicians and their main reason to give 
antibiotics. They often wrongly believe that antibiotics prevent secondary bacterial infections. 
Their behavior is also due to clinical guidelines that are often ambiguous, including the latest 
2014 version of IMCI that recommends to ‘Give appropriate antibiotic treatment for an identified 
bacterial cause of fever’ to febrile children that are negative for malaria (WHO and UNICEF, 
2014). Such a recommendation has a high risk to increase over-prescription of antibiotics. 
Policy makers sometimes argue that children will not be brought back if their condition worsens, 
because of long distance from home to health facilities, lack of transport and of cash money etc. 
The good clinical outcome observed in the intervention arm suggests that caretakers did come 
back when their child was worse, maybe because of clear messages given by clinicians. The 
present study thus demonstrates that giving antibiotics to all children at first place to prevent re-
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attendances or complications is not worth; it does not improve clinical outcome, provided the 
few children who need antibiotics are accurately identified.   
Giving unnecessary antibiotics does have deleterious consequences, namely the rapid spread 
of bacterial resistance, unnecessary adverse drug reactions, and unnecessary cost. In 
Tanzania, high levels of antibiotic resistance have already been reported (Temu et al., 2007, 
Moyo et al., 2011). Also, children infected with resistant microorganisms are more likely to die 
(Blomberg et al., 2007). Unfortunately the different approaches to reduce antibiotic prescription 
have been largely ineffective. In a systematic review, educational/training interventions 
successfully improved targeted antibiotic prescribing outcomes by only 20%, and these changes 
were not sustainable over time (WHO and DMP., 2001). Holistic strategies are needed to 
contain antibiotic resistance, including the use of electronic decision support to improve 
clinician’s compliance to guidelines. Such a strategy using electronic algorithms for the 
management of childhood illness in a rural dispensary in Tanzania showed promises (DeRenzi 
et al., 2008). The next step is thus to further evaluate this electronic ALMANACH in 
programmatic conditions.  
 
Clinical failure and/or secondary antibiotic prescription according to diagnosis type in 
ALMANACH arm 
Among children managed using ALMANACH, the diagnosis that led to the highest rate of 
clinical failure was pneumonia (7%), which also led to the highest rate of secondary antibiotic 
prescription (8%). In contrast, URTI was rarely associated with clinical failures (1 %) or 
secondary antibiotic prescription (2%). Because the vast majority of ARI are located in the upper 
tract and of viral origin, these children do not require antibiotics and cure by themselves. In 
young children, even most of lower respiratory tract infections, including pneumonias, are due to 
viruses and will thus not improve with the provision of antibiotics. This also explains why a 
significant number of these patients were not cured at day 7. 
The second diagnosis that led to the highest rate of clinical failure (6%) and secondary antibiotic 
prescription (5%) was skin conditions. Skin problems are not included in the main algorithm of 
IMCI algorithm. Half of the skin problems were mild infections such as impetigo that had 
worsened enough to require antibiotics at day 7. The other half corresponded to skin problems 
that took longer than 7 days to cure such as fungal infection or stable impetigo, but that did not 
require secondary antibiotics. 
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A ‘likely viral infection’ was the third diagnosis that led to a relatively high rate (6%) of secondary 
antibiotic prescription, but to a rather low rate (3%) of clinical failure at day 7. Antibiotics were 
given during follow-up because of the emergence of various conditions such as pneumonia, 
tonsillitis, UTI, cellulitis and diarrhea. This diversity shows that it is not possible to predict at day 
0 if, and what these children may develop in the following days. The only safe and rational 
solution is thus to evaluate them again when they do not improve. The aim of an efficient clinical 
algorithm is indeed not to have zero follow-up visits, but rather to have no child dying because 
of a delay once antibiotic are required. The message to bring the child back in case of persisting 
or worsening condition, or emergence of a new health problem seems to have been followed 
appropriately, as only one child has been secondarily admitted. When used wisely, it prevents a 
lot of unnecessary prescription of antibiotics during first clinical encounter.  
 
Limitations of the study 
One can argue that the appropriate control arm would have been a perfectly complied to IMCI 
algorithm. However, no study on the clinical outcome of children strictly managed according to 
IMCI has been performed in the past, so such results could not be used as gold standard. Also 
a perfectly implemented IMCI does not exist, which shows its limitation in terms of feasibility. 
We opted thus for the use of IMCI in real life conditions (routine practice) for the control arm to 
assess more precisely the public health benefit of the ALMANACH.  
The new algorithm was implemented in controlled conditions, which is a necessary step before 
implementation in routine conditions. Its real impact, which should directly depend on the level 
of uptake and compliance by clinicians, needs to be precisely evaluated. We already performed 
this step in a study investigating health worker’s performance when using ALMANACH in 
pragmatic conditions (reported in Rambaud-Althaus et al, submitted).  
No formal assessment of health worker satisfaction when using electronic devices was made in 
the present study. Previous findings from a pilot study conducted in Tanzania assessing the use 
of electronic IMCI showed that clinicians were enthusiastic to use it. However, this was not 
enough justification to believe that the clinicians would indeed follow the “standard practice 
ALMANACH” better than standard/routine practice. We also performed subsequently a 
qualitative study to assess health workers’ perception on barriers and facilitators for uptake of 
the ALMANACH algorithm in pragmatic conditions over time (reported in Shao et al, submitted).  
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Conclusion 
The new ALMANACH algorithm for the management of childhood illness, primarily aimed at the 
rational use of antimicrobials, improved clinical outcome and led to a drastic reduction of 
unnecessary antibiotic prescription when compared to standard practice. This achievement was 
related to more precise diagnoses and better identification of children with infections that 
required and did not require antibiotics. These results, obtained in both urban and rural places, 
are probably generalizable for most locations in Sub-Saharan Africa, and even wider, since the 
distribution of diagnoses in small children does not vary so much across regions and over-
prescription of antibiotics is a widespread problem in low resource settings (WHO., 2013). The 
building on mobile technology allowed easy access for clinicians and rapid update of the 
decision chart when new recommendations are put in place. Further studies are underway to 
assess the appropriateness and feasibility of using this electronic algorithm in routine practice. 
 
Acknowledgements  
The study was part of PeDiAtrick project which aimed to improve the quality of health care and 
rational use of medicines for children in Tanzania. This study would not have been possible 
without the great collaboration of all district medical officers, caretakers and patients who 
participated in this study. 
 
 
 
  
52 
 
PART IV: DIAGNOSTIC POTENTIALS OF THE NEW ALGORITHM FOR 
MANAGEMENT OF CHILDHOOD ILLNESS (ALMANACH) 
Chapter 7: Clinical presentation and outcome of children managed by the 
different branches of a new electronic algorithm for the management of 
childhood illness (ALMANACH) 
Amani F Shao1, 2, 3§, Clotilde Rambaud-Althaus 1, 2, Ndeniria Swai4, Blaise Genton1, 2, 5, Valérie 
D’Acremont1, 2, 5 
1Swiss Tropical and Public Health Institute, Basel, Switzerland  
2University of Basel, Basel, Switzerland 3National Institute for Medical Research, Tukuyu Medical 
Research Center, Tukuyu, Tanzania 
4City Medical Office of Health, Dar es Salaam City Council, Tanzania 
5Infectious Diseases Service and Department of Ambulatory Care and Community Medicine, 
University Hospital, Lausanne, Switzerland  
 
§Corresponding author 
Email addresses: 
AFS: shaotz@gmail.com 
CRA: rambaud.c@gmail.com 
NS: ndeniriaswai@gmail.com 
BG: Blaise.genton@unibas.ch 
VDA: Valerie.Dacremont@unibas.ch 
 
 
 
 
 
3
 
                                               
3
 This is a working paper to be submitted after being reviewed by co-authors 
53 
 
Abstract  
Background 
Clinical algorithms are rarely assessed in detail in terms of distribution of children in the various 
branches, antimicrobials prescription and clinical outcome. This information is essential to be 
able to evaluate their usefulness when applied to the target audience and patient population, 
and hence for their optimization. A new ALgorithm for the MANAgement of CHildhood illness 
(ALMANACH) built on an electronic support was developed and implemented in primary care 
facilities. This study aimed at examining for each branch of the algorithm: i) the distribution of 
patients according to their symptoms and signs, ii) the number of rapid tests performed, iii) the 
number of antimicrobial treatment prescribed and iii) the clinical outcome at day 7.   
Methods 
Data collected between December 2010 and June 2011 from acutely ill children aged 2-59 
months attending primary care facilities in urban and rural Tanzania were analysed. All children 
were prospectively included, managed by clinicians strictly following the ALMANACH algorithm, 
and followed-up at day 7 (or in-between if necessary) to assess if cured or not.  
Results 
842 consecutive patients were assessed. 0.1% (1/842) of children had general danger signs. 
67.8% (571/842) entered the fever, 59.1% the cough, 21.9% the diarrhoea and 14.5% the skin 
problems branches. 0.3% (1/351) of patients with fever and cough had lower chest indrawing. 
71.5 % (251/351) of them had a final classification of upper respiratory tract infection and 28.5% 
(100/351) of pneumonia. 5.6% (32/570) patients, for whom a malaria rapid diagnostic test was 
performed, had malaria. 7.1% (6/85) patients for whom a urine dipstick was performed had a 
positive result. None of the 32 patients, in whom abdominal tenderness (considered as 
predictive for typhoid fever) was searched for, presented this sign. On day 0, 1.9% (5/271) of 
non-febrile patients received antibiotics compared to 21.9% (125/571) of febrile patients.  Day 7 
cure rate in febrile and non-febrile patients was 97.2% and 97.4% respectively.  
Conclusions 
A vast majority of children had mild illnesses and most of them did not require antibiotics to be 
cured. A detailed count of patients with defined symptoms, signs, laboratory test results, and 
clinical outcome of patients managed by ALMANACH allowed to precisely assessing the value 
of each of the proposed branches of the algorithm in a primary care setting, and hence to 
decide on the relevance of keeping, modifying or deleting each of the algorithm component.  
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Background  
In the mid 1990’s WHO and UNICEF developed decision charts for the Integrated Management 
of Childhood Illness (IMCI) to address causes of childhood mortality (Gove, 1997). When used 
correctly, the IMCI algorithm has shown to reduce childhood mortality (Armstrong Schellenberg 
et al., 2004b), improve the quality of care and reduce cost of treatment (Bryce et al., 2004, 
Gouws et al., 2004, Armstrong Schellenberg et al., 2004a, Bryce et al., 2005). However, 
expected health impact due to IMCI has been less than anticipated because of low compliance 
of health workers (Simoes et al., 1997, Kelley et al., 2001, Camara et al., 2008, Walter et al., 
2009). Expensive training costs for paper based IMCI algorithms (WHO, 2003) and the 
perception by the health care workers that IMCI chart booklet takes too long during consultation 
(DeRenzi et al., 2008) have contributed to the low compliance to these guidelines.  
Efforts to improve compliance to IMCI algorithms includes programming paper IMCI chart 
booklet into an electronic algorithm (DeRenzi et al., 2008). A pilot study assessing the electronic 
IMCI (e-IMCI)  showed potential for improving compliance of health care workers during clinical 
encounters (DeRenzi et al., 2008). Health workers were enthusiastic to use e-IMCI (DeRenzi et 
al., 2008) and reported positive perceptions towards the use of electronic algorithms (Mitchell et 
al., 2012a). They commented that they simplify their work in terms of clinical examination, 
diagnosis and treatment choices (Shao AF et al, submitted). A new algorithm for the 
management of childhood illness (ALMANACH) aimed at a rational use of antimicrobials while 
ensuring good health outcome has been developed (Rambaud-Althaus et al, submitted) and 
evaluated under controlled conditions. The study showed better cure rates together with a 
drastic reduction of antibiotic prescription compared to routine practice (Shao AF et al, 
submitted). However, implementation of this new algorithm faced uptake challenges mainly 
because of the existing health system constraints (few health care workers, lack of motivation 
among the health care worker etc) and incompressible consultation time (Shao AF et al, 
submitted). In order to correctly manage a sick child, clinicians need to spend enough time with 
each patient in order to go through all the branches of the decision chart (Horwood et al., 2009). 
It is thus essential to avoid asking the unnecessary questions or checking the irrelevant clinical 
signs for a particular medical situation to gain time. Algorithms should thus only include the 
specific questions and signs that allow identifying quickly and reliably the few patients who need 
life-saving interventions and referral, while sending back home those who have a mild disease 
with, or most of the time without antibiotics or antimalarials. In order to know which elements or 
branches of the new ALMANACH algorithm were useful or not, we explored in detail the 
distribution of patients managed through various parts of the algorithm. To our knowledge, this 
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type of evaluation has never been undertaken in an integrated way for the IMCI algorithm. The 
aim of the present study was to find out the final diagnostic classification(s), the need for 
antimicrobial prescription and the clinical outcomes of febrile and non-febrile children managed 
using each branch of the ALMANACH algorithm. The expected output was to end up with an 
algorithm that is as simple as possible while keeping its ability to identify patients at risk of bad 
outcome, who need specific attention or care.  
Material and Methods 
ALMANACH algorithm  
The ALgorithm for the MANAgement of CHildhood illness (ALMANACH) is derived from the 
IMCI algorithm but includes new classifications as well as specific signs or rapid diagnostic tests 
to guide antimicrobial prescription. The development and exact content of the ALMANACH 
algorithm have been described elsewhere (Rambaud-Althaus et al, submitted). The main 
differences between IMCI and ALMANACH are summarized in columns 2 and 3 of Table 8. 
 
Study area and population 
The study population consisted of acutely ill children aged 2-59 months attending primary health 
care facilities in urban Dar es Salaam (Buguruni) and rural Morogoro (Signal) between 
December 2010 and June 2011. Patients were the same as those involved in the PeDiAtrick 
clinical study whose methods have been described elsewhere (Shao AF et al, submitted). 
Vaccination against Hib and pneumococcus were introduced in 2009 and 2010 in Tanzania 
respectively.   
 
Study procedures 
Two trained study clinicians applied the ALMANACH algorithm to all presenting children. Briefly, 
10 general danger signs were assessed, namely convulsions, lethargy/unconscious, history of 
convulsions, severe pallor, severe wasting, jaundice, cyanosis, stiff neck, child being unable to 
drink/breastfeed and vomiting everything. Then, the main complaint was recorded and clinicians 
asked for the other key symptoms, namely fever, cough or difficult breathing, diarrhoea, ear 
problem, measles and skin problem. Each symptom or sign leads the clinician to a specific 
pathway in the algorithm to reach one or more diagnostic classification(s) and the corresponding 
appropriate treatment(s) (Rambaud-Althaus et al, submitted).  The new algorithm was first used 
as a paper form and then on an electronic support (smart-phone). 
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Data management and analysis 
Paper phase data were double entered in Epi Info software version 3.5.3 (Center for Disease 
Control and Prevention, Atlanta, GA, USA). Smartphone’s data were recorded directly by the 
server. Number and proportions of patients with symptoms and signs, their diagnostic 
classification, antibiotic prescription and clinical outcome at day 7 (and at day 14 if not cured at 
day 7) were calculated. Re-attendances, secondary antimicrobial prescriptions, secondary 
hospitalisations and deaths were also analysed. Data management and analysis were done 
using STATA software version 10.1 (StataCorp, College Station, Texas, USA).  
 
Ethical clearance 
All procedures followed the Good Clinical Practice guidelines. The study protocol and related 
documents were approved by Ethikkommission beider Basel in Switzerland, by the Institutional 
Review Board of Ifakara Health Institute and by the National Institute for Medical Research 
Review Board in Tanzania.  
 
Role of the funding body 
The sponsor of the study (Swiss National Science Foundation) had no role in study design, data 
collection, data analysis, interpretation or writing of the report. 
Results  
A total of 842 consecutive patients aged 2-59 months (median age 14 months) were enrolled. 
407 (48.3%) were females. 522 (62.0%) were enrolled in the urban setting and the others in the 
rural setting. One (0.1%) patient had one or more general danger signs. The distribution of 
patients with one or more main complaints in the febrile and non-febrile branches of the 
algorithm is provided in Figure 7. 600/841 (72.3%) had one of the key symptoms while 110/841 
(13.1%) had two. 570/841 (67.8%) had a history of fever, of which 124 (21.8%) had no other 
complaint. There was no difference in the proportion of clinical failure at day 7 between febrile 
(16/570=2.8%) and non-febrile (7/271=2.6%) patients (p=0.85). 
The distribution of patients with the key symptoms in the febrile and non-febrile branches, the 
respective proportion of those who received antibiotics on day 0 or secondarily, and their clinical 
outcome on day 7 are provided in Figure 8. Out of 841 patients, 498 (59.2%) had cough, of 
which 351 (70.5%) had also fever. No patient with cough had difficulty in breathing, stridor, 
wheezing or prolonged cough for 3 or more weeks. No patient who was found to have fast 
breathing during the first count of the respiratory rate was found not to have it during the second 
count 5 to 10 minutes later. 184/841 (21.9%) had diarrhoea, of which 127 (69.0%) had also 
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fever. No patient had diarrhoea for 14 days or more.  No patient was lethargic/unconscious, not 
able to drink or drinking poorly, with skin going back very slowly or slowly, or restless/irritable. 
14/841 (1.7%) had ear problems, of which 12 (85.7%) had also fever.  9 of the latter had also 
pus discharge. No patients had tender swelling behind the ear.  11/841 (1.3%) had measles, all 
of them being febrile. None of them had clouding of the cornea, deep or extensive mouth ulcers, 
or pus draining from eyes or mouth ulcers. 122/841 (14.5%) had skin problems, of which 44 
(36.1%) had also fever. The highest number of children, who received antibiotics at day 0 were 
among those with fever and cough (116), followed by those with fever and diarrhea (15) and 
fever and ear problem (9). For children prescribed antibiotics secondarily, it was among children 
with fever and cough (14), fever without any other symptom (7) and fever with skin problem (4). 
The highest number of children not cured at day 7 was among those with fever and cough (11), 
with fever and skin problem (5) and with skin problem without fever (5).  
The distribution of patients with the diagnostic classifications, the proportion who received 
antibiotics on day 0 or secondarily, as well as their clinical outcome on day 7 are provided in 
Table 9. 588 out of 841 (69.9%) patients had a single diagnostic classification, 247 (29.4 %) had 
two classifications and 6 (0.7%) had three classifications. Fever was positively associated with 
having a single diagnostic classification (OR = 5.4; 95% CI = 3.9-7.5; p<0.001). Of 570 febrile 
patients, 32 (5.6%) had malaria. One (0.1%) patient had both malaria and pneumonia, while 10 
(1.2%) had malaria combined with URTI, diarrhoea or skin infection. Of 498 patients with cough, 
398 (79.9%) had URTI, the remaining 100 (20.1%) having pneumonia. 6 out of 570 (1.1%) 
febrile children had urinary tract infection (UTI).  
Out of 841 patients without general danger signs, 129 (15.3%), of which 124 were febrile, 
received antibiotics on day 0 for various classifications. These included 100 (80.6%) 
pneumonia, 9 (7.3%) acute ear discharge, 7 (5.6%) dysentery, 6 (4.8%) UTI, 1 (0.8%) soft 
tissue infection and 1 (0.8%) tonsillitis. Among the 5 non-febrile patients who received 
antibiotics on day 0, 3 had dysentery and 2 soft tissue infections.  
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Table 8. Key differences between IMCI and the new ALgorithm for the MANAgement of CHildhood illness (ALMANACH), proposed 
changes after assessment and their justification. 
 
IMCI algorithm New algorithm (ALMANACH)  Proposed changes 
in the  ALMANACH 
Justifications for proposed 
changes in the  ALMANACH 
General 
danger 
signs 
5 general danger signs 
managed at the beginning 
of the algorithm and 6 
additional danger signs 
assessed later 
10 general danger signs 
managed at the beginning of 
the algorithm and 6 
additional danger signs 
assessed later.  
Lower chest 
indrawinga to be 
shifted to non danger 
signs for pneumonia 
In compliance with recent WHO 
IMCI generic guidelines 
 Jaundice and Cyanosis 
not considered as general 
danger signs 
Jaundice and cyanosis added 
to ALMANACH as general 
danger signs 
Jaundice and 
Cyanosis to be 
dropped 
No patient detected with any of 
these 2 conditions 
Danger 
signs 
 
Infected skin lesion or 
lump larger than 4 cm or 
with red streaks or with 
tender nodes or multiple 
abscesses not considered 
as danger signs for skin 
problems 
Infected skin lesion or lump 
larger than 4 cm or with red 
streaks or with tender nodes or 
multiple abscesses considered 
as danger signs during 
assessment of skin problems  
 Changes remain in 
ALMANACH  
The ALMANACH propositions 
help to clearly identify children 
with skin infection who will 
benefit from antibiotics  
Fever  Fever is 1 out of 4 key 
symptoms assessed  
Fever is used as a dividing 
point between a febrile branch 
and a non- febrile branch in 
ALMANACH 
Change remain in 
ALMANACH  
The non-febrile children have a 
very low risk not to be cured at 
day 7, although antibiotics have 
not been prescribed 
Pneumonia Cough  
+ fast breathingb  
Fever + cough  
+ very fast breathingc 
Change remains in 
ALMANACH  
Children aged ≥ 12 months with 
RR between 40 and 50 were 
cured on day 7 without 
antibiotics (Shao AF et, 
submitted) 
 
Cough or difficult 
breathing  Cough or difficult breathing 
Difficult breathing can 
be dropped 
No patient with difficult 
breathing detected. Difficult 
breathing is probably detected 
through fast breathing 
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Counting respiratory rate 
is done once 
Counting respiratory rate twice 
(after 5 minutes if first count ≥ 
50/min  
Second count to be 
dropped and 
emphasis put on 
counting when the 
child is calm 
No patient found to have lower 
respiratory rate during the 
second count 
Urinary 
Tract 
Infection Not considered  
Perform  a urine dipstick for a 
child <2 years with no source of 
fever identifiedd or for a child ≥2 
years with dysuria and no 
source identifiedd 
Urine dipstick test can 
be dropped for 
children ≥2 years  
None of the febrile child ≥2 
years with dysuria had a 
positive urine dipstick test result 
Typhoid 
fever 
Not considered 
Antibiotic prescription for  child 
≥2 years with no source of fever 
identifiedd, and with abdominal 
tenderness 
Abdominal 
tenderness can be 
dropped and replaced 
with a reliable typhoid 
rapid test when 
available 
No patient with abdominal 
tenderness detected. Rapid test 
for typhoid needs to be 
considered if accurate enough 
taking into account the local 
prevalence 
Likely viral 
infection Not existing 
Febrile child with no 
classification at the end of the 
algorithm 
Change remains in 
ALMANACH  
This classification allowed to 
drastically reduce antibiotics 
prescription without affecting 
the cure rate 
 
Legend: 
a
 As noted in the new WHO/UNICEF generic IMCI for 2014 (WHO and UNICEF, 2014).  
b
 50 breaths/min for children aged 2 to 12 months, 40 breaths/min for children aged 12 months to 5 years.  
c
 50 breaths/min for all children (aged 2 months to 5 years).  
d
 No cough or difficult breathing, no diarrhea, no ear problem, no measles, no infected skin lesion or lump.  
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842 children aged 2-59 months with acute illness
1 (0.1% ) with lethargy and severe pallor841 (99.9% ) without general danger signs
271 (32.2%) had no history of fever or temperature570 (67.8%) with history of fever, 305 (53.5%) had temperature ≥ 
37.5° C. 
5 (1.9%) received antibiotics on day 0
3 (1.1% received antibiotics secondarily
263 (97.4%) were cured on day 7 
124 (21.8%) received antibiotics on day 0
16 (2.8%) received antibiotics secondarily
551 (97.2%) were cured on day 7 
 
Figure 7. Distribution of patients with general danger signs and the key symptoms in the febrile and non-febrile branches of the new 
ALMANANACH 
  
Figure 8. Proporiton of patients with key symptoms in the febrile and non febrile algorithms; proportion treated by antibiotics on da
or secondarily, and proportion not cured on day 7
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Table 9. Distribution of patients with main complaints alone or combined, their diagnostic classification, antibiotic prescription rates at 
day 0 and secondarily and clinical outcome in the febrile and non-febrile algorithms 
Main 
symptom(s) 
Classification(s)/diag
nosis(ses) 
Total 
number 
of 
children 
N=841 
(% among 
the total) 
Febrile 
children 
N=570 (% 
out of 
570) 
Children 
prescribed 
antibiotics 
on day 0. n 
(% among 
febrile 
classificatio
n) 
Children 
prescrib
ed 
antibioti
cs 
seconda
rily n (% 
among 
febrile) 
Childre
n not 
cured 
on day 
7 n (%) 
among 
febrile 
Non-
febrile 
children  
N=271 (% 
out of 271 
Children 
prescribe
d 
antibiotic
s on day 
0. n (% 
among 
non  
febrile  
Childre
n 
prescri
bed 
antibio
tics 
second
arily n 
(% 
among 
non-
febrile 
Childre
n not 
cured 
on day 
7 n (% 
among 
non-
febrile) 
Cough only URTI 301 (35.8) 169 (29.6) 0 3 (1.8) 1 (0.6)* 132 (48.7) 0 2 (1.5) 2 (1.5)* 
 Pneumonia 85 (10.1) 85 (14.9) 85 (100) 3 (3.5) 5 (5.9)* 0 0 0 0 
 Severe pneumonia 1 (0.1) 1 (0.2) 1 (100) 0 1 (100) 0 0 0 0 
 URTI and malaria 7 (0.8) 7 (1.2) 0 0 0 0 0 0 0 
 Pneumonia and 
Malaria 
1 (0.1) 1 (0.2) 1 (100) 0 0 0 0 0 0 
Cough and 
diarrhoea 
URTI and diarrhoea 50 (5.9) 43 (7.5) 0 1 (2.3) 0* 7 (2.6) 0 0 0 
 URTI and dysentery 3 (0.4) 3 (0.5) 3 (100) 0 0 0 0 0 0 
 Pneumonia and 
diarrhoea 
7 (0.8) 7 (1.2) 7 (100) 0 0 0 0 0 0 
 URTI, Malaria and 
diarrhoea 
2 (0.2) 2 (0.4) 0 0 0 0 0 0 0 
Cough and ear 
problems 
URTI and acute ear 
discharge 
3 (0.4) 3 (0.5) 3 (100) 0 0 0 0 0 0 
 URTI and non-febrile 
ear discharge 
1 (0.1) 0  0 0 0 1 (0.4) 0 0 0 
Cough and 
measles 
URTI and measles 2 (0.2) 2 (0.4) 0 0 0 0 0 0 0 
 Pneumonia and 
measles 
5 (0.6) 5 (0.9) 5 (100) 1 (20) 0 0 0 0 0 
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Cough and 
skin problems 
URTI and impetigo 19 (2.3) 18 (1.4) 0 0 2 (11.1) 1 (0.4) 0 0 0 
 URTI and eczema 2 (0.2) 0 0 0 0 2 (0.7) 0 0 0 
 URTI and larvae 
migrans 
1 (0.1) 0 0 0 0 1 (0.4) 0 0 0 
 URTI and scabies 3 (0.4) 0 0 0 0 3 (1.1) 0 0 0 
 Pneumonia and 
impetigo 
1 (0.1) 1 (0.2) 1 (100) 0 1 (100) 0 0 0 0 
 URTI, malaria and 
impetigo 
1 (0.1) 1 (0.2) 0 0 0 0 0 0 0 
Diarrhoea Diarrhoea  106 (12.6) 61 (10.7) 0 0 0 45 (16.6) 0 1 (2.2) 0 
 Dysentery 6 (0.7) 3 (0.5) 3 (100) 0 0 3 (1.1) 3 (100) 0 0 
Diarrhoea and 
ear problems 
Diarrhoea and acute 
ear infection 
1 (0.1) 1 (0.2) 0 0 0 0 0 0 0 
 Diarrhoea and acute 
ear discharge 
1 (0.1) 1 (0.2) 1 (100) 0 0 0 0 0 0 
Diarrhoea and 
measles  
Dysentery and 
measles  
1 (0.1) 1 (0.2) 1 (100) 0 0 0 0 0 0 
Diarrhoea and 
skin problems 
Diarrhoea and 
impetigo 
1 (0.1) 1 (0.2) 0 0 0 0 0 0 0 
 Diarrhoea and scabies 2 (0.2) 1 (0.2) 0 0 0 1 (0.4) 0 0 0 
 Diarrhoea and soft 
tissue infection 
1 (0.1) 0 (0) 0 0 0 1 (0.4) 1 (100) 0 0 
Ear problems Acute ear infection  2 (0.2) 2 (0.4) 0 0 1 (50) 0 0 0 0 
 Acute ear discharge 2 (0.2) 2 (0.4) 2 (100) 0 0 0 0 0 0 
 Non-febrile ear 
discharge 
1 (0.1) 0  0 0 0 1 (0.4) 0 0 0 
Ear and skin 
problems 
Acute ear discharge 
and impetigo 
3 (0.4) 3 (0.5) 3 (100) 0  0 0 0 0 0 
Measles Measles  3 (0.4) 3 (0.5) 0 0  0 0 0 0 0 
Skin problems Impetigo 61 (7.3) 15 (2.6) 0 1 (6.7) 1 (6.7) 46 (17) 0 0 2 (4.3) 
 Severe soft tissue 
infection  
2 (0.2) 1 (0.2) 1 (100) 0 1 (100) 1 (0.4) 1 (100) 0 0  
 Scabies 13 (1.5 0 0 0 0 13 (4.8) 0 0 1 (7.7) 
 Cutaneous larva 
migrans 
4 (0.5) 0 0 0 0 4 (1.5) 0 0 0  
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 Fungal infection 3 (0.4 0 0 0 0 3 (1.1) 0 0 1 (33.3) 
 Eczema 2 (0.2 0 0 0 0 2 (0.7) 0 0 0 
Cough, 
diarrhoea and 
skin problems 
URTI, diarrhoea and 
impetigo 
 
3 (0.4) 
 
3 (0.5) 
 
0 
 
0 
 
1 (33.3) 
0 0 0 0 
No cough, 
diarrhoea, 
measles or 
skin problems  
 
Likely viral infection  
 
95 (11.3) 
 
95 (16.7)  
 
0 
 
6 (6.3) 
 
3 (3.2) 
 
0 
 
0 
 
0 
 
0 
 UTI  6 (0.7) 6 (1.1) 6 (100) 1 (16.7) 0 0 0 0 0 
 Malaria 21 (2.5) 21 (3.4) 0 0 0 0 0 0 0 
 Oral thrush 2 (0.2) 1 (0.2) 0 0 0 1 (0.4) 0 0 0 
 Tonsillitis 1 (0.1) 1 (0.2) 1 (100) 0 0 0 0 0 0 
 Abdominal upset 1 (0.1) 0 0 0 0 1 (0.4) 0 0 0 
 Gaseous distension 1 (0.1) 0 0 0 0 1 (0.4) 0 0 0 
 Worm infection 1 (0.1) 0 0 0 0 1 (0.4 0 0 0 
Total  841 (100) 570 (67.8) 124 (21.8) 16 (2.8) 16 (2.8) 271 (32.2) 5 (1.8) 3 (1.1) 7 (2.6) 
 
* 4 patients (2 Pneumonia and 2 URTI) were lost to follow up. 
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On day 0, 1.9% of 270 non-febrile patients received antibiotics compared to 21.8% of 570 febrile 
patients. Day 7 cure rate for febrile patients who did not receive antibiotics on day 0 was slightly 
higher (97.9%; 96.7-99.3%) than that for those who received antibiotics (94.3%; 90.2-98.4%) 
(p=0.03). All non-febrile patients who received antibiotics on day 0 were cured on day 7 while 
97.4% of those who did not were cured (p=0.87). 
Figure 9 provides the pathway and test results for the 103 febrile patients without any other key 
symptom or sign and malaria negative. 6 (58%) of them had UTI, none had possible typhoid and 
95 (92.2%) had likely viral infection.  
Discussion  
We have provided detailed description of complaints, clinical features and, when applied, 
complementary investigations of acutely ill children aged <5 years at primary health care 
facilities, with their disease classifications, treatment and clinical outcomes following strict 
compliance by clinicians to a new algorithm for the management of childhood illness 
(ALMANACH).  This descriptive analysis shows that certain branches or sub-branches included 
few or no patients at all. We discuss below possible explanations for those observations and 
rationale for keeping or removing these branches from the ALMANACH and potential alternative 
solutions to improve the management of childhood illness in rural and urban settings in 
developing countries.  
General danger signs assessment 
Among 842 patients assessed for the 10 general danger signs, only 1 (0.1%) had severe pallor 
and lethargy (Figure 7). Previous studies have shown varying proportion of patients with general 
danger signs, from 5% to 28% (D'Acremont et al., 2014, Simoes et al., 1997, Rowe et al., 2007, 
Factor et al., 2001). . This variation is likely due to the different level of care at which patients 
have been recruited, i.e. at primary care health facilities, as in our study, versus emergency 
departments of referral hospitals. Danger signs may become rarer because of the changing 
epidemiology of diseases in the context of a number of interventions which have contributed to 
reduction in childhood mortality (WHO. and UNICEF., 2012). Also, increased awareness of 
caretakers to bring their child as soon as possible after symptom onset has resulted in less 
delay and hence less severe cases presenting to health facilities. It is also possible that this low 
rate of children with danger signs is due to limited skills of health workers to detect them, or 
difficulty to identify these somehow subjective signs.  
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In the ALMANACH algorithm, 2 danger signs (cyanosis and jaundice) have been added to those 
of IMCI but were never identified in our study. 
 
103 febrile patients
without other key symptoms
and a negative malaria test
71 (68.9%) aged 2 months - <2 
years
32 (31.1%) aged 2 - 5 years
4 (12.5%)
with dysuria
28 (87.5%)
without  dysuria
4 (100%)
with negative 
urine dipstick
0 (0%)
with abdominal 
tenderness
6 (8.5%)
with positive 
urine dipstick
65 (91.5%)
with negative 
urine dipstick
6 (8.5%)
with urinary tract 
infection
0
with possible 
typhoid fever
95 (97.9%)
with likely 
viral infection
2 (2.1%)
1 Tonsillitis
1 Oral thrush
 
Figure 9. Clinical and rapid test result (urine dipstick) in febrile children without other key 
symptoms and with a negative malria test 
Cyanosis was included because there was no danger sign in IMCI that could detect severe 
respiratory distress beside chest indrawing (not considered anymore as a danger sign in the 
2014 IMCI version (WHO and UNICEF, 2014)); it is however only found in very advanced 
stages of respiratory distress and thus very rare (Duke et al., 2001). Maybe using very fast 
breathing, as proposed by WHO for children older than 5 years and adults, could be an option, 
but it has been shown to be poorly predictive of hypoxemia (Duke et al., 2001). The lack of good 
clinical predictor for hypoxemia suggests that there is a need to have a better tool to identify 
these children. One possibility would be to use pulse oximeters (Duke et al., 2001, Duke et al., 
2008, Duke et al., 2009, Weber and Mulholland, 1998), which can identify children with 
hypoxemia either due to severe pneumonia or other causes, as a triage tool at primary care 
level to identify children who would benefit from referral to a level of care were oxygen is 
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available. Regarding jaundice, the reason why no child was identified with this sign might be the 
difficulty for health workers to identify it. ‘Vomiting everything’ seems to be an entity not well 
understood by caretakers probably due to the wording. Vomiting everything is a confusing term 
to caretakers because it has more than one meaning. It can mean a child vomits anything given 
orally or it can mean when the child takes food, s/he vomits it all and nothing is left in the 
stomach. Vomiting is a symptom which worries most caretakers such that when they bring a 
child who has vomited once or twice to the health facility and they asked if the child is “vomiting 
everything”, the answer is yes, irrespective of what the question wanted to capture. In this 
context, clinicians are argued to assess for frequency of vomiting and the quantity vomited to be 
able to conclude whether the child vomits everything instead of asking caretakers the direct 
question: “does the child vomit everything”? (WHO and UNICEF, 2014). In summary, an ideal 
solution for danger signs would be to develop objective, simple and affordable point-of-care 
tests, for example based on blood host biomarkers, which could be used at primary health care 
level to assist clinicians in identifying the few patients with severe disease, or who may become 
severe, and thus need immediate treatment and referral.  
 
Fever 
Fever was used as a dividing point between the febrile and the non-febrile branch of 
ALMANACH. In the non-febrile branch, none of the recommendations (except for the children 
with blood in stool or with significant infected skin lesions) was leading to the prescription of 
antibiotics because non-febrile children are probably at very low risk of suffering from serious 
bacterial infections. Therefore, only 2% of non-febrile compared to 22% of febrile patients 
received antibiotics on day 0. The finding that cure rates on day 7 for patients who received 
antibiotics was slightly higher could suggest that these children benefited from this treatment. It 
might however also reflect that patients with serious infections took a bit more time than the 
others to be cured and were thus well targeted to receive antibiotics. The only way to know 
which hypothesis is true would be to undertake a randomized control trial, similar to that for non-
severe pneumonia in Pakistan (Hazir et al., 2011), but including all non-malaria fevers. 
Respiratory diseases 
Of 841 patients, 498 (59.2%) had cough either as single complaint or in combination with other 
symptoms, both in febrile and non-febrile branches. This is within the range of previous studies 
that report proportion from 22% to 72% (Perkins et al., 1997, Gouws et al., 2004, Rowe et al., 
2007, Mukanga et al., 2012, Yeboah-Antwi et al., 2010, Horwood et al., 2011). The differences 
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observed are probably due to several factors, such as local epidemiology and environment, or 
type of patient population and level of the health system. Only 1 (0.2%) patient with cough had 
lower chest indrawing.  This is much lower compared to the 2% found in a recent study 
conducted in Tanzania among children with a temperature >38°C (D'Acremont et al., 2014). In 
the latter, patients were however recruited at outpatient department of hospitals, where 
diseases are generally more severe than at primary care level; indeed 8% of patients were 
admitted, while in the present study it was the case for only 0.4%. Recent studies report that 
patients with severe but not very severe pneumonia (i.e. those with cough and lower chest 
indrawing but no other danger signs) can be safely managed at home (Hazir et al., 2008, Addo-
Yobo et al., 2011). Therefore, WHO/UNICEF now consider lower chest indrawing as a sign for 
pneumonia next to fast breathing (WHO and UNICEF, 2014). Having only one patient with lower 
chest indrawing, suggests that either this sign is rare nowadays at primary care level in 
Tanzania (for example because parents attend early in the course of disease to test for 
malaria), or that health workers have difficulty to identify it. The other problem is that chest 
indrawing can be more or less severe and ‘severe chest indrawing’ is still used by WHO as a 
criteria to classify ‘severe pneumonia’ at hospital level (WHO, 2013). To put a severity threshold 
to chest indrawing to decide on referral seems however difficult and an objective measurement, 
such as oxygen saturation or other host markers, might replace in the future such criteria.  
Stridor has been kept in the 2014 version of IMCI as a sign of epiglottitis or foreign body in 
patients with cough (WHO and UNICEF, 2014). None of the patients in our study had this sign, 
maybe because of the introduction of Hib vaccination in Tanzania two years before the start of 
the study.  No patient had neither other specific respiratory signs, such as wheezing or duration 
of cough for >3 weeks. In other studies, proportion of children reported to present at least one 
episode of wheezing ranges from 28-49% (Moraes et al., 2014, Medeiros et al., 2011, Dela 
Bianca et al., 2010, Ferreira and Wandalsen, 2014). All these studies showing a high incidence 
were conducted in Brazil and involved infants. IMCI recommends that children with wheezing 
beside fast breathing and/or lower chest indrawing are given up to three cycles of a 
bronchodilator before being classified as having pneumonia or not (WHO, 2005a), to avoid that 
children with asthma are wrongly classified and treated with antibiotics unnecessarily. In 
ALMANACH we were proposing, rather than giving antibiotics, to refer these children for 
assessment and treatment of potential respiratory distress and for evaluation of asthma as a 
chronic condition. None of the children included had wheezing and we could thus not evaluate 
the appropriateness of this strategy.  
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A critical step in the assessment of cough is counting the respiratory rate to differentiate clinical 
pneumonia from URTI. ALMANACH does not recommend counting respiratory rate in patients 
with cough but without history of fever (representing a third of patients with cough in this study). 
Out of 147, 3 (2%) of them developed fever and clinical pneumonia, were treated with antibiotics 
secondarily and did not develop complications. This low rate suggests that it is fine not to 
consider and treat pneumonia in non-febrile children and to rather tell parents to come back in 
case fever appears. This strategy allows to save time and decrease unnecessary antibiotic 
prescription during the first encounter with clinicians. Also, counting respiratory rates twice at 5 
minutes interval did not help in differentiating pneumonia from URTI and this recommendation 
should be removed from ALMANACH. Maybe waiting more time could be useful to give a 
chance to the child to calm down and/or to lower his/her body temperature, so that the 
respiratory rate can decrease. This would be feasible in non-crowded health facilities or if 
automated respiratory rate devices would exist. The latter would vastly improve the assessment 
of this sign that is critical to appropriately target children in need for antibiotics (or in the future, 
for deciding to perform a bacterial pneumonia diagnostic test if available).   
 
Urinary tract infection and typhoid fever 
Only 8.5% of patients tested by urine dipstick were positive for leucocytes or nitrites (Figure 9). 
This is a third of what was found in another study conducted in the same setting, which showed 
that 22% of patients with a temperature ≥380C (and not just history of fever) had a positive 
dipstick (D'Acremont et al., 2014). Since there was no evidence that UTI is a major cause of 
mortality in children <5 years, WHO did not initially include this disease in IMCI. Then a WHO 
supplement for country adaptation proposed to use microscopy or urine dipstick in children less 
than 2 years with unexplained fever, should countries find it important and feasible (WHO, 
2005b). In ALMANACH, we proposed a urine dipstick to all children <2 years with fever without 
an identified source (but regardless of the malaria test result) and to those aged ≥2 years with 
dysuria. Only 4 children older than 2 years had dysuria (and all had a negative dipstick) which 
suggests that having this criterion does not add much to the age criteria.    
Abdominal tenderness was shown to be predictive of typhoid fever in children >2 years in a 
study on etiologies of fever (D’Acremont 2014, De Santis 2014 in preparation). This sign was 
thus included in ALMANACH for children >2 years with fever without an identified source to 
avoid having clinicians systematically prescribing antibiotics in this group due to the fear of a 
bacterial infection, in particular typhoid fever. In fact, in the present study, none of the patients 
had abdominal tenderness, either because this sign was rare or too difficult to assess for 
71 
 
clinicians. It was thus not useful and should probably be dropped. Eventually, in highly typhoid 
endemic areas, a specific rapid diagnostic test could be added for this group of children >2 
years without any identified source of fever. In low endemic areas, the limited sensitivity of the 
present rapid tests make them less useful but they could be considered as part of a surveillance 
system in sentinel primary care facilities to pick up epidemics early on.  
 
Limitations 
The findings of this study need to be interpreted with caution because the algorithm was tested 
in only one urban and one rural setting in Tanzania. As this algorithm was designed to integrate 
the management of several childhood illnesses, the number of patients per branch or per clinical 
or diagnostic element was quite low. Firm conclusions in terms of inclusion or exclusions of 
clinical or laboratory conditions in a decision chart based on this study alone can thus not be 
drawn.  
Conclusions  
A detailed description of symptoms, signs, laboratory test results, and clinical outcome of 
patients managed by the ALMANACH algorithm allowed to assessing the value of most of the 
proposed branches of the algorithm, and hence to decide on their relevance. An improved 
AMANACH taking into the present findings will be soon tested in the same patient population. A 
dynamic process is needed that allows incorporation of new predictors and point of care tests in 
the algorithm, using electronic decision support systems that ease rapid changes that can be 
quickly implemented and evaluated in the field.  New algorithms should be tested similarly to 
what was done in the present study to increase evidence and provide thus the best possible 
care for children and the highest satisfaction of health care professionals.  
Authors' contributions 
AFS, CRA, BG, and VDA designed the study. NS supported the organization for data collection. 
AFS and CRA collected and analysed the data. AFS drafted the manuscript. BG and VDA 
participated in data analysis and writing of the manuscript.  
 
Acknowledgements  
This study would not have been possible without the cooperation we got from the caretakers 
who volunteered their children to participate in this study. We thank clinicians who helped with 
data entry and the collaborators at the Dar es Salaam City Medical Office of Health, Swiss 
72 
 
Tropical and Public Health Institute (SwissTPH), D-Tree International, and Ifakara Health 
Institute (IHI) involved in the study.  
  
73 
 
PART V: FACTORS AFFECTING THE IMPLEMENTATION OF THE NEW 
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Abstract  
Background 
The impact of the Integrated Management of Childhood Illness (IMCI) strategy has been less 
than anticipated because of poor uptake. Electronic algorithms have the potential to improve 
quality of health care in children. However, feasibility studies about the use of electronic 
protocols on mobile devices over time are limited. This study investigated constraining as well 
as facilitating factors that influence the uptake of a new electronic Algorithm for Management of 
Childhood Illness (ALMANACH) among primary health workers in Dar es Salaam, Tanzania.  
Methods 
A qualitative approach was applied using in-depth interviews and focus group discussions with 
altogether 40 primary health care workers from 6 public primary health facilities in the three 
municipalities of Dar es Salaam, Tanzania. Health worker’s perceptions related to factors 
facilitating or constraining the uptake of the electronic ALMANACH were identified.  
Results 
In general, the ALMANACH was assessed positively. The majority of the respondents felt 
comfortable to use the devices and stated that patient’s trust was not affected. Most health 
workers said that the ALMANACH simplified their work, reduced antibiotic prescription and gave 
correct classification and treatment for common causes of childhood illnesses.  
Few HWs reported technical challenges using the devices and complained about having had 
difficulties in typing. Majority of the respondents stated that the devices increased the 
consultation duration compared to routine practice. In addition, health system barriers such as 
lack of staff, lack of medicine and lack of financial motivation were identified as key reasons for 
the low uptake of the devices.   
Conclusions 
The ALMANACH built on electronic devices was perceived to be a powerful and useful tool. 
However, health system challenges influenced the uptake of the devices in the selected health 
facilities. 
Keywords 
Smartphones, tablets, electronic clinical decision support, IMCI, primary care, barriers, 
electronic prescribing  
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Background  
In the mid-1990s, the World Health Organization (WHO), the United Nations Children's Fund 
(UNICEF) and other partners developed a strategy called ‘Integrated Management of Childhood 
Illnesses’ (IMCI) to improve the assessment, classification and treatment of the common causes 
of childhood mortality (Gove, 1997). It was also aimed at improving health worker’s skills as well 
as family and community practices (Lambrechts et al., 1999). When used correctly, these 
guidelines were shown to improve quality of care and reduce the cost of treatment (Bryce et al., 
2005, Armstrong Schellenberg et al., 2004a), and to reduce mortality in Tanzania (Armstrong 
Schellenberg et al., 2004b). 
However, the expected impact of IMCI worldwide has been less than anticipated due to limited 
uptake of the strategy (Victora et al., 2006). The latter has been due to various challenges 
facing IMCI implementation at various levels as discussed in a study by Ahmed et al. (Ahmed et 
al., 2010). For example, health workers (HWs) who are supposed to implement IMCI need 
about 11-16 days of training. The cost and time for this training has limited the uptake of IMCI 
worldwide (Ahmed et al., 2010). In Tanzania, health workers’ compliance to IMCI algorithms is 
uneven and often quite low, both in rural and urban settings (Armstrong Schellenberg et al., 
2004a, Walter et al., 2009). 
To address and overcome these challenges, new technologies are increasingly used, not only 
to facilitate training on IMCI (WHO and Development., 2007)  but also to improve compliance to 
evidence based guidelines (DeRenzi et al., 2008, Mitchell et al., 2009, Mitchell et al., 2012b, 
Mitchell et al., 2012a). In a pilot study, where HWs used personal digital assistance (PDAs) with 
an electronic version of IMCI (e-IMCI) in a rural dispensary in Mtwara, Southern Tanzania, 
DeRenzi et al. found that e-IMCI is as fast as routine practice (following IMCI from memory) and 
it increased compliance to the IMCI guidelines (DeRenzi et al., 2008). In another study by 
Mitchell et al  in Pwani region in Tanzania, HWs stated that it is much easier and faster to use 
electronic IMCI (e-IMCI) than paper-based IMCI for consultations (Mitchell et al., 2012a).   
However, still little is known about facilitating factors and barriers and their influence on the long 
term uptake of electronic devices in the context of IMCI in developing countries. Using in-depth 
interviews and focus group discussions with primary health care workers, the present study 
aimed at providing insights into factors influencing the sustainable uptake of two different mobile 
technologies, tablets and smartphones, used as electronic decision support to implement a new 
algorithm aimed for rational use of antibiotics and antimalarials for the management of children 
in 6 health facilities (HF) in Dar es Salaam, Tanzania.  
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Materials and Methods 
The PeDiAtrick project 
The study was conducted within the PeDiAtrick project which aimed at improving the quality of 
healthcare for Tanzanian children by assessing the use of electronic decision support to 
promote evidence-based medicine and rational use of drugs. The project was implemented in 
Dar es Salaam, the largest city in Tanzania, and in Ifakara, a town in south-eastern Tanzania. In 
a first step, a paper as well as an electronic version of a new algorithm for management of 
childhood illness (ALMANACH) were developed (Rambaud-Althaus et al, submitted) and 
assessed in a safety study (Shao AF et al, submitted).  
After the safety study had shown that the clinical outcome of patients was better using 
ALMANACH than with routine care, HWs from 3 selected HFs in Dar es Salaam received two 
days ALMANACH training by the field investigators (including first author) on the rational use of 
antibiotics and antimalarials using smartphones. Following the training each HW involved in 
taking care for children at the participating health facilities received face-to-face supervision by 
the field investigators (including first author) with several real patients onsite. In addition, user 
manuals on how to operate the smartphones were developed and given to each health facility 
for reference with training and face-to-face supervision. During the implementation of the 
smartphone study, the uptake and compliance to the algorithm by HWs was assessed 
(Rambaud-Althaus et al, submitted).  
The results from the smartphone arm were used to inform the design and introduction of tablets 
as electronic decision support for the management of similar group of sick children but in three 
other health facilities which were previously controls for the uptake and compliance study 
(Rambaud-Althaus et al, submitted). Figure 10 provides a summary of the intervention activities 
for the smartphones and tablets. Clinical data for each child managed by HWs using either 
smartphones or tables were sent to a web-based server. 
During the use of smartphones and tablets in the field over the course of three months, a 
decrease in the number of clinical data for children managed by HWs in both arms sent to the 
web based server was observed (Figure 11). 
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Figure 10. Timeline of the smartphone/tablet introduction and the qualitative study 
The present study was thus designed to investigate the determinants of uptake and perception 
of health workers of these electronic devices to support clinical practice.  
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Figure 11. Number of clinical cases sent to the web based server per month 
(smartphone/tablet) 
Study design and setting 
The qualitative study presented here was carried out in the urban intervention sites in Dar es 
Salaam city in Tanzania between February and March 2012 (smartphones) and between 
September and October 2012 (tablets). Dar es Salaam was selected because it is a setting with 
moderate malaria endemicity (Wang et al., 2006) but high use of antibiotics (D'Acremont et al., 
2011). The use of the new algorithm reduced unnecessary use of drugs both in low, moderate 
and high malaria endemic settings without exposing children to harm (Shao AF et al, submitted). 
Six health facilities (HF) were chosen from the three municipalities of Dar es Salaam, namely 
Ilala, Temeke and Kinondoni (Figure 12). 
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Figure 3 
 
 
 
In each municipality, 2 public owned HF under the Ministry of Health and Social Welfare 
(MoHSW) which were involved in the uptake and compliance study (Rambaud-Althaus et al, 
submitted) were selected. Their characteristics are illustrated in Participant selection and data 
collection 
Study participants were sampled among all clinicians who formed part of the project. In total 24 
HWs (12 of the smartphone and 12 of the tablet arm) were purposely selected (Suri, 2011, 
Adam and Kamuzora, 2008) using the following selection criteria: (1) 4 HWs per HF to represent 
each HF; (2) equal representation of 4 different uptake levels (for each of the four levels a 
  
Kinondoni district 
Temeke district 
Ilala 
Figure 12. Map of Dar es Salaam (including two selected health facilities in each 
district 
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Table 10.  
Participant selection and data collection 
Study participants were sampled among all clinicians who formed part of the project. In total 24 
HWs (12 of the smartphone and 12 of the tablet arm) were purposely selected (Suri, 2011, 
Adam and Kamuzora, 2008) using the following selection criteria: (1) 4 HWs per HF to represent 
each HF; (2) equal representation of 4 different uptake levels (for each of the four levels a 
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Table 10. Characteristics of the health facilities 
Characteristic Buguruni Vingunguti Mbagala Kizuiani Sinza** Tandale 
Maximun No of 
HWs 
13 13 14 13 13 14 
Number of 
smartphones  
4 N/A 5 N/A N/A 3 
Number of 
smartphones  
4 N/A 5 N/A N/A 3 
Number of tablets N/A 2 N/A 3 3 N/A 
Maximum No of 
HWs in the 
morning shift at 
OPD 
4 2-3 4-5 4 5 3 
Daily attendance 
of patients* 
200-250 120-150 400 150-200 500 300-500 
Daily attendance 
of children <5 
years* 
50-60 40-50 70-100 60 160 100-150 
 
Legend:  
OPD=Out Patient Department, N/A=Not Applicable 
*=Numbers were provided by health facility in-charges in 2010 
**= Was upgraded to a hospital in 2013 
median of the total number of patients recorded by the HWs for the first three months of 
implementation  either by smartphones or by tablets was calculated): very low uptake (median 
number of cases: 2), low uptake (median 12), high uptake (median 35) and very high uptake 
(median 81).  
The in-depth interviews were conducted by the first author, using a semi-structured and pilot 
tested interview guide in the local language, Kiswahili. The interviews were then transcribed in 
Kiswahili and translated into English by the first author. They took on average 44 minutes each 
(range 29-69 minutes). Only 1 HW from the smartphone arm refused to be tape-recorded but 
agreed to be interviewed. During this interview, detailed notes were taken. 
82 
 
In addition, at least 2 HWs from each of the 6 health facilities, who did not participate in the in-
depth interviews, were invited to participate in focus group discussions. Three focus group 
discussions (FGD) were conducted, two from smartphone arm and one from tablet arm. Each 
FGD from the smartphone arm had 5 participants while the one from the tablet arm had 6 
participants. Notes from the discussion were recorded by the first author and typed after 
completion of the discussion. All focus group discussions took about an hour.  
Data analysis  
All in-depth interviews were recorded, transcribed, and translated from Swahili to English. 
Detailed notes taken during focus group discussions were translated into English. Data analysis 
was based on content analysis (Mayring, 2000). ATLAS.ti version 6.0 software was used to 
code interview transcripts for identification of common themes. Emerging themes were debated 
by a multidisciplinary team involved in the study. Data from both arms were compared to gain 
insights into similarities as well as differences of barriers and facilitating factors between 
smartphones and tablets related to the uptake of the new algorithm. 
Ethical consideration 
The study was approved by the National Institute for Medical Research (NIMR) Review Board in 
Tanzania (NIMR/HQ/R.8a/Vol.IX/823). Approval was also provided by the institutional review 
boards of the University of Basel (EKBB) and the Ifakara Health Institute (IHI). All study 
participants provided written informed consent.  
Results  
Socio-demographic characteristics of the study participants  
A total of 40 clinicians participated in the study, (24 in the in-depth interviews and 16 in the 
focus group discussions).  For the in-depth interviews 24 clinicians were selected: 12 in the 
smartphone and 12 in the tablet arm. Of the 12 clinicians in the smartphone arm, 7 were 
females, 7 were aged below 40 years (range 24-55 years), 1 had smartphone experience and 1 
had computer experience. Of the 12 clinicians in the tablet arm, 8 were females, 8 were aged 
below 40 years (range 27-58 years), none had smartphone experience while 4 had computer 
experience. For the focus group discussion, of 16 clinicians, 10 in the smartphone and 6 in the 
tablet arm. Of the 10 clinicians in the smartphones, 7 were females, 5 were aged below 40 
years (range 27-53 years), none had smartphone experience while 2 had computer experience. 
Of the 6 clinicians in the tablet arm, 3 were females, 4 were aged below 40 years (range 30-48 
years), none had smartphone experience while 1 had computer experience. 
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Health care worker perceptions related to the application of smartphones and tablets 
This section explores factors influencing the uptake of the two different devices, smartphone 
and tablet. Three themes emerged from in-depth interviews and focus group discussion data 
analysis. Because of similarities in themes between in-depth interviews and focus group 
discussions, results from both groups are presented together. The first theme describes HWs 
perceptions related to the application of the ALMANACH compared to routine practice. The 
second theme focuses around the technical usability of the device by HWs. The third theme 
looks at health system factors that were identified by HWs as key barriers to the long-term 
uptake of the ALMANACH.  
Figure 13 illustrates different presentations of these themes depending on the uptake level of 
respondents. Perceptions presented below were independent of the socio-demographic 
characteristics of the participants. 
Perceptions related to the application of smartphones and tablets 
Feeling comfortable 
Almost all HWs (12 smartphone/11tablet) felt comfortable to use the electronic devices in front 
of the caretakers during consultation.  
 “Of course I feel comfortable, not only because the tablet is a modern equipment, I 
know, I will not forget any symptoms related to disease. But sometimes […] you cannot 
remember everything, but by using ALMANACH you can tell this [child] has high 
respiration rate”. (IDI, male, tablet, very high uptake) 
Rational judgement 
The majority of the study participants (9 smartphone/11 tablet) perceived that their rational 
judgment was not compromised by using the ALMANACH during consultations.  
“…the treatment provided by the tablet is short and clear, but there is also an opportunity 
to add other things […], it helps you to think more about the treatment”. (IDI, female, 
tablet, low uptake) 
Patient’s trust 
Majority of the HWs, (8 smartphone/9 tablet) stated that patient’s trust was not affected by the 
use of electronic devices during consultations.  
“Because as I have told you that from my experience, most of them want to be treated 
by using the ALMANACH, they believe that something that is electronically is much 
better, I think that is the belief of our patients.” (IDI, male, tablet, very high uptake) 
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Simplifying work 
The majority of the respondents (9 smartphone/11 tablet) said that smartphones and tablets 
simplified their work.  
“... for example […]  if the patient is coughing, for each cough we gave antibiotics but 
through the phone you know this is pneumonia or this is normal chest cough so there is 
no need of using antibiotics. But another thing is that, it simplifies work because you are 
instructed to give medicine according to the weight of the child, so you don’t need to do 
the calculation of a dose.” (IDI, male, smartphone, very low uptake) 
Reduction of antibiotic prescription 
Health workers pointed out that the ALMANACH assisted them to reduce antibiotic and 
antimalarial prescription as the device walked them step-by-step through the consultation 
starting from diagnosis to treatment including calculation of proper dosage of required drugs. 
Thus the majority of the study participants (10 smartphone/11 tablet) stated that both devices 
reduced antibiotic prescription compared to routine practice.  
“Yes, before I was prescribing antibiotics as antibiotics, I was just prescribing antibiotics, 
but truly now you don’t believe, now I know many diseases are febrile diseases, they 
don’t need antibiotics”. (IDI, female, smartphone, very high uptake) 
“... if you are using ALMANACH the antibiotic consumption is reduced, if you don’t use 
ALMANACH the consumption of antibiotics is high”. (IDI, female, tablet, very low uptake) 
Correct classifications 
The majority of study participants (9 smartphone/10 tablet) were quoted saying that both 
devices give correct classifications.  
“… so what was making me happy is that I used to get good diagnosis and good 
treatment” (IDI, female, smartphone, high uptake) 
“Because if you are following the phone, it guides you directly, so if you make a good 
follow-up, you will get accurate diagnosis”. (IDI, male, smartphone, low uptake) 
Correct treatment 
More than half of the respondents (8 smartphone/7 tablet) highlighted that the ALMANACH 
enabled correct treatment.  
“There are many advantages; first, the phone is a reference point in the sense that if you 
have forgotten what the patient is suffering from, or treatment or medication, by following 
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the instructions in the phone you will know the diagnosis and medicine to that diagnosis.  
So the phone helps a lot”. (IDI, male, smartphone, very low uptake) 
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Figure 13. Health worker's perceptions stratified per ALMANACH uptake level 
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Usability of devices 
Typing  
In general, technical usability of the smartphone as well as tablet was considered to be easy. 
Few users (2 smartphone and 2 tablet) who all belong to low and very low uptake levels had 
difficulties typing, irrespective of their socio-demographic factors as well as 
computer/smartphone literacy. 
“This [typing] was difficult. This was a challenge for me. I was not familiar with the typing, 
it takes time to type.... I sometimes have to press and press, several times, it is difficult 
to use.” (IDI, female, smartphone, very low uptake). 
Length of ALMANACH 
While the majority of health workers found both devices user-friendly, the vast majority (11 
smartphones/10 tablet) were concerned about the length of the ALMANACH as it led to 
increased consultation duration. Few of the study participants (2 smartphones /4 tablet), apart 
from health system barriers, the high number of questions in the ALMANACH for the low uptake 
of the two devices.  The average time for consultation duration using tablets was 8.7 minutes 
(range 2-38 minutes). The consultation duration for smartphones is not available because the 
smartphones arm involved a video component which was dropped in the subsequent evaluation 
of the tablets. 
“The biggest problem here is that we have few workers and a lot of patients, and if you 
see that you find it hard to ask a patient all those questions”. (IDI, female, smartphone, 
high uptake)  
Health system barriers 
Few health workers and many patients 
Health system factors were identified as key barriers of the electronic ALMANACH uptake. More 
than half of the respondents (8 smartphone/6 tablet) expressed difficulties using the devices in 
an understaffed setting. Vice versa, the presence of many patients was regarded by the majority 
of HWs (8 smartphone/8 tablet) as a factor that prevented primary health care workers to use 
the two devices continuously. Thus the application of the devices was associated with over 
hours due to longer consultation periods. In addition, study participants were concerned about 
patients getting unhappy because of longer waiting times. 
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“I feel free [to use the device] but the problem is the crowd of patients that we are 
supposed to attend, in our health facility we do not have enough staff, the use of phone 
is a barrier. The patients want to be treated and go back home early, so if they stay 
longer in the health facility, it becomes a problem”. (IDI, Male, smartphone, very low 
uptake) 
“... Now it is a challenge to us as I am alone, so sometimes I cannot use phone”. (IDI, 
Female, smartphone, very high uptake) 
 “…if we had enough health workers, some for children and some for adults, then it could 
have helped a lot”. (FGD, female, smartphone) 
Few laboratory staff  
Due to the use of the ALMANACH, more patients were sent to the laboratory compared to 
routine practice. Lack of laboratory personnel resulted in longer waiting hours for patients. In 
addition, clinicians had to wait for the patients whom they sent to the laboratory resulting in over 
hours. Few of the interviewed health workers (3 smartphone/3 tablet) stated that their concern 
about making patients wait negatively affected their uptake of the devices.  
“You find that our laboratory has many patients, so the patient stays in the queue for 
long time, waiting for the results”. (IDI, female, tablet, very low uptake) 
Lack of staff motivation 
Lack of financial incentive was mentioned in almost all interviews. Majority of the participants 
(10 smartphone/10 tablet) expected financial compensation for using the devices at their 
respective health facilities. Participation in interventions or studies is often linked to financial 
benefits, and regarded as extra work that should be paid. They based their expectations on 
various reasons as narrated by a female health worker below: 
“They [the health workers] know there is no financial benefit, and they have conditioned 
themselves that phones waste time, knowing also that they do not get any income out of 
the phone use, that is the only reason when you come with this . . . not only the phone, 
when you come with books [IMCI chart booklets], and one is working with children since 
morning, you find that they don’t even read them, they do not have any interest.  They 
take the phones the same way they deal with books. The only difference is that this is a 
phone and that is a book, which you need to open”. (IDI, female, smartphone, high 
uptake) 
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Increased paper work 
Health workers in Tanzania are required to keep records about cases in the Tanzanian Health 
Management Information System (HMIS) also known in Kiswahili as Mfumo wa Taarifa za 
Huduma za Afya (MTUHA) (DeRenzi et al., 2008). During consultation, health personnel are 
supposed to keep assessment records in patients’ notebooks including date of consultation, 
diagnoses and treatment. However due to lack of training and time the uptake of these registers 
is poor (Nyamtema, 2010). More than half of the health workers (7 smartphones/7 tablets) 
attributed increased paper work as an extra work because besides having to use the electronic 
devices, the registers had to be filled too.  
“…yeah, it adds more work to us, because we have to enter the data in the phone, and 
then write the same data in the file, or patient’s card/notebook.  In that way you do two 
things at the same time”. (IDI, male, smartphone, very low uptake) 
Lack of drugs 
The application of the smartphone and tablet raised expectations among patients related to 
treatment that often could not be fulfilled. Few of the respondents (4 smartphone/2 tablet) 
expressed their frustration about lack of medicines in the health facility. After having walked 
their patients through the ALMANACH, treatment services were often regarded to be 
discouraging. 
“There is nothing which discourages you more as when you are using that tablet, and 
the caretaker has waited for such a long time, at the end you tell her, “go and buy the 
medicine outside or go to the medicine’s window” and there is no medicine, even the 
caretaker becomes discouraged, you have enrolled her in your tablet, and you have 
concentrated, at the end of the day, when she goes to the pharmacy she fails to get [the 
medicine]”. (IDI, female, tablet, very low uptake) 
 “When caretakers see the phones, they also expect that drugs are available”. (FGD 
HW, male, smartphone)  
Discussion  
To our best knowledge, this is the first qualitative study which investigated facilitating factors 
and barriers for routine use of electronic decision supports, namely smartphones and tablets, in 
developing countries.  
Regardless of the type of device, results highlighted that the electronic ALMANACH was 
perceived to have various advantages over routine practice. Interestingly, the opinion on the two 
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different tools, smartphone and tablet, was quite similar. Respondents talked mainly about the 
content of the ALMANACH itself, as well as context, and less on device related factors that 
influenced the uptake. Thus it is argued that the small technical differences between both tools 
did not impact on the uptake. Moxey et al. in a systematic review report that computerized 
clinical decision support systems with minimal threats to professional autonomy have a better 
chance of being accepted by users (Moxey et al., 2010). The ALMANACH offered health 
workers the freedom to select and type additional information (DeRenzi et al., 2008).   
The majority of the health workers both in high and low uptake levels felt comfortable to use 
smartphones and tablets in front of the caretakers for consultations. In addition, they stated that 
their judgement was not restricted and that caretakers’ trust was not affected. In a study using 
PDAs in the context of IMCI conducted in Tanzania, health workers were more skeptical about 
electronic decision support (Mitchell et al., 2012a). The different findings can be explained by 
the study design. The long-term follow up over several months including training and face-to-
face supervision conducted in the present project contributed probably to the positive 
acceptance and evaluation of the devices. It is argued that long-term involvement is necessary 
to allow health workers to feel comfortable using mobile technology.  
The majority of health workers concluded that the ALMANACH simplified their work, reduced 
the use of antibiotics, and assisted them to reach the correct diagnosis and treatment.  Mitchell 
et al. also found that the use of PDAs lead to more accurate classifications compared to routine 
practice (Mitchell et al., 2013).  
Considering this positive assessment, the rather low uptake of the ALMANACH over time is 
surprising and needs to be looked at more carefully. Hereby two reported interlinked barriers 
require further discussion: 1) the reported length of the ALMANACH as well as 2) health system 
barriers. 
Length of ALMANACH 
To address the perceived excessive duration of consultation when using ALMANACH to 
manage patients, we are currently assessing the utility of each diagnostic pathway (branch) in 
the decision tree so that unnecessary questions can be discarded without jeopardizing safety 
and efficacy (Shao AF et al, in preparation).  However, the length of the ALMANACH can only 
be shortened to a certain extent. In 2005, Tanzanian clinicians trained in paper IMCI took on 
average 8.2 minutes per child for a consultation (Adam et al., 2005). In this study clinicians used 
on average 8.7 minutes (2-38 minutes) per child for consultation with tablets. Findings from 
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another study (Mitchell et al., 2012a) conducted in a rural setting in Pwani Region in Tanzania, 
which highlighted that it is faster to use electronic protocols than IMCI chart booklet, could not 
be confirmed. Instead results from urban Dar es Salaam showed that electronic clinical decision 
support systems lead to more laboratory tests done compared to routine practice (Moxey et al., 
2010) resulting in longer consultation duration and more laboratory work. However, it must be 
considered that consultation time varies depending on the setting. In rural areas it is often 
longer than in urban ones. Earlier studies showed that the shorter the consultation duration, the 
higher the risk that children are not properly assessed (Baiden et al., 2011a, Horwood et al., 
2009). This can lead to poor clinical outcomes especially when danger signs are not properly 
identified. Case management and health outcomes cannot be improved if clinicians are not 
prepared to allocate sufficient time for consultations following IMCI guidelines (Horwood et al., 
2009). The willingness to follow medical standards is a pre-requisite for the sustainable 
application not only of electronic tools such as ALMANACH but also decision charts in general, 
whatever the support.  
 
Health system barriers 
Although the majority of the respondents assessed the devices very positively and highlighted 
their strengths, they also reported health system related barriers in almost all interviews. The 
Tanzanian health system is characterized by shortage of health care providers, which affects 
also intervention aimed at improving health care delivery (Bryan et al., 2006, Munga and 
Maestad, 2009, Dominic A and Kurowski C, 2005). Understaffing and high number of patients 
prevented many clinicians from making long-term use of the electronic devices as they were 
concerned that these new tools lead to excessive delays for patients and over hours of health 
workers. This may be the reality in some places, but it may also be due to health workers’ 
perception and beliefs. An assessment of health workers performance during outpatient 
consultations in Dodoma (urban) and Morogoro region (rural) reported that clinicians have 
ample time and are not overworked (Maestad et al., 2010). On the other hand, the same 
researchers mention that there could be a relationship between low performance of clinicians 
and high workload (Maestad et al., 2010). 
Health care workers complained about recording clinical records for patients in both the mobile 
tools and the clinical registry books (MTUHA) required by the Tanzanian HMIS. This was 
perceived as double work. However, this duplication was related to the nature of this pilot 
implementation where routine data collected through the electronic devices directly to the server 
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were not considered suitable for the continuous monitoring of diagnoses and treatment, 
because they could not be linked to the usual HMIS. This concern would ultimately no more be 
relevant, once all clinical data can be collected directly in an integrated electronic monitoring 
system. 
Lack of financial incentive was an additional barrier mentioned by the interviewees. Health 
workers perceived the use of the electronic tools as extra work, and expected therefore extra 
payment. No incentives were given during field implementation because the smartphone or 
tablet were designed and used as an aid to appropriately assess a sick child, and not as a 
research tool to satisfy scientific curiosity. The same procedure was applied when Rapid 
Diagnostic Tests for malaria were pilot-implemented in Dar es Salaam, and the intervention 
went smoothly and was then scaled up in a national strategy (D'Acremont et al., 2011).This is of 
course a risk since previous studies reported poor performance of health personnel when there 
was no monetary or non-monetary incentives (Paul F, 2009, Leshabari et al., 2008, Hor et al., 
2010, Maestad et al., 2010). It is common practice to pay incentives when extra work is asked to 
the clinician and no benefit to either staff or patients is expected. In the present study, the use of 
smartphones and tablets was aimed at improving clinical outcome and reducing unnecessary 
antibiotic prescriptions. As a result, mechanisms for clinicians to get informal payments such as 
by running “private” drug shops (selling medicines within the consultation room) (Maestad and 
Mwisongo, 2011) were not possible. Therefore it is possible that the absence of incentives for 
what could be considered as extra work because of the research environment, and the potential 
reduction of informal payments because of smartphone or tablet use, could have contributed to 
their poor uptake. 
Previous studies reported that interventions which interrupt or slowdown patients’ flow can lead 
to uptake challenges (Fossum et al., 2011, Sedlmayr et al., 2013). This was confirmed by the 
participants who complained about a slowdown caused by the use of the ALMANACH. Patients 
assessed using the electronic devices were more likely to be sent to the laboratory for testing.  
The way respondents presented health system barriers was in most of the cases the same 
regardless of the uptake levels. Belonging to a low uptake level was therefore not linked to a 
negative assessment of the device. The very same health personnel with low uptake level that 
praised the ALMANACH, highlighted the impact of health system barriers and held them 
responsible for the low uptake. In a nutshell, health system barriers countervailed the positive 
evaluation and continued use of the ALMANACH.  
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Sufficient health workforce, good access to medical products and technologies, effective service 
delivery systems are crucial for achieving good quality of care (WHO, 2010b). Results of this 
study highlight that sufficient staff, adequate payment system, enabling working environments 
including supportive supervision, and access to affordable medicine are important factors that 
influenced the uptake of the ALMANACH. However, increasing, staffing, training and 
supervision might not be sufficient (Maestad et al., 2010, Leonard et al., 2005). Additional 
factors such as the individuals’ motivations or how much energy the individual staffs decide to 
invest in improving the quality of health care, are necessary for enhancing the quality of health 
care. These factors are  influenced by other determinants such as individual’s ethical and 
medical standards (Maestad et al., 2010).  
Study limitations 
The study focused on primary health care workers in the largest city of Tanzania, Dar es 
Salaam. While the results might be applicable to other urban settings, they cannot be 
generalized to rural settings that are often characterized by less patients and different health 
care infrastructure.  
The role of the first author which included project implementation as well as data collection 
might have influenced the responses of the study participants. In order to deal with that, all 
study participants were encouraged to be as open as possible prior to the interview. In addition, 
participants were assured that the interviews aimed at assessing the ALMANACH and factors 
affecting its implementation following the low uptake observed. The interviews showed that 
respondents felt at ease sharing their experiences with the first author as they had over the 
years developed trust and mutual respect.  
Although the caretaker’s perspectives were not considered in the study, high proportion of 
health personnel spoke about the positive reactions of caretakers and concluded that their trust 
was not affected.  
It is argued that future studies should not only focus on technical aspects of mobile technology. 
Context related aspects needs to be addressed as well in order to foster a setting that allows for 
sustainable uptake and use of mobile devices. 
Conclusions 
The present study contributed to the increasing body of mobile health literature from the 
perspective of primary care health workers. Findings show that smartphones as well as tablets 
using ALMANACH have the potential to improve the management of childhood illness. The 
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majority of the health workers had no technical problems using the two electronic devices 
(smartphones and tablets) with the ALMANACH. Both were perceived as powerful tools which 
simplify work, give correct classification and reduce unnecessary use of antibiotics. However, 
health system barriers influence the long-term uptake. To ensure sustainable uptake of mHealth 
interventions such as ALMANACH, contextual barriers identified in this study should be 
addressed.  Further studies are needed in order to better understand whether uptake is feasible 
for health workers given health system barriers and additional contextual factors. The  
ALMANACH presented in this paper will  be improved and further tested in similar patients 
population in resource poor settings. Hereby barriers highlighted by health workers will be 
addressed. 
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PART VI: DISCUSSION, CONCLUSION AND RECOMMENDATIONS 
Chapter 9: Discussion 
This chapter builds on the previous discussion of the study main findings regarding the 
ALMANACH design, its safety and content assessment and HWs’s perception on its use on 
mobile devices in supporting them to follow evidence based guidelines. These findings include 
drastic reduction of unnecessary use of antibiotics which resulted from deliberate inclusion of 
broad categories of general danger signs and clinical strategies to differential viral illnesses from 
bacterial illnesses. In addition, training and supervision improved HWs’ compliance, trust and 
positive attitude toward ALMANACH use on mobile devices. It also provides recommendations 
and highlights further research areas potential for sustainable scaling up of similar interventions 
in similar settings.  
9.0 The content and the safety of the new algorithm for the management of childhood 
illness ALMANACH lead to improved quality of care 
The new algorithm for management of childhood illness has the potential to cover broad 
spectrum of childhood illnesses which need pre-referral treatment and urgent referral early 
during assessment of a sick child. This is because more danger signs are assessed early in the 
algorithm as compared to the current version of IMCI. In practice, this would have implied that 
more patients should be referred to the next level compared to the standard practice. However, 
when ALMANACH was applied in controlled conditions, fewer patients were referred to the next 
level of health care. A pilot study comparing ALMANACH on mobile devices and ALMANACH 
on paper version versus standard practice found that HWs could identify more patients with 
serious conditions when using the electronic ALMANACH compared to the paper one. This 
implies that the HWs could follow electronic ALMANACH better than paper one during 
consultations. However, the paper ALMANACH was not better than the standard practice 
(Clotilde Rambaud-Althaus et al, submitted).   
Our findings also suggest that the new algorithm for management of childhood illness 
(ALMANACH) has the potential to reduce antibiotic prescription in the management of acutely ill 
children aged 2 to 59 months attending primary health care facilities. The likely reasons are: (1) 
the unique cut off point of respiratory rate for the diagnosis of clinical pneumonia, (2) the 
separation of febrile and non-febrile patients, the latter receiving none or very minimal 
antibiotics, (3) inclusion of a urine dipstick test for urinary tract infections in all febrile children 
less than 2 years of age or above 2 years but with dysuria and only those with positive urine 
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dipstick should receiving antibiotics. In addition, the two new diagnoses proposed in 
ALMANACH to guide HWs on when to give antibiotics: (1) ‘possible typhoid’ for febrile children 
with abdominal tenderness and (2) ‘likely viral infection’ for acute ill children with negative 
results (no cause of fever identified) (Clotilde Rambaud-Althaus et al, submitted). All these 
strategies were recommended in ALMANACH in order to guide HWs on how and when to 
prescribe antibiotics rationally. In IMCI, no such strategies were proposed to guide HWs on what 
to do in case of negative malaria test.  The lack of such recommendations in IMCI algorithm 
leaves for HWs a room to prescribe antibiotics to febrile children with negative malaria test. In 
summary, witholding antibiotics to acutely ill children when using ALMANACH did no harm. This 
observation suggests that the majority of children attending primary health care facilities have 
illnesses of viral origin rather than bacterial ones. It implies that health workers in these settings 
need to be reminded from time to time through on job trainings that once a specific cause of 
illness is not found, caretakers should be counseled to go home without treatment and return 
the child if symptoms persist.  Such messages are important to combat the problem of antibiotic 
resistance, which is growing over time.  
In our study, we found that cure rates on day 7 was better in the ALMANACH arm as compared 
to the control arm (chapter six).  The rates of complications in ALMANACH were similar in both 
arms. Our study provides initial evidence of good clinical outcomes when using a newly 
designed algorithm for the management childhood illness. This is an important step that has 
never been conducted with the current IMCI algorithm.  We recommend such studies to assess 
new algorithm in controlled conditions to be systematically conducted. Rather than focusing on 
one disease only, it is important to assess these clinical algorithms holistically.   
In order for HWs to reach a proper diagnosis or classification, HWs need to follow a defined 
clinical process for which they need supportive tools that guide them through which symptoms 
to ask for, what signs to check for and what investigations to perform for the most common 
complaints children present at primary health care settings. Without such tools, children will 
continue to receive low quality health care, as it has often been the case with an IMCI poorly 
complied to, or even not followed at all. 
There are many reasons for which HWs have not been able to use paper-based IMCI guidelines 
and these have been summarized in previous studies (Ahmed et al., 2010). One of the potential 
solutions to enable healthworkers to follow evidence-based clinical guidelines is to incorporate 
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these clinical guidelines into an electronic tools (DeRenzi et al., 2008). Below we discuss the 
benefits of using electronic mobile devices to implement evidence based clinical guidelines.  
9.1 The benefits of using electronic mobile devices to implement evidence clinical 
guidelines 
Using ALMANACH on mobile devices results in better care than on paper-based guidelines 
First patients can be assessed and managed more appropriately when using mobile devices 
rather than when using paper-based clinical guidelines because the mobile devices guide HWs 
from step to step in such a way that HWs cannot skip assessment or treatment (DeRenzi et al., 
2008). When HW’s performance was assessed using the same algorithm on paper or 
electronically, we found that HWs could identify more patients with serious conditions when 
using the electronic ALMANACH than with the paper one. This shows that the electronic 
ALMANACH was more powerful than the paper one. Moreover, the paper ALMANACH was not 
better than standard practice (Clotilde Rambaud-Althaus et al, submitted). The reason is that 
paper-based ALMANACH was probably too complex to follow and thus did not add much to 
standard practice (chapter 5). These findings highlight further the potential of electronic mobile 
devices in supporting HWs in primary health care setting in following complex algorithms.  
The use of ALMANACH on mobile devices is associated with fewer stigmas than using paper-
based IMCI chart booklets 
The findings suggest that these tools are acceptable and can be trusted (chapter 8). In addition, 
health workers were confortable to use these tools in front of caretakers unlike the use of chart 
booklets. This implies that the stigma associated with the use of paper-based clinical guidelines 
such as IMCI has been alleviated by the use of electronic mobile devices.  Therefore, 
implementing clinical guidelines with the support of mobile devices might have a higher uptake 
than paper-based clinical guidelines like IMCI. 
The use of ALMANACH on mobile devices is associated with improved compliance and more 
rational use of antimicrobials than paper-based IMCI chart booklets 
Our findings suggest that the use of electronic tools to implement evidence-based clinical 
guidelines does simplify consultation work because it guides HWs through the consultation 
process from history taking (which questions to ask), physical examination (signs to check for), 
guided laboratory work (which tests to do) and incorporates all these to end up with disease 
classification(s), type of medicine to prescribe, dose and schedule to prescribe, and advice to 
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caretaker on when to return to the health facility. Unlike paper-based guidelines like IMCI that 
request flipping back and forth in looking for assessment and treatment recommendations, 
electronic tools with clinical decision support like ALMANACH have simplified all these 
procedures. Previous studies on the use of electronic devices to implement clinical guidelines 
have shown that electronic devices improves compliance to clinical guidelines (DeRenzi et al., 
2008). A pilot study assessing the use of ALMANACH by HWs in pragmatic conditions reported 
improved compliance to electronic ALMANACN than to paper-based ALMANACH (Clotilde 
Rambaud-Althaus, submitted) because paper-based ALMANACH is more complex to follow. In 
practice, these findings suggest that HWs using electronic tools are less likely to prescribe 
antimicrobials compared to those not using these tools because of improved compliance. The 
fight against unnecessary use of antibiotics is thus much easier if HWs are provided with 
electronic tools such as mobile devices with clinical algorithms. 
Updating electronic ALMANACH is easier and less costly than paper-based ALMANACH 
The use of mobile electronic decision supports has the potential to prevent clinicians from using 
outdated paper guidelines. The process of developing a fully electronic version of ALMANACH 
was iterative. Based on the experience we gained during this process, we learned that it was 
easier to incorporate new information and recommendations in the electronic version of the 
ALMANACH and load the application on the mobile phones (smartphones) and tablets than 
updating the paper-based ALMANACH which needed us to print all the paper versions. In 
addition, there were costs associated with distributing all the printed paper versions of the 
ALMANACH to the HWs. The costs related to printing and distributing all the paper-based 
clinical algorithms could be used for other purposes in the health care system like buying 
medicines or improving incentives for health care workers. In this way, the HWs can be retained 
in the health care system for longer duration than it is now. We did not yet collect cost-
effectiveness data comparing the use of ALMANACH on mobile devices to standard practice, 
but intend to do so.  
Training health care workers to use ALMANACH on mobile devices costs few days 
One of the challenges to implement paper-based clinical guidelines such as IMCI is the huge 
costs associated with training of HWs. It requires up to 11 days on site to train HWs on IMCI 
case management. HWs in our study were able to follow ALMANACH on mobile devices after 
two days of training and one day of face to face supervision in their health facilities with real 
patients. These findings suggest that training HWs to use ALMANACH on mobile devices can 
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be reduced from 11 days used for paper-based IMCI case management to three days. In 
practice, these findings suggest that the huge costs associated with paper-based IMCI training 
can be saved for training HWs to use ALMANACH on mobile devices. One of the barriers 
associated with the use of electronic devices such as mobile phones or computers to support 
HWs in providing clinical care is the fear that these tools cost a lot (Jarvis, 2009). However, our 
findings suggest a different hypothesis. Further studies assessing the cost-effectiveness of 
ALMANACH on mobile devices as compared to the standard practice are recommended.  
Using ALMANACH on mobile devices has the potential to improve collection of accurate real 
time data  
Our own field experience shows that when the health facilities are busy and health workers are 
few, HWs give priority in taking care of patients rather than conducting consultations and keep 
records of the respective patients in the health management information system (HMIS) 
registers (known as MTUHA registers). Consultation data are thus filled in these HMIS registers 
at a later time in the day, which often leads to collection of inaccurate data. As these are used 
for projections at the health facility, district and national level, there is risk of poor planning. 
When consultations are conducted using ALMANACH on mobile devices, HWs are collecting 
clinical data directly. However, data resulting from the use of ALMANACH on mobile devices 
need further processing for it to be user-friendly. Also, there is a need of further collaboration 
between software developers and researchers so that this data can be generated, processed 
and returned to the the health facility at least on a monthly basis for timely use. This should be a 
good incentive for HWs to use the tool as they will not be asked to process the data manually as 
it is the case now. The time saved from the data generated from the system could be used for 
other activities by the HWs.  
Using ALMANACH on mobile devices has the potential to improve routine supervision  
The other potential advantage of using ALMANACH on mobile devices is the possibility to 
generate data which can be used directly for routine supervision. The collected data from health 
facility can be easily linked to individual HW’s performance and in that way HW’s performance 
can be monitored by the Council Health Management Team (CHMT) remotely from the data 
sent to the server. Efficiency can thus be improved and costs associated with routine 
supervision can be reduced significantly. This further suggests that conducting a phased scale-
up of the ALMANACH use on mobile devices is a viable option.  
99 
 
9.2 Factors influencing implementation of ALMANACH on mobile devices: 
challenges and solutions 
Several factors could negatively influence the sustainable uptake and compliance to the 
ALMANACH on mobile devices over time. These factors include mobile device related factors, 
the content of the ALMANACH on the mobile related factors and the health system related 
factors as detailed in chapter 8 of this thesis. The brief discussion gives insight on how to design 
innovative strategies in order to improve the sustainable uptake and compliance to ALMANACH 
on mobile divices.  
The ALMANACH content related factors 
Our findings suggest that the increased number of items to check in the ALMANACH might 
have contributed to an increased consultation time and low uptake of ALMANACH on the mobile 
devices. The first thought solution was to review the current ALMANACH and propose some 
branches or pathways to modify or drop in order to improve ALMANACH uptake and 
compliance. This has been detailed in chapter 7 of this thesis and the proposed improved 
ALMANACH will soon be tested in the same population.  
The second potential solution is to design a specific branch or pathway in the ALMANACH 
which can be used by nurses to fill in registration, triage and demographic data and to link this 
data with the improved ALMANACH used for consultation by the HWs. The same strategy can 
be applied for laboratory section where the ordered lab tests are filled in by the lab personnel 
and link this data to the HWs consultation process. This proposed task delegation is 
hypothesized to save time and reduce paper work, and hence operational costs of the health 
facilities. In addition, linking ALMANACH data to the overall HMIS data collected at health 
facilities will reduce paper work, and duplicate work as it was the case during the study.  These 
strategies can also contribute to improve the data for planning at health facility, district and 
national level. 
The health system related factors  
Health system related factors such as lack of health workers, lack of enough motivation among 
health workers, presence of duplicate work (entering HMIS data in MTUHA books and on 
mobile devices) and shortage of medication and supplies have been discussed in chapter 8. 
Potential strategies to respond to shortage of health workers in addition to task delegation 
discussed above could be task shilfting and introducing appointment. In Tanzania, the official 
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prescribers include Medical officers (with at least five years of medical school training plus one 
year of internship), assistant medical officers, clinical officers and assistant clinical officers. 
Nursers of all levels are not official prescribers in Tanzania. However, anecdotal evidence 
shows that in most of the rural health facilities, nurses are the ones who attend patients when 
the official prescribers are not available. This level of HWs could be trained on how to use 
ALMANACH and achieve rational use of antimicrobials in children less than five years. We 
recommend to conduct a pilot study during a phased scale-up to compare health outcomes of 
children managed by nurses with ALMANACH with other official prescriblers in primary health 
care settings.  
Currently patients come to health facilities without appointments (walk-in patients). In most 
cases, we observed that patients’ peak hours are between 0900hrs and 1300hrs, after which 
most of the health facilities have few patients. Introducing appointments in this case could 
distribute these patients to all HWs who will be working according to a specific schedule. Further 
studies to investigate and document how patients are distributed on hourly basis and reasons 
for such distribution will be useful in making informed decision to introduce appointment for 
patients to the primary health care facilities or not. 
Because the use of ALMANACH gives the opportunity to monitor individual HWs’ performance, 
a system could be introduced to reward those who are perfoming better than others. Paying 
incentives through a system of pay per performance could motivate HWs to improve uptake and 
compliance to the ALMANACH. Regarding stockouts of medication and medical supplies, 
systems such as short messages could be put in place to send out information to central 
medical store for refill. Such systems have been shown to decrease the stockout of 
antimalarials (Barrington et al., 2010) and can be expanded to include other items frequently out 
of stock in primary health care facilities.  
The mobile device related factors 
The mobile device related factors which can influence implementation of ALMANACH includes 
things like the costs of the devices, their management to prevent high rates of turnover, and 
data bundle. No device was lost during the implementation of the project because all mobiles 
devices were kept and locked in a safe place at the health facilities either in the in-charge or 
dispensing room. An ALMANACH coordinator was chosen among the HWs using the devices to 
take care of them including charging them. The credits for sending data to the web-based server 
were the responsibility of the study coordinators. These tasks were possible due to the nature of 
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this project but not without challenges. For example, when the health facility coordinator arrived 
late or devices not charged or power cuts frequent, the uptake was compromised. For a larger 
phased implementation, we recommend the devices to be taken care by the individual health 
workers similar to the way they are supposed to take care of IMCI chart booklets soon after the 
training.  Such a strategy could give them more time to practice with the devices and gain 
experience to use them, as currently most of the HWs had no experience to use smartphones or 
tablets. Regarding credits for sending data, this can be managed centrally through the use of 
selected mobile company network. Additional challenge relataed to the internet bundle for 
sending data by the HWs could also be taken care of by the software and system administrators 
proposed earlier.  
In terms of costs, the price of electronic devices will go down so a phased scale-up of 
ALMANACH should not be too much of an issue. Because the devices will be taken care of by 
the HWs, they will feel ownership for the tools and the likelihood of loss is expected to be 
minimal. However, this hypothesis will require further confirmation during phased scale-up.  
How and where to store the data and which types of devices to use can be discussed with the 
information technology personnel taking in to consideration the existing market prices at the 
time of phased scale-up of ALMANACH on mobile devices. 
9.3 Study limitations 
Unlike IMCI chart booklet which covers the management of all children less than five years of 
age, the current ALMANACH covers management of children aged 2 months to 5 years. The 
current ALMANACH needs further modification to include patient’s follow-up data and full 
security of patients’ data. Furher studies are recommended to find out how to design and 
incorporate algorithm to covers children less than 2 months of age. Such a development will 
enable all children less than 5 years of age to be addressed in one ALMANACH.  
Study coordinators were responsible to update all mobile devices in the six health facilities 
involved in the project. This task was possible because all health facilities were reachable and 
were located in urban setting. There is a need to design a feature which will enable HWs to 
update on their own the devices to incorporate the new recommendations once they are out.  
The current ALMANACH is compatible with mobile devices with android operating system. For 
sustainability of the intervention, there is a need to design an ALMANACH which will be 
compatible with different operating systems on mobile devices. Having software running on 
different platforms might contribute to a huge reduction of cost.  
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9.4 Conclusion 
The drastic reduction of unnecessary use of antimicrobials (antibiotics and antimalarias) and 
improved clinical outcomes in the era of declining malaria as a result of HWs using the new 
(ALMANACH) suggests that it is time to make effective use of available technologies such as 
mobile devices (smartphones and tablets) and rapid diagnostic tests to improve the quality of 
health care for children in developing countries. While guiding HWs to deliver high quality care, 
the effective use of these tools have the potential to prevent HWs using out of date clinical 
algorithms (because it is easy to incorporate any new recommendations on real time basis) and 
improve the quality of clinical data collected at point of care, which is needed at health facility, 
district and the national level for accurate planning for the effective health care system.   
9.5 Recommendations 
Irrational use of antimicrobials (antibiotics and antimalarials) is a global challenge requiring 
effective use of available technologies and different partners to join effort in fighting against it. 
Both local and international collaborations are highly needed to address the irrational use of 
antimicrobials which is one of the major causes of emerging drug resistance we see spreading 
all over the world. While addressing that challenge, the world at larger will not only improves the 
quality of health care provided to children but also other population groups (adults and elderly). 
We therefore recommend practical applications and further research for responding to this 
challenge as outlined below: 
Practical application areas 
1. It is time to develop policy which will encourage paper-based clinical guidelines to be 
incorporated in to electronic formats for easy updating and distribution to HWs at various levels 
of health care. 
2. We recommend that efficacy of clinical algorithm for managing different illnesses to be 
assessed holistically instead of assessing individual disease entities because assessment of 
individual disease entities might give false impression of efficacy and safety of the entire 
algorithm.   
3. Development of clinical guidelines should be an iterative process that involves all 
stakeholders (for example health care providers who will use them) 
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Further research 
1. We recommend a phased scale-up evaluation of the improved ALMANACH following the 
proposed modifications to the current ALMANACH to find out how safe are the new 
recommendations, how much consultation time is saved, its uptake over time and cost-
effectiveness when compared to routine practice.   
2. Find out how the improved ALMANACH can be integrated in to HMIS in order to collect 
accurate and timely data for planning and policy change at all levels of health care. 
3. Find out how the improved ALMANACH can be used to improve routine supervision 
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